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1. GENERAL INTRODUCTION 
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1.1 The importance of heterocyclic compounds 
Literature survey revealed that the history of heterocyclic chemistry began in the 1800's, 
consequentially to the first noteworthy developments like the works of Brugnatelli, Dobereiner, 
Runge… After World War II, there was an enormous increase of the research in the field of 
heterocycles. About one half of over six million compounds recorded in Chemical Abstracts 
are heterocyclic. Heterocyclic chemistry is one of the most complex and intriguing branch of 
organic chemistry and heterocyclic compounds constitute the largest and most varied family of 
organic compounds.1 
Heterocyclic compounds are the cyclic organic compounds which contain at least one hetero 
atom; the most common heteroatoms the nitrogen, oxygen and sulphur but heterocyclic rings 
containing other hetero atoms are also widely known. Heterocyclic compounds are considered 
one of the vital classes of organic compounds, which are used in many biological fields, due 
their activity in multiple illnesses. Heterocyclic compounds played an important role in 
biological processes and are wide spread as natural products. They are widely found in nature 
particularly in nucleic acids, plant alkaloids, anthocyanins and flavones as well as in 
chlorophyll. Additionally some vitamins, proteins, hormones contain aromatic heterocyclic 
system (Figure 1). 
Heterocyclic compounds have a wide range of application: they are predominant among the 
type of compounds used as pharmaceuticals, as agrochemicals and as veterinary products. 
Heterocycles are the key to biological activity in many small molecule drugs due to their ability 
to hydrogen bond, alter polarity and modulate lipophilicity at specific sites in the pathogen or 
host with the overall effect of inhibiting the biological processes that lead to programmed 
progression of diseases. These subunits thus have the ability to improve pharmacological, 
pharmacokinetic, toxicological and physicochemical properties of compounds, making them 
more effective in alleviating a variety of afflictions. In fact more than 90% of new drugs contain 
heterocycles and the interface between chemistry and biology, at which so much new scientific 
insights, discoveries and applications are taking place, is crossed by heterocyclic compound 
(Figure 2).2 
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Figure 1: Natural compounds contain heterocycles: a-Thymine b-Adenine c-Guanine d-Cytosine           
e-Berberine f-Caffeine g-Tryptophan h-Thiamine i-Vitamin C 
Figure 2:  Synthetic compounds contain heterocycles: j-Amoxicillin k-Sildenafil l-Alprazolam 
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1.2 1,2-Diaza-1,3-dienes as useful building blocks 
1,2-Diaza-1,3-dienes (DDs) are characterized by a carbon-carbon, nitrogen-nitrogen conjugate 
double bond system. Those compounds are extremely versatile: in fact, for over thirty years, 
they were used as building blocks for the synthesis of several five-, six- and seven-membered 
heteroring systems. The chemical properties of DD are strictly related to the electron-
withdrawing effect of the azo group in the heterodiene system, as showed from the resonance 
structures in Scheme 1 that make these compounds good Michael acceptors. 
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Scheme 1:  Resonance structures of DDs 
 
DDs feature an umpolung of the classical carbonyl reactivity, since these neutral compounds 
enable nucleophilic additions at the terminal carbon atom of the azoene system (Scheme 2). 
This atom is originally located in the α-position to the ketone function from which DDs are 
prepared. It is well known that such a carbon atom is a nucleophilic rather than an electrophilic 
site. Therefore, the reactivity of DD proceeds contrary to the natural polarity of the parent 
carbonyl derivatives and their employment represents a valid approach to reverse the normal 
polarity of carbon atom in the α-position to the carbonyl group. 
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Scheme 2:  DDs as umpolung of the classic carbonyl reactivity  
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DDs are usually prepared by means of 1,4-elimination of a good leaving group X (frequently 
chloride or bromide) in the α-position with respect to an hydrazone function. The leaving group 
can be present in the starting carbonyl derivatives (Scheme 3, Path A) or introduced later in the 
hydrazone compounds (Scheme 3’, Path B). Both cyclic and acyclic ketones can be used in the 
preparation of DDs. 
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Scheme 3:   Synthetic pathways to prepare DDs 
 
Substituents influence the physical and chemical properties of DD. Electron-withdrawing 
groups (e.g. esters or amides) on the terminal carbon and/or nitrogen atom favor their stability 
and enhance the electrophilic character of the heterodiene system (Figure 3).3 In addition the 
yellow, orange, red or amaranth color of DDs, due to their conjugation, is a convenient and 
useful “internal litmus” to check the progress of the reaction. In fact, the transformation of these 
compounds is accompanied with the change of the initial color of the reaction mixture to the 
final colorless or pale-yellow state. 
  
path A 
path B 
4 5 6 7 
4 8 6 7 
- 9 - 
 
N
N
O
EtO
O
NHPh
N
N
O
Me2N
O
OMe
N
N
O
EtO
O
NH2
N
N
O
Me2N
O
NHPh
Me2N
N
N
O
O O
Me2N O
O2N
CO2Et
CO2Et
S
O2N
NO2
Ph
Ph
O
MeO
CN
CN
Me2N
O
O
O
F
MeO
O
O
O
O
-13.28
-13.90
-14.91
-15.38
-12.76
E
-16.36
-17.67
-10.80
-10
-14
-13
-11
-12
-17
-16
-15
-12.33
-18
-11.87
-13.56
-15.03
-10.28
 
 
 
Figure 3:  Reactivity scale: influence of substituents on the electrophilicity of DDs 
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1.2.1 1,2-Diaza-1,3-dienes as acceptors in 1,4-conjugate additions  
Nucleophilic conjugate addition is one of the most famous organic reactions to form C-C bond. 
Ordinary nucleophilic additions or 1,2-nucleophilic additions deal mostly with additions to 
carbonyl compounds. With the introduction of an α,β-unsaturation to a C=O, we can have a 
different regioselectivity. The β position is an electrophilic site as shown on Scheme 4 which 
can react with a nucleophile generating a new bond. 
These reactions are usually called nucleophilic conjugate additions or simply 1,4 nucleophilic 
additions. 
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Scheme 4:  Resonance structure of conjugate olefin 
 
The most famous nucleophilic conjugate addition is the Michael reaction,4 where the 
nucleophile is an activated methylene able to react with a conjugate olefin. Also the terminal 
carbon atom of the azo-ene system of DDs, can undergo a nucleophilic attack by a variety of 
carbon and hetero nucleophiles such as oxygen, nitrogen, sulfur, selenium and phosphorus (Nu1, 
Scheme 5), making this substrate a good Michael acceptor. These 1,4-additions produce highly 
functionalized hydrazones (Scheme 5). In this key step, together with the attacking 
nucleophiles, we can introduce various other nucleophiles (Nu2, Scheme 5) or electrophile (E, 
Scheme 5) functions. 
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Scheme 5: DDs as Michael acceptors 
 
We studied this versatile compound 12, because is a potential starting material for further 
interesting structural modifications through controlled regioselective reactions leading to 
complex heterocyclic systems. In fact, different intramolecular ring closures are possible 
(Scheme 6). 
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Figure 4: Exploitable reaction sites in the highly functionalized hydrazones 
 
As we can observe in Figure 4, the most important reactive sites of these compounds are 
focused in: 
- The hydrazone: the sp2 hydrazonic nitrogen could act like nucleophile: the loss of the 
hydrogen in -position to the hydrazone moiety promotes its nucleophilic behavior. 
- The C atom in position 4: the loss of acidic hydrogen in -position, not always 
promotes the activation of hydrazonic N atom, but sometimes can react like a 
nucleophile. 
- The sp3 hydrazine nitrogen: also this N could act like nucleophile thanks to its 
electronegativity. 
- The hydrazone C=N bond: this function can be involved as electrophile for a further 
addition. 
If during the first Michael addition, we have introduced other functionalities, we can exploit 
different intramolecular reactions and combinations to form several cyclization products. 
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1.2.2 1,2-Diaza-1,3-dienes as dienes in IEDDA 
On the other hand, cycloaddition reactions, probably, is the most widely used methodology in 
organic synthesis; these synthetic methodologies make possible to widely plan ab initio the 
substituents of the rings by means of the preliminary preparation of simple and more accessible 
starting materials. In general, these reactions do not require anhydrous solvents or inert 
atmospheres, occur under mild conditions and need simple work-up procedures. 
Electron-donating substituents in the diene influence the rate of cycloaddition. Electron-
donating substituted dienes accelerate the reaction with electron-withdrawing substituted 
dienes: this is the normal electron-demand Diels-Alder reaction. On the other hand, electron 
withdrawing groups in the diene accelerate the cycloaddition with dienophiles having electron-
donating groups (Figure 5).5 
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Figure 5  (a)- neutral; (b)- inverse electron demand; (c)- normal electron demand 
 
The cycloadducts are usually obtained with a high degree of regio- and stereo-selectivity, as 
expected by the molecular frontier orbital interactions in which the dienophile is the part of 
donors (HOMO) and the diene is the acceptor (LUMO). 
 
 
. 
Figure 6  According to frontier orbital theory, normal Diels–Alder additions (a) show a reduced 
HOMOdiene–LUMOdienophile separation (compared to the HOMOdienophile–LUMOdiene 
separation) which dominates the reactivity and finally, inverse electron demand (b) Diels–Alder 
reactions are governed by the HOMOdienophile–LUMOdiene gap.6 
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The presence of two nitrogen atoms, combined with one or, more often, with two electron-
withdrawing substituents, makes DDs very good starting materials in the “inverse-
electrondemand” Diels–Alder reactions. Consequently, the main regioisomer obtained results 
from the terminal atom interaction of the electron rich dienophile (greater coefficient HOMO) 
with the terminal carbon atom of DDs (greater coefficient LUMO). 
The reaction with carbon dienophiles7 produces 2,3,4,5-tetrahydropyridazines 14 (Scheme 6) 
and follows the scheme of the donor-acceptor, in which the electron-rich alkenes 13 is the 
partner of the electron-deficient DDs 1. 
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Scheme 6: Inverse electron demand Dies Alder (IEDDA) of DDs and electron rich olefin 
 
 
An example of this mechanism is reported in the work of Favi et al.8 The synthesis of substituted 
tetrahydropyridazines shows the regioselectivity of IEDDA reaction (Scheme 7). 
 
 
 
Scheme 7: Significative example of IEDDA reaction 
 
 
In this work DDs are not directly used, but they were generated in situ from -hydrazones in 
basic conditions. 
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1.3 Results 
Using DDs as building blocks, we have obtained a great number of useful heterocycles. Thanks 
to their reactivity, previously showed in paragraphs 1.2.1 and 1.2.2, those versatile compounds 
are involved in several annulations (Figure 7). 
 
 
 
Figure 7  DDs as building blocks 
 
In this paragraph, we are going to have a focus to the most important reactions involved DDs 
with 1, 2, 3 or 4 atoms included in the final heterocyclic products. The next info graphic 
schedule reports some papers published in the past years.  
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Info graphic 1:  Representative examples of our group works 
- 16 - 
 
 Info graphic 2:  Representative examples of our group works 
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 Info graphic 3:  Representative examples of our group works  
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2.  FACILE ODOURLESS QUANTITATIVE SYNTHESIS 
OF 3-HYDROXY-3,4-DIHYDRO-2H-1,4-THIAZINES  
 
 
 
 
 
 
CHAPTER 2 
 
 
 
 
 
 
 
 
 
 
G. Mari, G. Favi, L. De Crescentini, S. Santeusanio, O. A. Attanasi, F. Mantellini 
Asian J. Org. Chem., 2016, 5, 705709 
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2.1 Introduction  
One of the main objectives of the modern organic chemistry is the easy transformation of 
readily available precursors into target-relevant products in a rapid, economical, efficient and 
eco-friendly manner. In particular, in the last time, the environmental protection and waste 
prevention have increased interest and relevance in an overcrowded world where demand 
becomes more pressing. The efficiency in atom economy combined with quantitative reaction 
can play a key role in the environmental field. In fact, waste-free synthesis (total atom economy) 
yielding single product in pure form that does not require solvent-consuming purification steps, 
avoiding further procedures such as chromatography, extraction or recrystallization 
corresponds to a fundamental benefit both from the environmental and the economical point of 
view.9 
The 1,4-thiazine core (thiomorpholine) represents a recurrent structure in organic chemistry 
because it is present in some numerous compounds that found application both in 
medicinal/pharmaceutical chemistry, as well as in chemical manufacturing. 
In fact, the biological properties shown by these aza-sulphur heterocycles range from 
antibacterial10 or antimicrobial11 to anti-inflammatories characteristic,12 from hepatoprotective 
features13 to calcium antagonistic,14 from vasopressin receptor antagonistic15 to anticancer 
activities,16 from antioxidant to hypolipidemic agents.17 
Besides, the 1,4-thiazine derivatives are commonly used as stabilizer or inhibitor, 18 and it is 
well known how this heterocyclic nucleus plays an important role in numerous pigments19 and 
dyestuffs.20 
The thiomorpholine core contributes to constitute also the skeleton of different natural products 
(Figure 8): for example, it is present in the structure of Adaciaquinones B,21 a compound 
extracted from marine sponge Petrosia alfiani that showed antitumor activities, or in a 
metabolite produced by endophytic fungus Paraphaeosphaeria neglecta FT462 isolated from 
the Hawaiian plant Lycopodiella cernua,22 or in cytotoxic terpene derived Conicaquinones A 
or B isolated from Mediterranean ascidian Aplidium conicum.23 
By virtue of these numerous applications, different methods have been developed for the 
preparation of thiomorpholine cores.11,24 Usually, these approaches require harsh conditions, 
elaborated work up procedures and the thiols employed as starting materials are flammable, 
harmful, and strong smelly reagents, which can lead to serious environmental and safety 
problems. The most common synthetic route that involves 1,2-dihaloderivatives as starting 
materials furnishes low yields due to side-reactions such as elimination, requiring different 
purification procedure.25 
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Figure 8:  Representative examples of natural products containing a 1,4-thiazine core. 
 
Aware of this interest, in the last years, we have proposed a synthetic route to obtain dihydro- 
or benzo-1,4-thiazine derivatives employing 1,2-diaza-1,3-dienes and 1,2-mercaptoamines as 
starting materials. In this case, the desired heterocycles were obtained in good yields through a 
formal [4+2] cyclization, in which the DDs contribute with 2 carbon atoms.26 
Also, the synthesis of containing 1,4-thiazine core bis-heterocycles such as 2-
oxo[1,2,4]triazolo[5,1-c][1,4]thiazines was developed by our group using DDs and 
mercaptoketones in acidic medium.27 Some limits affect this methodology: the overall yields 
were moderate, the 1,4-thiazine intermediates cannot be isolated, and, employing phosphonyl-
substituted-DDs, the target heterocycles were not obtained.  
Furthermore, despite of the variety of synthetic methodologies which are available for the 
construction of thiazine ring, dihydrothiazines bearing a quaternary carbon center such as 
emiheminal have been difficult to obtain. Until now, only one example of 3-hydroxy-dihydro-
1,4-benzothiazine has been reported.28 
For these reasons, we decided to find out new reagents able to react with DDs29 to overcome 
these issues. The air stable, and odorless 1,4-dithiane-2,5-diol that has shown to be an useful 
synthon for the preparation of various sulphur containing heterocycles such as 
tetrahydrothiophenes,30 1,3-oxathiolanes,31 thiazoles,32 tetrahydrothiopyranols33 should be a 
valid candidate.  
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2.2 Results and Discussion 
Initially, we set out to identify the possible mild conditions under which the reaction of DDs 
with dithiane-2,5-diol 19 would proceed choosing DD 1a as representative compound. 
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Scheme 8: Used reagent for the optimization of the synthesis of 3-hydroxy-3,4-dihydro-2H-1,4-thiazine 
 
Entry Base Equivalent of base Solvent Vol. solvent (mL) Time (h) Yield (%) of 21a[b] 
1 DIPEA 0.1 CH2Cl2 10.0 0.15 37 
2 TEA 0.1 CH2Cl2 10.0 0.15 68 
3 DABCO 0.1 CH2Cl2 10.0 0.15 66 
4 K2CO3 0.1 CH2Cl2 10.0 0.15 21 
5 TEA 0.2 CH2Cl2 10.0 0.15 75 
6 TEA 0.3 CH2Cl2 10.0 0.15 73 
7 TEA 0.2 MeCN 10.0 0.15 51 
8 TEA 0.2 EtOAc 10.0 0.15 49 
9 TEA 0.2 EtOH 10.0 0.15 36 
10 TEA 0.2 THF 10.0 0.15 81 
11 TEA 0.2 Et2O 10.0 2.15 93 
12 TEA 0.2 Et2O 25.0 3.50 86 
13 TEA 0.2 Et2O 5.0 1.50 95 
14 TEA 0.2 Et2O 2.0 1.15 Quant. 
15 TEA 0.2 SFC 0 5.00 31[c] 
16 TEA 0.2 SFC 0 5.00 34[d] 
17 Resin[e] 0.2 Et2O 2.0 1.00 38 
18 Resin[e] 1.0 Et2O 2.0 1,00 42 
19 DMEA 0.2 Et2O 2.0 1.50 Quant. 
 
Table 1:  Optimization of reaction conditions for the synthesis of 3-hydroxy-3,4-dihydro-2H-1,4-thiazine. 
All the reactions were carried out under the following conditions: 1,4-dithiane-2,5-diol 19 (0.5 
mmol), DD 1a (1.0 mmol), room temperature. [b] The yields were determined by 1H NMR 
spectroscopy of the crude (4-nitrotoluene as internal standard).34 [c] DD 1a was employed as 
solvent-reagent in the molar ratio of 1:0.5 referred to 1. [d] DD 1a was employed as solvent-
reagent in the molar ratio of 3:0.5 referred to 19. [e] Merck Millipore 104767 Ion exchanger 
III. 
 
Our investigation began evaluating different bases, necessary to generate in situ the 2-
mercaptoethanal 19’ (Scheme 8, Table 1, entries 1-5). The desired 3-hydroxy-3,4-dihydro-2H-
1,4-thiazine 21a was obtained with higher yields using 1,4-diazabicyclo[2.2.2]octane 
(DABCO) and triethylamine (TEA) in dichloromethane (entries 2,3, Table 1). Between these 
two bases, the cheapest TEA has been chosen. We have observed that product 21a during the 
chromatographic procedure spontaneously gave decomposition reactions. For this reason, the 
yield of the thiazine 21a was determined directly on the crude mixture by 1H-NMR analisys.34 
By increasing the amount of TEA to 0.2 eq, the yield of the product 21a was enhanced to 75% 
(entry 5, Table 1). No further improvement in the yield was observed when TEA was 
19 1a 21a 
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incremented to 0.3 eq. (entry 6, Table 1). Then we proceeded testing different solvents such as 
acetonitrile, ethyl acetate, ethanol, tetrahydrofuran and diethyl ether (entries 7-11, Table 1). 
The best outcome was in diethyl ether (entry 11, Table 1). An increment of the solvent amount 
generates lower yields with longer reaction time (entry 12, Table 1), while more concentrated 
solutions provide better yields and faster reactions (entries 13, 14, Table 1). Encouraged by 
these findings, we have carried out the reaction in solvent free conditions (SFC), in which DD 
1a acts as solvent-reagent (mp of 1a < 15 °C). The desired thiomorpholine derivative 19a was 
formed only in poor yields, employing either 1 or 3 equiv. of 1a (entries 15, 16, Table 1).  
These latter results probably are due to the low solubility of 1,4-dithiane-2,5-diol 19 in these 
conditions. With our delight, we have found that, at room temperature, in 2 mL of diethyl ether 
and in the presence of 0.2 equiv. of TEA, the reaction between 1,4-dithiane-2,5-diol 19 (0.5 
mmol) and DD 1a (1.0 mmol) furnished quantitatively the desired 3-hydroxy-3,4-dihydro-2H-
1,4-thiazine 21a (entry 14, Table 1). Taking advance of this fact, to facilitate the separation of 
the desired thiomorpholine 21a from the promoter, we have tested other bases easily removable 
from the crude such as a basic resin, readily turned away by filtration, or N,N-
dimethylethylamine (DMEA) (bp 36-38 °C) easily and fully evaporable under vacuum. While 
the use of the resin both in a catalytic (0.2 equiv.) or in stoichiometric amount provided the 
desired 21a only in moderate yields (entries 17, 18, Table 1), the employ of the DMEA 
produced 21a in quantitative manner without formation of any by-product (entry 19, Table 1). 
It is remarkable that in this latter case, to obtain the crude and pure desired product 21a, solely 
the evaporation of the solvent and DMEA was necessary. Avoiding the chromatographic 
separation, the degradation processes previously observed during the development of the 
procedure did not take place. In fact, the direct 1H- and 13C-NMR analyses of the crude showed 
exclusively the signals related to the proposed structure of compound 21a confirming that the 
yields are quantitative. 
The gradual disappearance of the red colour imparted to DDs by their internal conjugation 
permits the visual check of the reaction progress. Therefore, this occurrence contributes to make 
this methodology very facile, eventually requiring only the evaporation step at the end of the 
reaction shown by a colour change of the solution. Identified the optimal conditions, reactions 
of 1,4-dithiane-2,5-diol 19 with a range of different DDs 1ak were evaluated (Table 2). In all 
cases, products 21ak were quantitatively obtained simply by under vacuum evaporation at 
room temperature of the solvent and DMEA without any other purification step. Notably, the 
synthesis of 3b was scaled up to the gram-scale without any noticeable drawback (Table 2).  
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Table 2: The yields were determined by 1H NMR spectroscopy of the crude pure products.34 
 Reaction was carried out on gram scale with 1.0 g of 1b 
 
Employing 4-phosphonyl-DD 1k, the corresponding phosphorylated 1,4 thiazine 21k was 
achieved. It is noteworthy that the introduction of organophosphorus moieties in simple 
synthons may provide valid substrates for the preparation of biologically active compounds. 
  
21a quantitative yeld 21b quantitative yeld 
 
21c quantitative yeld 
 
21d quantitative yeld 
 
21e quantitative yeld 
 
21f quantitative yeld 
 
21g quantitative yeld 
 
21h quantitative yeld 
 
21i quantitative yeld 
 
21j quantitative yeld 
 
21k quantitative yeld 
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The plausible mechanism contemplates the in situ generation of 2-mercaptoethanal 19’ that is 
readily captured from the terminal carbon atom of the azo-ene system of DDs 1. This initial 
sulpha-Michael addition leads to the formation of the odourless -sulpha-functionalized 
hydrazone intermediates 20. Intramolecular nitrogen nucleophilic attack on carbonyl group 
furnishes the final 21ak through a formal [3+3] cycloaddition. In this way, the reaction comes 
to completion without any formation of unpleasant stench. 
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Scheme 9:  Plausible mechanism for the synthesis of 3-hydroxy-3,4-dihydro-2H-1,4-thiazines 21ak. 
 
2.3 Conclusions 
In conclusion, here we report a new simple and convenient methodology for easy access to a 
series of 3-hydroxy-3,4-dihydro-2H-1,4-thiazines. This procedure proceeds rapidly to 
completion, produces only the desired compounds without formation of by-products, and offers 
the final pure products without any chromatography process. The in situ generation of 2-
mercaptoethanal using odourless, and inoffensive dithiane-2,5-diol 19 is an appropriate solution 
to serious environmental and safety problems due to the utilization of volatile and unpleasant 
smelling thiols.Then, quantitative yields, absence of tedious separation procedures, total atom 
efficiency, mild reaction conditions, readily available and inexpensive starting materials, 
operational simplicity, clean reaction profiles as well as energy efficiency, are the key 
advantages of the present method. 
  
19 19’ 1 
20 21 
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3.  UNEXPECTED SYNTHESIS OF 2,3,5,6-TETRAHYDRO-
1H-PYRROLO[3,4-C]PYRIDINE-1,3,6-TRIONES 
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3.1 Introduction 
One of the most intriguing targets of organic chemists is the possibility to obtain complex 
transformations in a single-step reaction, starting from a set of various reagents to give directly 
the final product. 
This kind of transformations in which several bonds are formed in one sequence in the same 
reaction conditions without isolating the intermediates and without adding additional reagents 
or catalysts are commonly called domino or cascade reactions.35,36 
It appears clear that the advantages of this synthetic methodology can be of economical, 
ecological and operative interest, as it increases the synthetic efficiency and in parallel 
decreases the amount of solvents, reagents, catalysts used and the number of laboratory 
operations required.35,36 
The utility and versatility of 1,2-diaza-1,3-dienes in the construction of a variety of heterocyclic 
rings are well known and are demonstrated by significant activity in this field over recent 
years.3,29,37 In particular, they can react not only as Michael acceptors in conjugated additions 
but they can also be employed in cycloaddition reactions with a wide range of partners.3,29,37,39 
In most cases reported in the literature for the Michael addition, DD participates with one unit 
in the construction of the final heterocycle, while there are only few examples in which it takes 
part with two units. In particular, in the spiroheterocycle-pyridines previously synthesized by 
our group starting from DDs and some oxindole or barbiturate derivatives, the two molecules 
of DDs contribute to the final pyridine core with 3 and 2 atoms (Structure A, Figure 3).29b,29d 
Another example is represented by pyridazines derived from the cyclodimerization of two 
molecules of DDs that results in formal [4+2] cycloaddition (Structure B, Figure 3).39 
Recently, Shelke and Suryavanshi have reported the synthesis of tetrazocine derived from [4+4] 
cycloaddition (Structure C, Figure 3).39a 
In the present work, for the first time, two units of DDs participate in the construction of a 
system containing two fused heterocycles of the formed pyrrolo-pyridines with 4 and 2 atoms 
(Structure D, Figure 3). In particular, one unit of the DDs contributes in both the pyridine and 
pyrrole nuclei of the final molecule. Our initial intent was to obtain 4-oxo-2-thioxo-1-thia-3,8-
diazaspiro[4.5]deca-6,9-diene-6,10-dicarboxylates A (Scheme 10, Route B), since rhodanines 
represent a privileged scaffold in drug discovery, and they are known to exhibit a wide spectrum 
of pharmacological properties.40 
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Figure 3: Participation of two DDs units in heterocyclic assembly.  
 
 
Previously, some of us investigated the reaction between DDs 1 and N-unsubstituted rhodanines 
22’ (Figure 1, Route A).41 In this case, the sulphur of the rhodanines acted as nucleophile. To 
avoid this eventuality, we have planned to explore the reaction between two equivalents of DDs 
1 and some N-substituted rhodanine derivatives 22 in which carbon at position 5 should act as 
nucleophile. 
After the formation of bis-adducts by means of a double Michael addition of the rhodanine 22 
to two molecules of the DD 1, the intramolecular ring closure could have furnished the desired 
spiro derivatives A in analogy to what previously observed 29b,29d (Scheme 10, Route B). 
But things went different and the reactions have surprisingly furnished interesting 2,3,5,6-
tetrahydro-1H-pyrrolo[3,4-c]pyridine-1,3,6-triones 26 (Scheme 10, Route C). These bicyclic 
compounds represent a new family of HIV-1 integrase inhibitors that showed low micromolar 
inhibitory potency in vitro HIV-1 integrase assays, with good selectivity for strand transfer 
reactions as compared with 3’-processing inhibition.42 They have reported in literature to be 
prepared by ‘Plummer cyclization-deprotonation-cycloaddition’ cascade reactions of 
imidosulfoxides.42 
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Scheme 10: Our intent to synthesize 4-oxo-2-thioxo-1-thia-3,8-diazaspiro[4.5]deca-6,9-diene-6,10-
dicarboxylates A: the supposed (Route B), the obtained (Route C). 
 
3.2 Results and Discussion 
Several methods are reported in the literature for the synthesis of rhodanines.43 To start our 
investigations, we have prepared 3-ethyl, 3-phenyl-, 3-(4-chlorophenyl)- and 3-(4-methoxy)-2-
thioxothiazolidin-4-ones 22ad according to the procedure reported by Ravi et al.43a  
So, we began our studies by carrying out a preliminary reaction between two equivalents of DD 
1d and 3-phenyl rhodanine 22b, chosen as examples, in basic conditions, using two equivalents 
of K2CO3. As expected, bis-hydrazone-functionalized rhodanine 24d was formed in 93% yield, 
resulting from a double Michael-type addition of the rhodanine 22b to two equivalents of DD 
1d (Table 3).  
22’ 
22 
1 
26 
1 
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Scheme 11: Used reagents for the optimization of the synthesis of 2,3,5,6-tetrahydro-1H-pyrrolo[3,4-
c]pyridine-1,3,6-trione  
 
 
entry Solvent 
Temp. 
(°C) 
Catalyst 
(C) 
Molar ratio 
24d/C 
26e 
yield (%)[b] 
1 DCM r.t. TFA 1/0.1 Complicated mixture 
2 THF r.t. NaH 1/0.1 14 
3 THF[c] r.t. NaH 1/1.5 14 
4 THF r.t. NaH 1/2 16 
5 THF r.t. NaH 1/3 13 
6 THF r.t. NaH, then Amberlyst 15H 1/2/2 25 
7 THF Reflux NaH, then Amberlyst 15H 1/0.75/0.75 15 
8 EtOH r.t. NaH 1/1 Complicated mixture 
9 CH3CN r.t. NaH 1/1 Complicated mixture 
10 THF r.t. NaOMe 1/0.1 8 
11 THF r.t. NaOMe 1/1.5 32 
12c THF r.t. NaOMe 1/5 21 
13 DCM r.t. CuCl2 1/0.1 No reaction 
14 DCM r.t. ZnCl2 1/0.1 No reaction 
15 THF 55 °C NaH 1/1 21 
16 THF 55 °C NaOMe 1/1 52 
17 THF 55 °C K2CO3 1/5 61 
18[d] THF 55 °C K2CO3 1/5[e] 66[f] 
Table 3  Screening of different conditions in the cyclization reaction of bis-hydrazone functionalized 
rhodanine 24d for the synthesis of 2,3,5,6-tetrahydro-1H-pyrrolo[3,4-c]pyridine-1,3,6-trione 
26. The reactions were performed at 0.5 mmol scale of 24d in 3 mL of solvent.  [b] Yields of 
isolated 26e, based on 24d. [c] The reaction was performed at 0.5 mmol scale of 24d in 100 mL 
of solvent.  [d] The reaction was performed in a one pot procedure starting from 1d (1.0 mmol) 
and 22b (0.5mmol).  [e] Molar ratio between rhodanine 22b and K2CO3. [f] Yield of isolated 
26e, based on 22b. 
 
At this point, we have dealt with the development of a procedure for cyclization of 24d testing 
several solvents, such as DCM, THF, EtOH, and acetonitrile, at different temperatures (r.t., 
reflux). Furthermore, a series of catalysts were used, such as K2CO3, NaH, NaH/Amberlyst 
15H, MeONa, TFA, CuCl2 and ZnCl2, as well as different molar ratios between 24d/catalyst 
were employed (Table 3). We have observed that, using EtOH or CH3CN and NaH in equimolar 
ratio (Table 3, entries 8 and 9), the reactions gave complicated mixtures. The same behaviour 
26e 24d 
22b 1d 
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was pointed out in the reaction in DCM, using TFA as catalyst (Table 3, entry 1), while, 
employing CuCl2 or ZnCl2 in catalytic amount, no reactions were detected (Table 3, entries 13 
and 14). In all the other cases (Table 3, entries 2-7 and 10-12), instead of the expected 4-oxo-
2-thioxo-1-thia-3,8-diazaspiro[4.5]deca-6,9-diene-6,10-dicarboxylate, a different product was 
achieved, that was isolated and characterized as 2,3,5,6-tetrahydro-1H-pyrrolo[3,4-c]pyridine-
1,3,6-trione 26e, whose formation took place with the loss of CS2. Considering that its boiling 
point is 46.3 °C, we have decided to perform other tests at 55 °C, keeping open the reaction 
flask, in order to facilitate the removal of CS2 and using the best conditions found at room 
temperature, such as THF and base (Table 3, entries 15-17). The best results in terms of highest 
yield of 26e (61%) involve the use of 5 equivalent of K2CO3 (Table 3, entry 17). At this point, 
we have tested the same reaction between 1d and 22b using from the beginning 5 equivalent of 
K2CO3 at 55°C, in order to obtain 2,3,5,6-tetrahydro-1H-pyrrolo[3,4-c]pyridine-1,3,6-trione 
26e directly in one pot procedure. Indeed, product 26e was formed in 66% yield (Table 3, entry 
18). So, with these optimal conditions in hand, we explored the reactions of various DDs 1ah 
with rhodanines 22ad, both in step by step (Scheme 12, Path A) and in one pot way (Scheme 
12, Path B). 
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Scheme 12: Synthesis of dialkyl 2,2’-((3-substituted-4-oxo-2-thioxothiazolidine-5,5-diyl)bis(4-alkoxy-4-
oxobutan-3-yl-2-ylidene)) bis(hydrazine-carboxylates) 24af and of 2,3,5,6-tetrahydro-1H-
pyrrolo[3,4-c]pyridine-1,3,6-triones 26al: the proposed mechanism.  
26a-l 24 a-f 
22 
1 
1 a-g 
1 a,c,d 
1 a,c,d 
23 
25 
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Entry 1 R1 R2 R3 22 R4 
1 1a Et CO2Me Me 22a Et 
3 1b Me CO2tBu Me 22a Et 
4 1a Et CO2Me Me 22b Ph 
5 1c Me CO2Et Me 22b Ph 
6 1d Et CO2t-Bu Me 22b Ph 
7 1e Me CO2Et Bu 22b Ph 
8 1f Et CO2Bn Me 2b Ph 
9 1g Me CO2Me Me 22c 4-Cl-Ph 
10 1b Me CO2t-Bu Me 22c 4-Cl-Ph 
11 1c Me CO2Et Me 22c 4-Cl-Ph 
12 1c Me CO2Et Me 22d 4-OMe-Ph 
13 1d Et CO2t-Bu Me 22d 4-OMe-Ph 
 
Table 4 Substrates used for the synthesis of bis-hydrazone functionalized rhodanine 24d and for the 
synthesis of 2,3,5,6-tetrahydro-1H-pyrrolo[3,4-c]pyridine-1,3,6-trione 26e 
 
In particular, following the Path A, by reacting DDs 1a,ce with rhodanines 22ad, in THF, 
with 2 equivalents of K2CO3, at room temperature, bis-hydrazone-functionalized rhodanines 
24af were obtained in good to excellent yields (79-93%) and the reactions were completed in 
0.10.5 h (Scheme 12, Path A, Table 5).  
Their basic treatment with 5 equivalents of K2CO3 in THF at 55 °C in open flask furnished the 
corresponding 2,3,5,6-tetrahydro-1H-pyrrolo[3,4-c]pyridine-1,3,6-triones 26a,ce,j,l, in 
2.05.0 h in acceptable yields (3961%) (Scheme 12, Path A, Table 5). 
More conveniently, the 2,3,5,6-tetrahydro-1H-pyrrolo[3,4-c]pyridine-1,3,6-triones 26al were 
obtained in good yields (4366%) by means of one pot procedure, carrying out the reaction 
between DDs 1ag and rhodanines 22ad, in THF, with 5 equivalents of K2CO3, at 55 °C in 
open flask. Under these conditions the reactions were completed in 1.05.0 h (Scheme 12, Path 
B, Table 5). 
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Table 5: Yields of pure isolated products referred to rhodaines 22ad. 
Any attempt to isolate the mono-adduct 23, deriving from the Michael-type addition of the 
rhodanine 22 to one equivalent of DD 1 failed (Scheme 12); in fact, in all the tests carried out 
in different conditions and in the DD/rhodanine equimolar ratio, only bis adducts 24 were 
formed. Having in hand the products 23 would have given us the opportunity to add them to 
DDs molecules different from the starting ones. 
The plausible mechanism of this cascade reaction involves the preliminary double attack 
(Michael-type) of the carbon atom in 5 position of the rhodanine 22 to the terminal carbon atom 
of the azo-ene system of two molecules of the DD 1, with the formation of the bis-hydrazonic 
intermediate 24. The key step in the construction of the tetrahydro-1H-pyrrolo[3,4-c]pyridine-
1,3,6 trione system is the opening of the 2-thioxothiazolidin-4-one ring which results in the loss 
24a 79% 24b 85% 
24c 92% 24d 93% 
24e 88% 24f 93% 
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of CS2. This process is triggered by the removal from the base of the acidic proton originally 
located in position 4 of the first azo-ene molecule, with the consequent activation of the nitrogen 
deriving from rhodanine core. Its nucleophilic attack on the ester function derived from the 
second DD molecule promotes the formation of the pyrrolidine-2,5-dione core of the non-
isolable intermediate 25. The further cyclization to obtain pyridin-2(1H)-one nucleus occurs as 
a result of the basic removal of the analogous proton deriving from the second molecule of DD 
that promotes the nucleophilic attack of the sp2 nitrogen at the ester carbonyl function originally 
located in the first DD (Scheme 12). 
It is noteworthy that a double interaction between the two fragments derived from the two DDs 
occurs and in the one pot procedure, this cascade reaction furnishes two new single carbon-
nitrogen bonds as well as a single and a double carbon-carbon bonds. 
The two activated protons play a crucial role by promoting the double nitrogen nucleophilic 
attack onto the ester function of the other fragments.  
To the best of our knowledge, just one example of ring-opening/ring-closing process of the 
rhodanine core is reported in literature.44 Differently from this, our sequence occurs with the 
loss of a molecule of carbon disulphide so activating the substituted nitrogen of the rhodanine 
as nucleophile in the first cyclization event. 
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26a 44%a 42%b 26b 58%a 
26c 60%a  26d 55%a 53%b 
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Table 5:.  [a] Yields of pure isolated products referred to rhodanines 22ad, in the one-pot procedure 
(Path B of Scheme 2) [b] Yields of pure isolated products referred to bis-hydrazones 24af 
(Path A of Scheme 2).   
26e 66%a 61%b 26f 63% 
26g 43% 26h 46% 
26i 51% 26j 58%a 39%b 
26k 59% 26l 64%a 64%b 
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The structure of compounds 24 and 26 was confirmed by mono and bidimensional NMR 
measurements and the data are perfectly comparable to those reported in the literature for 
similar compounds.42,45 
Further evidence of the proposed structure for compounds 26 was furnished by the hydrolytic 
cleavage of the hydrazone moiety in position 27 of the pyridine ring of compound 26e, chosen 
as an example, that was obtained under heterogeneous conditions, using acetone/water (9:1) 
and Amberlyst 15H.46 In these acidic conditions also the loss of the tert-butoxycarbonyl moiety 
occurred to give the corresponding 7-acetyl-5-amino-4-methyl-2-phenyl-1H-pyrrolo[3,4-
c]pyridine-1,3,6(2H,5H)-trione 27a in very good yield (83%) (Scheme 13).  
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Scheme 13: Hydrolytic cleavage of 2,3,5,6-tetrahydro-1H-pyrrolo[3,4-c]pyridine-1,3,6-trione 26e to 7-
acetyl-5-amino-4-methyl-2-phenyl-1H-pyrrolo[3,4-c]pyridine-1,3,6(2H,5H)-trione 27a 
 
3.2 Conclusions 
In conclusion, starting from 1,2-diaza-1,3-dienes and rhodanine derivatives, we have developed 
a synthetic strategy to have access to 2,3,5,6-tetrahydro-1H-pyrrolo[3,4-c]pyridine-1,3,6-
triones via double Michael addition/CS2 extrusion/double cyclization sequence. To the best of 
our knowledge, this work represents the first example of ring-opening/ring-closing process with 
concomitant extrusion of carbon disulfide from the rhodanine core. The easy availability of the 
starting materials, the simplicity of the experimental method, as well as the potential biological 
activities and utilities of products can increase the synthetic usefulness of this novel procedure. 
Furthermore, employing the step by step approach, also highly functionalized rhodanines could 
be easily obtained in satisfactory yields 
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4.  SEQUENTIAL ONE POT SYNTHESIS OF 2,5-
DIHYDROTHIOPHENES AND THIOPHENES 
 
 
 
 
 
 
CHAPTER 4 
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4.1 Introduction 
One of the main aim for a synthetic chemists is the development of highly efficient procedures 
to assemble valuable compounds with high structural complexity resorting to simple available 
materials.47 This request can be meet by exploiting the multicomponent reactions (MCRs) that 
allows incorporation into the final products of three or more reactants. MCRs lead to wide 
molecular diversity, minimizing the work-up procedures and consequently saving both time 
and solvents.48 A class of MCR is the sequential reactions, where the reagents are added 
consecutively in a defined order in the same reaction environment under constant conditions In 
this way, it is possible to stop the synthetic sequence at every step, and so the intermediates can 
be isolable. Thereby, the intermediates can be isolable by stopping the sequence at the right 
moment.49 Thiophene is the key structural unit of numerous pharmacophores such as Plavix, 
(adenosine diphosphate P2Y12 receptor antagonist),
50 Raloxifene (selective estrogen receptor 
modulator),51 PaTrin 2 (MGMT inactivating drug),52 articaine (local anaesthetic),53 Cymbalta 
(selective serotonin norepinephrine reuptake inhibitor).54  
Furthermore, its peculiar electronic properties and the relevant structural rigidity make the 
thiophenes derivatives interesting cores in the production of innovative organic materials like 
organic semiconductors, organic light emitting diodes (OLED), organic photovoltaics (OPV), 
organic field effect transistors (OFET), solar cells, liquid crystals.55 
About the preparation of thiophenes, a plethora of synthetic approaches have been reported, 
some of which can be related to classical Gewald, Fiesselmann, Paal-Knorr, and Hinsberg 
reactions,56 and many others examples.57 However, most of these procedures require multistep 
protocols with consequent laborious isolation operation. 
Also the dihydrothiophene compounds represent a common structural motif of numerous 
bioactive derivatives and they has shown to be versatile intermediates for synthetic 
applications.58 consequently, notable attention has been directed toward new and convenient 
synthetic procedures to prepare both dihydrothiophenes and thiophenes. 
During our ongoing studies37,59 on the versatility of 1,2-diaza-1,3-dienes,38 as synthetic starting 
materials, inspired by the work of Alizadeh,60 we have investigated the reaction between DDs 
1 and 3-alkylamino-2-(carbamothioyl)but-2-enoates 28 (ACTs) to tentatively obtain 
thiazepines A by means of a formal [4+3] cyclization (Scheme 1, path A), in analogy to the 
results previously obtained.60 Surprisingly, the reaction furnish 5-(phenylimino)-2,5-
dihydrothiophenes (DHTs) 29 through an unusual formal [4+1] cyclization,61 where the DDs 
contributes in the final heterocyclic structure only with one carbon atom (Scheme 14, path B). 
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4.2 Results and Discussion 
In order to realize a one-pot reaction by subsequent addition of reagents, we began our 
investigation on the preparation of ACTs 28. The methodology requires the preliminary 
formation of enamino ester intermediates,62 that successively react with aryl-isothiocyanates to 
produce the desired ACTs 28. Among all the proposed procedures,63 Alizadeh describes the 
most convenient way, where all the steps are performed under solvent free conditions (SFC).60  
 
Scheme 14: Expected and observed behaviour of the reaction between DDs 1 and ACTs 28 
 
We have observed that conducting the addition of the enamino ester 32 to the aryl 
isothiocyanates 34ac in methanol, the desired ACTs 28 directly precipitate from the reaction 
medium as pure products with better yields, avoiding any other purification procedures. 
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Scheme 15: Synthesis of 3-alkylamino-2-(carbamothioyl)but-2-enoates 28. 
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Table 7:  Yields of isolated ACT 28 based on alkyl amines 31 
 
Based on our previous experience,64 we have tested also the reaction between alkynoates and 
primary amines to prepare enamino ester derivatives. Only in this case of aza-Michael reaction 
between ethyl 3-phenylpropiolate 33a and benzyl amine 31b conducted in SFC at room 
temperature, we have quantitatively obtained a waxy solid that was identified as the desired 
28a 72% 28b 49% 28c 58% 
28d 35% 28e 51% 28f 55% 
28h 40% 28g 75% 
28j 33% 28k 45% 
28i 50% 
28l 34% 28m 27% 
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enamine ester 32a. The subsequent addition of the phenyl isothiocyanates 34a to the reaction 
mixture in SFC produces ACT 28l only in poor yield, probably because the scarce solubility. 
Then, various solvents such as dichloromethane (DCM), tetrahydrofuran (THF), ethanol, 
acetonitrile (ACN), dimethylformamide (DMF), and temperatures were evaluated in the second 
step (Table 8). The best result was obtained in methanol, at room temperature, but unfortunately 
even in this case the yield was only of 37%. 
 
33 R4 R5 31 Alk 34 R6 2 Solventa Yield (%)b Solventc Yield (%)b 
a Ph Me b Bn a Ph m SFC 13 SFC/MeOH 37 
a Ph Me b Bn a Ph m   SFC/THF 15 
a Ph Me b Bn a Ph m   SFC/ACN 17 
a Ph Me b Bn a Ph m   SFC/DCM 21 
a Ph Me b Bn a Ph m   SFC/DMF 6 
a Ph Me b Bn a Ph m   SFC/MeOH 22d 
a Ph Me b Bn a Ph m   SFC/MeOH 18e 
 
Table 8: aReaction conditions: alkyl amines 31 (0.5 mmol) were added to ethyl phenylpropiolate 33a (0.55 
mmol) under solvent-free conditions at room temperature. After 0.5 h aryl isothiocyanates 34a-
c (0.5 mmol) were added and the reactions were stirred until the disappearance of the enamino 
esters 32 (monitored by TLC). b Yields of isolated ACT 2 based on alkyl amines 31. cReaction 
conditions: alkyl amines 31 (0.5 mmol) were added to ethyl phenylpropiolate 33a (0.55 mmol) 
under solvent-free conditions at room temperature. After 0.5 h aryl isothiocyanates 34a-c (0.5 
mmol) in MeOH (1.5 mL) were added and the reactions were stirred until the disappearance of 
the enamino esters 32 (monitored by TLC). dReaction conducted at 0 °C. eReaction conducted at 
50 °C. 
 
Thus, a preliminary study of the next step of this sequential reaction was conducted using DD 
1a and ACT 28b chosen as examples (Table 9, Scheme 16). In SFC the low solubility affects 
the reaction; in fact the main spot was isolated with unsatisfactory yield. Spectroscopic studies 
have revealed that the main product was the corresponding 2,5-dihydrothiophene 29b. In 
particular, the signal at 75.4 ppm in the 13C NMR spectra of the quaternary carbon in position 
two of the thiophene ring is diagnostic. So, different solvents such as DCM, THF, ACN, 
methanol were tested. Despite the low solubility of the ACTs 28 in MeOH, this solvent has 
furnished the best result in term of yield. Probably the gradual dissolution and the consequent 
lower concentration of ACTs 28 favour a better selectivity and promote greater selectivity. 
While the temperature does not affect the reaction, on the contrary, to an increment of DDs 
equivalents correspond an appreciable improvement in the final yield. In fact, the primary 
amine released in the cyclization process gives a nucleophilic attack to the azo-ene system 
subtracting the DDs 1 from the reaction medium.65  
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Scheme 16: Reagents used for the optimization of the synthesis of 29b 
 
Entry Solvent T (°C) molar ratio 1a/28b 29b yield (%)a 
1 SFC r.t. 1:1 trace 
2 SFC 80°C 1:1 trace 
3b DCM r.t. 1:1 5 
4b THF r.t. 1:1 8 
5b ACN r.t. 1:1 33c 
6b MeOH r.t. 1:1 43 
7b MeOH 50°C 1:1 42 
8b MeOH r.t. 2:1 83 
9b EtOH r.t. 2:1 73 
10b EtOH 70°C 2:1 70 
 
Table 8:  Screening of different conditions in the reaction between DD 1a and ACT 28b. 
 
. 
So, assembling all the information collected on the individual reactions we have finally 
conducted the one-pot synthesis on a representative model. Butyl amine 31a (1.0 equivalents) 
was added to ethyl acetoacetate 30b (1.1 equivalents) under SFC. A slight excess of -ketoester 
30 is necessary to completely convert the amine 31, preventing its nitrogen nucleophilic attack 
to the isothiocyanate 34 that would have led to the formation of the unwanted thiourea.  
So, assembling all the information collected on the individual reactions we have finally  
After 0.5 h, a TLC analysis revealed the quantitative formation of the enamino ester 32. To the 
reaction medium were then added 3mL of methanol and phenyl isothiocyanates 34a. The 
reaction is completed in 6.0 h and ACT 28b appears as yellow precipitate. After the final 
addition of two equivalents of DD 1a, the gradual dissolution of the yellow solid is observed, 
together with the disappearance of the typical red colour imparted to the solution by the 
conjugation of the azo-ene system. The reaction ends in 5.0 h furnishing the corresponding 2,5-
1a 
28b 
29b 31a 
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dihydrothiophene 29b in 83 yields (Scheme 16, Table 9). Based on the success of the one-pot 
model, various -ketoesters 30ai, isothiocyanates 34ac, and DDs 1aj were employed and 
the results are summarized in Scheme 17. Generally, the yields are good and it is possible to 
diversify two, one and three substituents on -ketoesters, isothiocyanates and DDs respectively, 
allowing wide molecular diversity. The primary amine employed in the formation of the initial 
enamine ester derivatives do not influence the efficiency of the process: compound 29b in fact 
obtained using both n-butyl- and benzylamine with comparable yields. 
The method well tolerated both moderate electron withdrawing group such as chlorine or strong 
electron donating moiety as methoxy on the aromatic ring of isothiocyanates.  
This procedure was applied also for ethyl phenylpropiolate 33a, benzyl amine 31b, and DDs 
1b furnishing only in moderate yields the 2,5-dihydrothiophene 29j.  
A gram scale synthesis of 2,5-dihydrothiophene 29 was attempted by means of the here reported 
sequence and the target product was obtained in 63% yield, confirming the effectiveness of our 
synthetic protocol. 
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Scheme 17: Sequential four-component reaction of primary amines 31a,b, -ketoesters 32a-i (or ethyl 
phenylpropiolate 33a), aryl isothiocyanates 34ac, and DDs 1a-j: synthesis of 
2,5dihydrothiophenes 29ax.  
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29a 78% 29c 58% 
 
29b 83% 
29d 88% 
 
29f 69% 
 
29e 78% 
 
29g 81% 
 
29i 73% 
 
29h 65% 
 
29l 86% 
 
29k 86% 
 
29m 84% 
64 
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Table 10:  Yields of isolated 2,5-dihydrothiophenes 29ax based on compounds 30ai or 33a.  
 
2,5-Dihydrothiophenes 3ac,eg,l,m,r,t were then treated with Amberlyst 15H in a mixture of 
acetone/water to tentatively hydrolyse the hydrazone moiety.66 Surprisingly, instead of the 
expected 2-acetyl 2,5-dihydrothiophene, the reactions have furnished in good yields the 5-
amino thiophene-2,4-dicarboxylates 35aj (Scheme 18, Table 11). The structures of the 
aromatic compounds 35 were supported by spectroscopic data and unambiguously confirmed 
by comparison of diethyl 3-methyl-5-(phenylamino)thiophene-2,4-dicarboxylate 35e with the 
same derivative previously synthesized by Kirsch.67 It is noteworthy that this aqueous treatment 
is very selective leaving unaltered functional groups that are usually sensitive to acidic aqueous 
conditions such as esters and in particular BOC (35k) or allyl moiety (35h,j). 
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Scheme 18: Synthesis of 5-arylamino thiophenes 35aj by acidic treatment of 2,5-dihydrothiophenes 29., 
29j 78% 
 
29p 81% 
 
29r 63% 
 
29q 75% 
 
29u 65% 
 
29t 63% 
 
29v 60% 
 
29x 77% 
 
29a-c,e-g,l,m,r,t 35a-j 
29w 84% 
 
- 45 - 
 
On the base of this evidence, a plausible mechanism can involve a double Michael reaction. In 
facts, probably the sulphur of the ACTs 28 gives a first nucleophilic attack to the terminal 
carbon atom of the azo-ene system of the DDs 1 with formation of the intermediates 36. The 
carbon in  to the hydrazone function is strongly activated and is able to give nucleophilic 
vinylogous attack at the conjugated system deriving from the starting ACT with consequent 
formation of the heterocyclic structure 37. The final elimination of the amino moiety affords 
the 2,5-dihydrothiophenes 29. In this formal [4+1] cyclization the carbon atom originally 
located in position four in the azo-ene system (highlighted in Scheme 19) covers a crucial role 
behaving initially as electrophilic centre and then as nucleophilic site. 
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Table 11:  Yields of isolated 5-arylamino thiophenes 35aj based on 2,5-dihydrothiophenes 29.  
 
The acidic treatment in a mixture of acetone/water of 2,5-dihydrothiophenes 29 initially 
probably causes the expected hydrolysis of the hydrazone function producing the non-isolable 
2-acyl 2,5-dihydrothiophenes 38. The reaction conditions favour the addition of a water 
molecule to the carbonyl moiety producing intermediates 39. The loss of the carboxylic acid 
35a 82% 
 
35b 80% 
 
35d 78% 
 
35c 81% 
 
35e 78% 
 
35f 79% 
 
35g 81% 
 
35h 70% 
 
35i 81% 
 
35j  83% 
68 
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group triggers an electronic shift that produces final 5-arylamino thiophenes 35aj. The 
aromatization is the driving force of this process. 
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Scheme 19: Plausible mechanism for the formation of 2,5-dihydrothiophenes 29ax and 5-arylamino 
thiophenes 35aj. 
 
Surprisingly, a different behavior was observed when DHTs 28 are subjected to basic treatment 
(Scheme 20). By adding two equivalents of sodium hydride to a solution of DHTs 
8a,b,df,h,j,m,n in THF, at room temperature, novel 2-arylamino 5-hydrazono thiophene-3 
carboxylates (AHTs) 41ag were obtained in satisfactory yields. The aromatization process, in 
this case, takes place following the hydrolysis of the ester function. The subsequent 
decarboxylation process promotes the aromatization of the ring. The two distinct 
regioselectivities observed in the formation of ATDs 35 or AHTs 41, respectively, are probably 
ascribable to the different electrophilicity of the substituents in position 2 of DHTs 29. In acidic 
conditions, the hydrolysis of the hydrazone generates the ketonic function, that it is notoriously 
35a-j 
28a-l 
 
1a-j 
 
36 
 
37 
 
38 
 
39 
 
29ax 
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more electrophile with respect to the ester function. In basic medium, instead, the hydrolysis 
involves the ester function in position 2 of DHT, promoting a different aromatization process.  
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Scheme 20:  Synthesis of 2-arylamino 5-hydrazono thiophene-3 carboxylates (AHTs) 41ag by basic 
treatment of DHT 29 
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Table 12:  Yields of isolated AHTs 41ag based on DHT 29  
29a,b,d-f,h,i,m,n 40 40ag 
41a 71% 41b 78% 
41c 77% 
 
41g 68% 
 
41d 73% 
 
41e 78% 
 
41f 78% 
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Scheme 21:  Different ways in the treatment of DHTs 29 
 
From the conversion of DHTs 29 in to ATDs 35 or in to AHTs 41 it emerges that the elimination 
of one substituent in position two triggers an aromatization process. To realize the direct 
synthesis of aromatic 2-amino thiophenes through a sequential multi component synthesis, 
similar to that described above, we have planned to insert an easily removable hydrogen in 
position 2 of the DHTs 29. The carbon in position two of DHT 29 derives from the DDs, 1 and 
originally is located in position four of the azo-ene system. Then, employing 4-unsubstituted 
DDs we should achieve the proposed target. As these substrates showed poor stability, they are 
usually generated in situ by basic treatment of the corresponding -alo hydrazones 15ag.38,68 
This circumstance requires an adjustment of the reaction conditions previously employed. As 
29 
39 
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above described, initially we prepared the enamino ester intermediates 32 under solvent free 
conditions and successively the aryl isothiocyanates 33ac was added furnishing the desired 3-
alkylamino-2-(carbamothioyl)but-2-enoates (ACTs) 28am. To the reaction mixture were 
added the -halo hydrazones 14 were added and four equivalents of potassium carbonate were 
needed for the conversion of the hydrazones in the 4-unsubstituted DDs. The methanol, 
previously used as solvent, reacts with derivatives 14 giving the substitution of the halogens. 
Some other solvents were then tested, and the best results were obtained using dichloromethane 
(Scheme 22).  
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Scheme 22:  One pot sequential synthesis of 2-arylamino 5-hydrazono thiophene-3 carboxylates (AHTs) 
41hr starting from in situ generated 4-unsubstuited DDs. 
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Table 13:  Yields of isolated AHTs 41hr based on -ketoesters 32a. 
  
41h 80% 41i 82% 41j 87% 
 
41q 91% 
 
41k 53% 
 
41m 80% 
 
41l 58% 
 
41n 85% 
 
41p 87% 
 
4o 62% 
 
41r 74% 
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On the basis of this evidence a plausible mechanism can involve a sulphur nucleophilic attack 
of ACTs 28 to the terminal carbon atom of the azo-ene system of the 4-unsubstitued DDs 15. 
The basic medium favors the loss of the first acid proton activating the carbon nucleophilic 
vinylogous attack at the conjugated system deriving from the starting ACT 28. By means of 
this annulation, the first sulphur-heterocyclic structure of the tetrahydrothiophene intermediates 
was created. The conjugated elimination of the amino moieties affords the corresponding 2,5-
dihydrothiophene intermediates. The loss of the second proton promotes the aromatization of 
the ring. In summary, when there are two hydrogens at the terminal carbon atom of the azo-ene 
of 4-unsubstituted DDs 15, the aromatization process can be easily incorporated in the synthetic 
sequence, obtaining directly the 2-arylamino 5-hydrazono thiophene-3 carboxylates 41hr. On 
the other hand, employing 4-substytuted DDs 1aj, lacking an easily removable group, the final 
aromatization is not possible, and the sequence stops at the formation of DHTs 29ax (Table 
13). 
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Table 14:  Yields of isolated AHTs 43a-g based on AHT 41. 
  
  
43g 62% 
 
43a 63% 
 
43c 61% 
 
43b 57% 
 
43d 63% 
 
43f 58% 
 
43e 56% 
 
43h 64% 
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2-Arylamino 5-hydrazono thiophene-3 carboxylates (AHT) 41 are valuable starting materials 
to create a second sulphur-containing-heterocycle direct linked to the thiophene ring. In fact, 
the treatment of AHTs 41ag containing a methyl substituted hydrazone moiety with thionyl 
chloride, according to a typical Hurd-Mori conditions, produces new 2-(phenylamino)-5-(1,2,3-
thiadiazol-4-yl)thiophene-3-carboxylates (ATTs) 43ad. 
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Scheme 23:  Progress of the Hurd-Mori reaction. 
 
Initially, the reactions were conducted on AHTs 41a (0.5 mmol) chosen as representative 
compound at room temperature in dichloromethane (2.0 mL) testing different molar ratios of 
thionyl chloride. With one or two equivalents the reactions do not come to completeness, while 
with five equiv. the reaction proceeds slowly (36 h, monitored by TLC) and together with the 
desired ATT 43a (26% yield) also the corresponding methyl 4-(chloromethyl)-2-
(phenylamino)-5-(1,2,3-thiadiazol-4-yl)thiophene-3-carboxylate 43e (17% yield) was 
produced. 
The best result was achieved employing ten equivalents of SOCl2. In fact, under this condition 
the desired ATT 43a was formed in 63% yield in 1.5 h together with traces of the corresponding 
4-chloromethyl ATT 43e (monitored by TLC). On the other hand, the introduction of an 
halogen makes this latter compound 43e interesting reaction intermediate that can be further 
functionalized through simple nucleophilic substitution reactions. For this reason, we have also 
developed a method for its preparation. Prolonging the reaction time to 15 hours, under the 
same reaction conditions previously employed, the 4-chloromethyl ATT 43e was produced in 
56%yield, and no traces of the corresponding ATT 43a were detected. On the basis of these 
evidences, it can be deduced that the chlorination proceeds slowly, and prolonging the reaction 
time the 4-chloromethyl ATT 43e becomes predominant. Using 5.0 equiv. of thionyl chloride, 
the Hurd-Mori reaction proceeds slowly and the chlorination reaction also occurs, while 
employing 10.0 equiv. Hurd-Mori reaction is faster minimizing the formation of the compound 
43e.  
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4.3 Conclusion 
In conclusion, we have developed with success a sequential MCR that produces 2,5-
dihydrothiophene derivatives by reaction of DDs and ACTs. Importantly, this protocol provides 
wide and flexible substitution patterns in the 2,5-dihydrothiophenes allowing the planning “ab 
initio” of six different substituents by appropriately selecting the starting -ketoesters, 
isothiocyanates or DDs. This opportunity, together with mild and simple reaction conditions 
(no catalysts, or dry solvents, or inert atmosphere), make this sequential MCR well suitable for 
the easy creation of broad libraries.  
A careful selection of the starting materials enables the choice up to six different variation in 
the architecture of the final products. Employing the in situ generated 4-unsubstituted DDs the 
same methodology produces directly the 2-arylamino 5-hydrazono thiophene-3 carboxylates, 
incorporating the aromatization process in the sequence. Also the 2,5-dihydrothiophenes are 
valuable intermediates producing in turn regioselectively the corresponding 5-amino thiophene-
2,4-dicarboxylates or 2-arylamino 5-hydrazono thiophene-3 carboxylates simply by acid or 
basic treatment. All these aspects highlight the versatility of this sequential multicomponent 
reaction that under mild conditions can produce a broad variety of thiophene derivatives. And 
last but not least, the synthesis of unknown new 2-(phenylamino)-5-(1,2,3-thiadiazol-4-
yl)thiophene-3-carboxylates further enriches the range of sulfuric heterocycles obtainable, 
combining in this latter case the properties of both thiophene and 1,2,3-thiazoles. 
  
- 54 - 
 
 
 
5.  N-ACYLIMINIUM IONS AS NOVEL MANNICH-TYPE 
ACCEPTORS IN 1,4 ADDITIONS OF NUCLEOPHILES 
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5.1 Introduction 
Iminium ions play a significant role in a range of enzyme-catalyzed processes69 and synthetic 
transformations as key (reactive) intermediates70 for the construction of C-C and C-Het bonds. 
For example, nature utilizes type I aldolase enzymes to catalyze an aldol process that operates 
via an iminium cation under physiological conditions. 
In the field of organocatalysis71 and in the emerging photoredox catalysis,72 a plethora of stereo- 
and enantioselective methods have been achieved that rely on the use of chiral iminium ions.73 
Within the iminium species, N-acyliminium ions74 (NAIs) are recognized to be much more 
reactive as electrophiles than N-alkyliminium counterparts due to the electron-attracting 
properties of the carbonyl group on nitrogen. Among different named reactions involving NAIs, 
the two most-studied types, Mannich75 and Pictet−Spengler76 reactions, have been extensively 
employed for the assembly of alkaloids, natural-product-like compounds, and biologically 
active molecules. The generation of these highly unstable (effective reactive or transient 
electrophilic) species, which typically require acidic conditions, is followed by in situ trapping 
by nucleophiles or dienes in both addition and cycloaddition reactions, respectively.  
Despite significant advances in the nucleophilic addition of NAIs,77 reactions that involve the 
intermolecular addition of conjugated N-acyliminium acceptors still remain elusive due to the 
challenging issue of regioselectivity (Figure 10). To date, (to the best of our knowledge) only 
rare examples have demonstrated the feasibility of the γ-selective addition of nucleophiles to 
cyclic conjugated N-acyliminium ions.78 Although these procedure can furnish the γ-adduct in 
a 1,4-addition fashion, they are often complicated by the formation of mixture of α- and γ-
regioisomers as well as limited to a few dicarbonyl nucleophiles only. In addition, these 
reactions provide functionalization at the C4-position of the azaheterocyclic (e.g. piperidine) 
skeleton since an endocyclic double bond results in olefin N-acyliminium ion structures of type 
A. On the other hand, heterocyclic architectures featuring an iminium cation flanked by an 
exocyclic double bond of type B (e.g. 5-methylene N-acyl dihydropyridazinium ions) have not 
yet reported. This is surprising, because they could be used to effect direct functionalization at 
the γ’ position, a transformation that would permit to introduce nucleophiles onto exo methylene 
group of the ring (olefin terminus). 
- 56 - 
 
N
O R
'


Het
Nu

and/or
N
O R



Het
N
O R

Het
Nu N
O

Het
Nu
addition addition
R
this work
Nu
N
O R


Het
Nu
A
B 'addition
 'selective
'
previous works
 
Figure 10:  Nucleophilic Addition to Conjugated Cyclic N-Acyliminium ions. 
 
The challenge and opportunity of controlling regioselectivity as well as the possibility of adding 
a variety of nucleophiles have prompted us to investigate the reactivity of these intriguing 
acceptors in addition reactions. Along these lines, our interest in the chemistry of the 
azaheterocycles led us to consider 5-methylene-6-methoxy-1,4,5,6-tetrahydropyridazines 
(N,O-acetals) easily prepared via a regioselective inverse-electron-demand hetero-Diels-Alder 
reaction of in situ generated 1,2-diaza-1,3-dienes with methoxyallene.8 For this purpose, the 
most widely applied method for NAI formation that involves the release of a leaving group 
from the α-position of the acyl nitrogen under acidic reaction conditions has been used to assist 
the formation of transient electrophilic species. Following this strategy, a varied repertoire of 
adducts featuring nontraditional dihydropyridazine-based skeleton connections molecules or 
difficult-to-access 5-methylenyl-substituted 1,4-dihydropyridazines can be assembled in high 
yield and excellent regioselectivity in the first example of a direct, Michael-type addition 
reaction of nucleophiles to in situ generated cyclic 5-methylene N-acyl dihydropyridazinium 
ions (β-methylene N-acyliminium ions or exocyclic ene conjugated iminium ions). 
5.2 Results and discussion 
It well-known that various Brønsted or Lewis acids such as TiCl4, BF3·OEt2, SnCl4, InCl3, 
NbCl5, Zn(OTf)2, HNTf2, Zn(NTf2)2, TMSOTf
74,75 are effective for the Mannich-type additions 
of N-acyliminium ions. Among the different Lewis acids tested in our preliminary experiments 
(BF3·OEt2, CuI, Cu(OTf)2, ZnBr2, Zn(OTf)2, Y(OTf)3, InBr3, LiClO4), only indium tribromide 
(40%) and boron trifluoride etherate (73%) were found to be productive. The superiority of 
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BF3·OEt2 to promote the generation of cyclic NAIs, followed by the addition of allyl silane 44a 
was evaluated with β-methylene tetrahydropyridazine N,O-acetals 18a at room temperature in 
CH2Cl2 (Scheme 24). 
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Scheme 24:  BF3•OEt2-mediated conjugated addition of allyltrimethylsilane 44a to N-acyliminium ions 
derived from 18a 
 
To our delight, under these reaction conditions, a complete γ’-selectivity was observed and the 
exclusive corresponding γ’ adduct 45a was isolated in 73% yield after 10 min. Lowering the 
reaction temperature to 0 °C did not provide any obvious beneficial effect (had not influence 
on the reaction) (72%). 
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Figure 11:  Representative nucleophile used to valid thee method. 
The scope of this transformation was next evaluated with different 5-methylene-6-methoxy-
1,4,5,6-tetrahydropyridazine substrates 18a−g and a series of representative nucleophiles 
44a−i. The allyl silane 44a acted as a good nucleophile with 18a−f to give the corresponding 
β-homoallyl substituted dihydropyridazines 45a−f with better results being osserved with 
45a−d when compared to 45e and 45f. Also, silyl enol ether 44b reacted with 18c gave 45g in 
65% yield. β-Diketones 44c and 44d reacted with electrophiles 18a−c to give the corresponding 
adducts 45g−i. Good results were observed in the addition of heterocyclic nucleophiles (Friedel 
Crafts alkylation), such as furans and indoles. Interestingly, while furan 44e was employed as 
substrate, the formation of the expected monoalkylation product 45k (56%) was accompanied 
by the presence of the dialkylation product bis-adduct 45l (34%) deriving from a further 
addition of 45k on 18a.79 
When 2-methyl furan 44f was used, the sole products 45m,n were afforded in 30% and 94% 
yields, respectively. Also NH-indole 44g and N-methyl indole 44h reacted with 18a−c,g to give 
the relative adducts. Finally, reduction of 18b with Et3SiH (44i) successfully furnished the 
desired product 45s (53%).  
44i 
 
18a 
 
44b 
 
44a 
 
44g R=H 
44h R=CH3 
44a 
 
45a 
 
44e R=H 
44f R=CH3 
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Scheme 25:  Novel iminium ion activated nucleophilic addition. 
 
Although the explanation for these results is not clear at the present time, the Mannich-type 
additions of a variety of nucleophiles to exocyclic ene conjugated iminium ions afforded 
exclusive 1,4-adducts with only trace amounts of 1,2-regioisomers being detected in a few 
cases.  
 
 
45a 82% 45b 69% 45c 75% 
45d 79% 45e 26% 45f 31% 
45g 65% 45h 97% 45i 86% 
45j 42% 45k 58% 
18 
 
44 
 
45 
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Table 15:  Yields of isolated γ’ adducts 45as based on 43. 
 
The pyridazine and perhydropyridazine frameworks are often encountered as structural 
components of compounds possessing biological activity since both nitrogen atoms can be 
involved in interactions with the protein target. In particular, the 1,4-dihydropyridazine rings 
are important synthetic targets due to their significance in pharmacological activity80 whereby 
they have found used as vasodilators and coronary therapeutic agents, or as spasmolytic 
agents.81 By exploiting the inherent reactivity of conjugated N-acyliminium ion intermediates 
it was possible to develop an unprecedented method that allowed the direct incorporation of a 
variety of groups/substituents at exocyclic γ’ position of the 1,4-dihydropyridazine rings. 
Notably, the installed plural functionalities are versatile handles for further synthetic 
manipulations. In view of the importance of these target molecules (partially saturated 
pyridazines/privileged structural motifs) and their rare representation in literature, we hope this 
methodology may be of value for further studies/applications.  
45q 58% 45r 47% 
45l 39% 45m 30% 
45n 94% 45o 49% 45p 41% 
45s 53% 
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5.3 Conclusion 
In conclusion, we have developed a procedure for the preparation of otherwise inaccessible 1,4-
dihydropyridazine derivatives (diversely substituted 1,4-dihydropyridazines, uniquely 
multifunctionalized scaffolds or small dihydropyridazine-based library) by Lewis acid-
mediated Mannich-type addition of nucleophiles to 5-methylene-6-methoxy-1,4,5,6-
tetrahydropyridazines, which is easily realized via iminium chemistry. From a synthetic 
perspective, the chemistry here reported is relevant since it provides a straightforward method 
for the direct installation of diverse σ- and π-nucleophiles at the methylene (γ’) position of 
heterorings, a transformation for which there are no (only sporadic) precedents. These reactions 
proceed under simple, mild conditions in high yields and with a high level of regioselectivity.  
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6.1 Introduction 
One of the main interests of the organic chemists is directed to the development of simple, 
viable strategies to access structurally complex polyheterocyclic cores, by assembling ready 
available building blocks.82,83 
Among these polyheterocycles, berberine (BB) (Figure 12) and its derivatives are of 
considerable interest because they are known to possess several healthy properties.8488 
Berberine is an isoquinoline alkaloid extracted from rhizomes and roots of several species of 
plants, such as Coptis (Coptis chinensis and Coptis japonica), Hydrastis and Berberis (Berberis 
vulgaris and Berberis croatica). These plants have long been used in traditional Chinese, 
Ayurvedic and Native American medicine for the treatment of different maladies. BB is known 
to possess a variety of pharmacological and therapeutic activities and it was employed to treat 
diarrhea,84 stomatitis84 and hepatitis,84 due to its antiprotozoal,84,85 antimicrobial84 and anti-
inflammatory properties.84 Recently, BB has been identified as a good candidate for the 
treatment of type 2 diabetes mellitus84 and of cardiovascular diseases.84 Numerous studies also 
reported its activity as anticancer agent, in different stages of cancer development (proliferation, 
growth, metastasis).84,86,87 This effect is ascribable to the antiproliferative activity of berberine 
and its derivatives against several cancer cellular lines.87 
Tetrahydroberberine (THB) (Figure 12), the fully reduced form of BB, is a naturally occurring 
alkaloid mainly extracted from Corydalis ambigua and it is known to have significant 
pharmacological properties that differ from that of the parent berberine.88 In fact, THB shows 
little antiproliferative activity toward several lines of cells, but instead it is effective as an 
antioxidant89a and a Ca2+ channel blocker.89b 
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Figure 12:  Berberine (BB) and its reduced forms dihydroberberine (DHB) and 7,8-tetrahydroberberine 
(THB). 
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Additionally, THB has also been observed to block ATP-sensitive K+ ion channels involved in 
the pathogenesis of Parkinson’s disease,89c indicating an important neuroprotective role. 
As part of our program aimed at focusing new strategies for the construction of potential 
biologically active compounds, we devised a strategy aiming at the synthesis of structurally 
complex tetrahydroberberine analogues containing the pyrrolo[2,3-b]pyridine system. The 
pyrrolo[2,3-b]pyridine core is structurally important because, for example, it is related to the 
alkaloids of the chaetominine and kapakahine families (Figure 13)82,90 and it has been found in 
several pharmaceutical active molecules and drug candidates.91 The same nucleus can be found 
in isoschizogamine and isoschizogaline (Figure 13), belonging to the family of schizozygane 
alkaloids, that exhibit antimicrobial and antifungal activities at low micromolar 
concentrations.83 
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isoschizogamine (R1, R2 = OMe) and
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R2 N
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Figure 13:  Pyrrolo[2,3-b]pyridine core of chaetominines and kapakahines and of isoschizogamine and 
isoschizogaline. 
 
The retrosynthetic analysis of this fused-bicyclic structure emphasizes two strategic 
disconnections of the pyrrole ring: the first one is along the N(1)-C(7a) and the second one 
along C(3)-C(3a) bonds. This reveals two subunits that trace the left half back to the zwitterionic 
amine A and the right half to the pertinent heterocyclic zwitterion B (Scheme 26). Fragment A 
can be correlated to the azo-ene system of 1,2-diaza-1,3-dienes, that represent the main field of 
our research for the past several years.92 The fragment B can be related to the pertinent dihydro-
pyridine D, that is contained in the structure of 7,8-dihydroberberine (7,8-DHB), the partially 
reduced form of berberine (Figure 12, Scheme 26). 
In fact, 7,8-DHB contains an enamine moiety that could react with the azoene system of DDs, 
as previously reported in literature by several authors93 and also by some of our group.94  
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Figure 14:  Retrosynthetic analysis of pyrrolo[2,3-b]pyridine systems. 
 
6.2 Results and Discussion 
Following known procedures, we prepared 7,8-dihydroberberine 4795 and 8-acetonyl-7,8-
dihydroberberine 47’96 (Scheme 26). Both 7,8-dihydroberberines 47 and 47’ possess the 
enamino function, required for the nucleophilic attack on the DDs. 
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Scheme 26:  Synthesis of 7,8-dihydroberberine 47 95 and of 8-acetonyl-7,8-dihydroberberine 47’,96 starting 
from commercial berberine chloride 46. 
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By choosing DD 1e and 7,8-DHB 47 as representative examples, we investigated the reaction 
in different conditions of solvents (dichloromethane, tetrahydrofuran, diethyl ether, ethyl 
acetate and acetonitrile) and temperatures (r.t., 0 °C and -15 °C) (Scheme 27). In all the 
conditions tested, the reaction took place with the formation of the corresponding fused 
pyrrolino-THB derivative 49e in good yields. By using acetonitrile, the reaction proceeds at 
room temperature and 49e directly precipitates in 87% yield from the reaction medium.  
Having optimized the conditions, we explored the reactions of various DDs 1an with 7,8-
DHB derivatives 47 and 47’. The berberberino derivatives 49an were obtained in good to 
excellent yields (4992%), with the exception of 49g (22%), and all the reactions were 
completed in 0.25 h (Table 16). 
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Scheme 27:   Mechanism for the synthesis berberino derivatives 49an. 
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Table 15:  Yields for the synthesis of berberino derivatives 49an referred to 1  
 
49e R=H  87% 
49e’  R=CH3COCH3   72% 
49f 96% 
 
49g 22% 
 
49h 73% 
 
49i 62% 
 
49i 61% 
 
49k 55% 
 
49l 61% 
 
49m 85% 
 
49n 61% 
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Compounds 49 possess an intriguing fused esacyclic new system and three of the rings are 
arrayed around the aminal carbon. Their formation occurs through a formal [3+2] cycloaddition 
and the plausible mechanism could involve a preliminary regioselective Michael type addition 
of the -carbon atom of the enamino function in position 13 of 7,8-DHBs 47,47’ to the 
electrophilic terminal carbon of the azo-ene system of DDs 1 producing the non-isolable 
zwitterionic hydrazone intermediates 48. The loss of the hydrogen in -position to the 
hydrazine moiety of 48 could promote the nitrogen intramolecular nucleophilic attack onto the 
iminium function, determining the formation of the dihydropyrrole ring of 49 (Scheme 27). To 
the best of our knowledge, only one other example of Michael-type addition involving DHB 
derivatives was reported.97 
The structures of compounds 49 were determined by mono and bidimensional NMR 
measurements. Additionally, X-ray diffraction studies of 49e, derived from DD 1e and 7,8-
DHB 47, and of 49e’, derived from the same DD 1e and 8-acetonyl-7,8-DHB 47’, were 
performed and they unequivocally confirmed the proposed structures (Figures 15 and 16).98 
 
Figure 15:  X-ray structure of compound 49e 
 
 
Figure 16: X-ray structure of compound 49e’  
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6.3 Antioxidant properties: 
The novel THB derivatives 49an were found to exhibit antioxidant properties at various 
degrees, by using the ORAC (Oxygen radical absorbance capacity) method.100 (Table 16 and 
Graphic 1). In particular, ORAC values of 49a, 49b and 49e were comparable to those of THB. 
A slight ORAC decay (10%) was observed for the compounds 49d and 49h, followed by 49f 
(20%). Instead, compounds 49g, 49i and 49l showed 30% antioxidant capacity decay as 
compared to that of THB. The analogues 49c, 49j, 49k, 49m and 49n showed the lowest ORAC 
values. 
 
Graphic 1:  Antioxidant capacity of THB and its analogues 49an detected by the ORAC 
method. (p<0.05, one-way ANOVA). 
 
SAMPLES ORAC values (μmol TE/mmol) 
THB 1577±72 
49a 1629±42 
49e 1565±56 
49b 1504±18 
49d 1474±60 
49h 1440±49 
49f 1255±9 
49j 1164±51 
49g 1133±57 
49i 955±15 
49m 855±71 
49c 512±19 
49k 206±7 
49l 185±46 
49n 87±3 
Table 16:  Antioxidant capacity value of THB and its analogues 49an   
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Based on synthesis procedures and ORAC values, 7 out of 14 THB derivatives were selected 
for further in vitro antioxidant assays: 2 with high ORAC values (49d and 49e), 2 with 
medium/high values (49g and 49j), 2 with medium values (49i and 49m) and 1 with a low 
ORAC value (49l).  
 
Referring to the DCFH-DA assay, experiments were conducted in NCTC-2544 cells both in the 
absence (basal condition) and in presence (oxidative condition) of the oxidant molecule H2O2.  
In basal conditions, cells were incubated with the selected THB derivatives up to 3h, and then 
the intracellular oxidation levels were evaluated by recording DCFH-DA fluorescence 
emission. As reported in Graphic 2, NCTC-2544 cells incubated for 1h with compounds 49e 
and 49i presented significantly lower oxidation levels as compared to untreated control cells 
(p<0.05 vs. CTR). The same trend was observed for 49e even after 3 h of cell incubation with 
the test molecule.  
 
 
 
Graphic 2:  Relative intracellular oxidation levels in NCTC-2544 cells incubated for 1 and 
3h with THB derivatives (30 µM) or vehicle (0.1% DMSO, CTR). Data are 
expressed as mean ± SD (n=3). *p<0.05 vs. untreated cells (CTR). 
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In oxidative conditions, NCTC-2544 cells were pre-incubated with the selected THB 
derivatives up to 3 h and then oxidized with H2O2. DCFH-DA fluorescence emission was 
recorded for 30 min after H2O2 administration. As shown in graphic 3, both THB and its 
derivatives significantly reduced H2O2-induced intracellular oxidation (p<0.05 vs CTR+). 
Among THB derivatives, 49e and 49i presented the highest antioxidant protection against H2O2. 
In particular, 49e exhibited an antioxidant capacity significantly different from THB as well as 
from the negative control (non-oxidized cells). 
 
 
Graphic 3:  Relative intracellular oxidation levels after H2O2 administration (100 µM) to NCTC-2544 cells 
pre-incubated for 1 and 3 h with THB derivatives (30 µM). CTR-: non-oxidized cells (negative 
control, reference value). CTR+: H2O2-treated cells (positive control, maximum oxidation). 
Data are expressed as mean ± SD (n=3). *p<0.05 vs. CTR-. #p<0.05 vs. THB. 
 
 
The effects of the selected THB derivatives on cell viability were also explored. As reported in 
Graphic 3, compounds 49d, 49e, 49i and 49j had no significant effects on NCTC-2544 cell 
growth when compared to untreated cells (CTR). Compounds 49l and 49m showed a bland 
stimulatory effect on cell growth (p>0.05 vs. CTR), while 49g, after an initial stimulatory effect 
(p<0.05 vs. CTR), exhibited a late inhibitory action (cell growth decrement by 35% at 72h as 
compared to CTR, p<0.05).  
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Graphic 4:  Effect of THB derivatives (30 µM) on NCTC-2544 cell growth after 24, 48, and 72 h of 
incubation. Data are expressed as mean ± SD (n=3). *p<0.05 vs. untreated cells (CTR). 
6.4 Conclusion 
In conclusion, starting from easily available starting materials, such as DDs and 
dihydroberberines, we developed a facile procedure for the synthesis of novel unprecedented 
pyrrolino-tetrahydroberberine derivatives through a formal [3+2] cycloaddition. These 
compounds are fascinating in virtue of the fact that they possess a complex fused esacyclic new 
system and three of these rings are arrayed around an aminal carbon. Besides, the pyrrolino-
tetrahydroberberines synthesized have shown a promising antioxidant activity, as a study 
carried out with the ORAC method and NCTC-2544 cell line text have been demonstrated. 
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7.  GENERAL CONCLUSION 
 
 
 
 
 
 
 
CHAPTER 7 
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The results reported in this thesis demonstrate the usefulness of DDs as powerful Michael 
acceptors. DDs allow various functionalizations of the carbon atom adjacent to the masked 
carbonyl moiety that permit the construction of many types of five- and six-membered 
heterocycles. 
Most of the reactions surveyed herein occur with good yields under very mild conditions, 
usually at room temperature especially in the first step of the 1,4-addition of the nucleophilic 
agents to the azo-ene systems. This step, as well as the heterocycle formation are often 
spontaneous, and, at times, may be favoured by acid or basic catalysis. Rarely, the 
eterocyclization process is affected by temperature. Although most of the reactions described 
formally proceed through many chemical steps, in practice they can frequently be executed in 
one pot and in no case, require anhydrous solvent or inert atmosphere. Finally, the equipment 
(generally magnetic stirring) and work-up procedures (normally extraction with water, 
purification by column chromatography and/or crystallization) are very simple. 
The creation of a new library of several compounds with a large scaffold diversity, highlights 
the utility of these compound as valuable products and key intermediates in organic and 
pharmaceutical chemistry.  
In this regard, an example is provided by the new berberino derivatives, that have shown a 
significant antioxidant activity both in chemical and biological experiments. 
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8.  EXPERIMENTAL SESSION 
 
 
 
 
 
 
 
CHAPTER 8 
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CHAPTER 2 
General information 
All chemicals and solvents were purchased from commercial suppliers and used as received. 
1,2-Diaza-1,3-dienes were prepared as reported[99] and used as EE/EZ isomer mixtures. Melting 
points were determined in open capillary tubes and are uncorrected. FTIR spectra were obtained 
as Nujol mulls. All 1H NMR and 13C NMR spectra were recorded at 400 and 100 MHz, 
respectively. Proton and carbon spectra were referenced internally to solvent signals, using 
values of  = 2.50 ppm for proton (middle peak) and  = 39.50 ppm for carbon (middle peak) 
in DMSO-d6 and  = 7.27 ppm for proton and  = 77.00 ppm for carbon (middle peak) in 
CDCl3. All coupling constants (J) are given in Hz. All the NH and OH exchanged with D2O. 
Precoated silica gel plates 0.25 mm was employed for analytical thin layer chromatography. 
All new compounds showed satisfactory elemental analysis. Mass spectra were recorded in the 
EI mode (70eV). The nomenclature was generated using ACD/IUPAC Name (version 3.50, 5 
Apr. 1998), Advanced Chemistry Development Inc., Toronto, ON (Canada). 
General Procedure for the Synthesis of 3-hydroxy-3,4-dihydro-2H-1,4-thiazine 21ak. 
To a solution of dithiane-2,5-diol 1 (0.5 mmol, 1.0 equiv.) and  DDs 1ak (1.0 mmol, 1.0 
equiv.)[99] in diethyl ether (2.0 mL), at room temperature, N,N-dimethylethylamine  (0.2 mmol, 
0.2 equiv.) was added under magnetic stirring. At the disappearance of the starting materials  
(visual and TLC monitoring), the solvent and the N,N-dimethylethylamine were evaporated 
under vacuum at room temperature obtaining the corresponding crude pure 3-hydroxy-3,4-
dihydro-2H-1,4-thiazines 21ak.  
 
Methyl 4-[(tert-butoxycarbonyl)amino]-3-hydroxy-5-methyl-
3,4-dihydro-2H-1,4-thiazine-6-carboxylate 21a.  
White foam; 1H NMR (400 MHz, CDCl3):  = 1.32 (s, 9H), 2.24 
(s, 3H), 2.60-2.80 (m, 2H), 3.56 (s, 3H), 4.25 (brs, 1H), 4.97 (s, 
1H), 7.85 (s, 1H); 13C NMR (100 MHz, CDCl3)  = 16.0 (q), 28.1 
(q), 31.8 (t), 51.6 (q), 80.6 (d), 81.6 (s), 91.3 (s), 152.1 (s), 154.7 (s), 165.9 (s).; IR (nujol): max 
= 3462, 3292, 1762, 1723 cm-1; MS m/z (%): 304 (M+) (25), 300 (7), 247 (54), 231 (79), 203 
(35), 172 (53), 144, (38), 111 (90); anal. calcd. for C12H20N2O5S (304.3637): C 47.35, H 6.62, 
N 9.20; found: C 47.19, H 6.59, N 9.37. 
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Ethyl 4-[(tert-butoxycarbonyl)amino]-3-hydroxy-5-methyl-
3,4-dihydro-2H-1,4-thiazine-6-carboxylate 21b.  
White foam; 1H NMR (400 MHz, CDCl3):  = 1.23 (t, 3H, J = 7.2 
Hz), 1.41 (s, 9H), 2.33 (s, 3H), 2.63-2.86 (m, 2H), 3.72 (brs, 1H), 
4.12 (q, 2H, J = 7.2Hz), 5.04 (s, 1H), 7.51 (s, 1H); 13C NMR (100 
MHz, CDCl3)  = 14.3 (q), 16.1 (q), 28.2 (q), 32.0 (t), 60.6 (t), 80.5 (d), 81.8 (s), 91.9 (s), 152.2 
(s), 154.6 (s), 165.5 (s); IR (nujol): max = 3452, 3286, 1742, 1706 cm-1; MS m/z (%): 318 (M+) 
(25), 300 (14), 261 (76), 245 (43), 230 (76), 188 (35); anal. calcd. for C13H22N2O5S (318.3903): 
C 49.04, H 6.96, N 8.80; found: C 48.92, H 6.93, N 8.94. 
 
 
Ethyl 4-[(tert-butoxycarbonyl)amino]-3-hydroxy-5-propyl-3,4-
dihydro-2H-1,4-thiazine-6-carboxylate 21c.  
White foam; 1H NMR (400 MHz, CDCl3):  = 0.90 (t, 3H, J = 8.0 
Hz), 1.24 (t, 3H, J = 8.0 Hz), 1.39-1.43 (m, 11H),  2.55-2.91 (m, 4H), 
3.70 (brs, 1H), 4.12 (q, 2H), 5.04 (brs, 1H), 7.37 (brs, 1H); 13C NMR 
(100 MHz, CDCl3)  = 14.3 (q), 22.3 (q), 28.1 (q), 31.4 (t), 31.9 (t),  37.6 (t), 60.5 (t), 80.0 (d), 
81.9 (s), 91.9 (s), 154.4 (s), 155.7 (s), 165.0 (s); IR (nujol): max = 3465, 3274, 1759, 1704 cm-
1; MS m/z (%): 346 (M+) (5), 290 (11), 247 (9), 216 (21), 167 (53), 149 (100); anal. calcd. for 
C15H26N2O5S (346.4434): C 52.00, H 7.56, N 8.09; found: C 52.11, H 7.59, N 7.98. 
 
 
Benzyl 4-[(tert-butoxycarbonyl)amino]-3-hydroxy-5-
methyl-3,4-dihydro-2H-1,4-thiazine-6-carboxylate 21d.  
White foam; 1H NMR (400 MHz, CDCl3):  = 1.44 (s, 9H), 
2.39 (s, 3H), 2.66-2.91 (m, 2H), 4.03 (brs, 1H), 5.07 (s, 1H), 
5.15 (s, 2H), 7.19-7.41(m, 5H), 7.69 (brs, 1H); 13C NMR 
(100 MHz, CDCl3)  = 16.2 (q), 28.2(q), 32.0 (t), 66.2 (t), 
80.6 (d), 81.9 (s), 91.5 (s). 127.7 (d), 127.9 (d), 128.5 (d), 136.4 (s), 152.5 (s), 154.7 (s), 165.3 
(s); IR (nujol): max = 3467, 3235, 1752, 1701 cm-1; MS m/z (%): 380 (M+) (37), 362 (8), 324 
(100), 306 (68), 289 (12), 281 (10), 250 (82), 234 (30); anal. calcd. for C18H24N2O5S 
(380.4596): C 56.82, H 6.36, N 7.36; found: C 56.66, H 6.32, N 7.53. 
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 Methyl 3-hydroxy-4-[(methoxycarbonyl)amino]-5-methyl-3,4-
dihydro-2H-1,4-thiazine-6-carboxylate 21e.  
White foam; 1H NMR (400 MHz, CDCl3):  = 2.30 (s, 3H), 2.61-2.86 
(m, 2H), 3.62 (s, 3H), 3.65 (m, 3H), 5.05 (brs, 2H), 8.30 (brs,  1H); 13C 
NMR (100 MHz, CDCl3)  = 16.4 (q), 31.9 (t), 52. 0 (q), 53.1 (q), 80.4 
(d), 92.1 (s), 152.1 (s), 156.7 (s), 166.2 (s); IR (nujol): max = 3468, 3251, 1758, 1708 cm-1; MS 
m/z (%): 262 (M+) (34), 244 (14), 231 (11), 188 (52), 159 (100); anal. calcd. for C9H14N2O5S 
(262.2839): C 41.21, H 5.38, N 10.68; found: C 41.37, H 5.41, N 10.54. 
 
 
Ethyl 3-hydroxy-4-[(methoxycarbonyl)amino]-5-methyl-3,4-
dihydro-2H-1,4-thiazine-6-carboxylate 21f.  
White foam; 1H NMR (400 MHz, CDCl3):  = 1.19 (t, 3H, J = 8.0 
Hz), 2.28 (s, 3H), 2.61-2.83 (m, 2H), 3.64 (s, 3H), 4.07 (q, 2H, J = 
8.0 Hz), 4.50 (brs, 1H), 5.03 (s, 1H), 8.20 (brs, 1H); 13C NMR (100 
MHz, CDCl3)  = 14.5 (q), 16.4 (q), 32.0 (q), 53. 2 (q), 60.8 (t), 80.5 (d), 92.4 (s), 151.7 (s), 
156.6 (s), 165.8 (s);  IR (nujol): max = 3463, 3302, 1773, 1714 cm-1; MS m/z (%): 276 (M+) 
(20), 258 (7), 233 (20), 173 (15); anal. calcd. for C10H16N2O5S (276.3105): C 43.47, H 5.84, N 
10.14; found: C 43.65, H 5.88, N 9.98. 
 
 
 Benzyl 3-hydroxy-4-[(methoxycarbonyl)amino]-5-
methyl-3,4-dihydro-2H-1,4-thiazine-6-carboxylate 21g. 
White foam; 1H NMR (400 MHz, CDCl3):  = 2.34 (s, 
3H), 2.68-2.87 (m, 2H), 3.67 (s, 3H), 4.23 (s, 1H), 5.07 (s, 
1H), 5.12 (s, 2H), 7.24-7.34 (m, 5H), 7.96 (brs, 1H); 13C 
NMR (100 MHz, CDCl3)  = 16.5 (q), 32.3 (t), 52.1 (q), 68.1 (t), 80.6 (d), 92.2 (s), 128.5 (d), 
128.8 (d), 128.9 (d), 135.6 (s), 152.1 (s), 155.9 (s), 166.1 (s); IR (nujol): max = 3431, 3261, 
1758, 1704 cm-1; MS m/z (%): 338 (M+) (75), 320 (23), 307 (6), 279 (6), 264 (53), 247 (5), 
171 (52), 159 (100); anal. calcd. for C15H18N2O5S (338. 3799): C 53.24, H 5.36, N 8.28; 
found: C 53.09, H 5.32, N 8.42. 
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(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 3-hydroxy-4-
[(methoxycarbonyl)amino]-5-methyl-3,4-dihydro-2H-1,4-
thiazine-6-carboxylate 21h. 
 White foam; 1H NMR (400 MHz, CDCl3):  = 0.70 (d, 3H, J = 
8.0 Hz), 0.83 (d, 6H, J = 8.0 Hz), 1.00-1.07 (m, 1H), 1.29-1.63 
(m, 4H), 1.82-1.98 (m, 3H), 2.06-2.12 (m, 1H), 2.31 (s, 3H), 
2.59-2.91 (m, 2H), 3.31 (t, 1H, J = 8.0 Hz), 3.67 (s, 3H), 4.56-4.64 (m, 1H), 5.01 (brs, 1H), 8.12 
(brs, 1H); 13C NMR (100 MHz, CDCl3)  = 16.2 (q), 21.2 (q), 22.4 (q), 23.2 (t), 25.9 (t), 31.8 
(t), 34.7 (d), 41.2 (d), 45.1 (t), 50.2 (d), 53.1 (q), 71.6 (d), 80.4 (s), 93.1 (s), 151.1 (s), 157.0 (s), 
165.3 (s); IR (nujol): max = 3477, 3275, 1762, 1705 cm-1; MS m/z (%): 386 (M+) (24), 368 (11), 
355 (18), 327 (47), 247 (25), 231 (37), 144 (64); anal. calcd. for C18H30N2O5S (386.5073): C 
55.93, H 7.82, N 7.25; found: C 56.09, H 7.86, N 7.11. 
 
Methyl 4-[(etoxycarbonyl)amino]-3-hydroxy-5-methyl-3,4-
dihydro-2H-1,4-thiazine-6-carboxylate 21i 
. White foam; 1H NMR (400 MHz, CDCl3):  = 1.25 (t, 3H, J = 8.0 
Hz), 2.38 (s, 3H), 2.65-2.87 (m, 2H), 3.70 (s, 3H), 4.11-4.19 (m, 
3H), 5.09 (s, 1H), 7.61 (brs, 1H); 13C NMR (100 MHz, CDCl3)  = 
14.7 (q), 16.5 (q), 32.2 (t), 52.0 (q), 62.5 (t), 80.6 (d), 92.2 (s), 152.1 (s), 156.0 (s), 166.1(s); IR 
(nujol): max = 3470, 3301, 1758, 1698 cm-1; MS m/z (%): 276 (M+) (40), 258 (15), 245 (7), 233 
(40), 202 (55), 173 (75),111 (100); anal. calcd. for C10H16N2O5S (276.3105): C 43.47, H 5.84, 
N 10.14; found: C 43.62, H 5.87, N 9.97. 
 
Ethyl 4-[(etoxycarbonyl)amino]-3-hydroxy-5-methyl-3,4-
dihydro-2H-1,4-thiazine-6-carboxylate 21j. 
White foam; 1H NMR (400 MHz, CDCl3):  = 1.05-1.26  (m, 
6H), 2.28 (s, 3H), 2.61-2.71 (m, 2H), 4.01-4.11 (m, 5H), 5.02 
(brs, 1H), 8.02 (brs, 1H); 13C NMR (100 MHz, CDCl3)  = 14.2 
(q), 14.4 (q), 16.1 (q), 31.8 (t), 60.6 (t), 62.1 (t), 80.5 (d), 92.0 (s), 151.5 (s), 155. 9 (s), 165.6 
(s); IR (nujol): max = 3465, 3276, 1764, 1712 cm-1; MS m/z (%): 290 (M+) (32), 272 (15), 247 
(32), 227 (7), 216(45), 173 (90), 156 (35), 129 (65), 111 (100); anal. calcd. for C11H18N2O5S 
(290.3371): C 45.50, H 6.25, N 9.65; found: C 45.36, H 6.22, N 9.79. 
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Dimethyl {4-[(tert-butoxycarbonyl)amino]-3-hydroxy-5-
methyl-3,4-dihydro-2H-1,4-thiazin-6-yl}phosphonate 21k.  
White foam; 1H NMR (400 MHz, CDCl3): δ = 1.36 (s, 9H), 2.15 (s, 
3H), 2.68 (brs, 1H), 3.60 (s, 3H), 3.63 (s, 3H), 4.25 (brs, 1H), 3.66-
3.77 (m, 2H), 5.06 (s, 1H), 8.06 (brs, 1H); 13C NMR (100 MHz, 
CDCl3) δ = 17.2 (q), 28.1 (q), 32.4 (t), 52.6 (q, 2JCP = 5.4 Hz), 52.8 (q, 2JCP = 5.1 Hz),81.0 (d), 
81.4 (s), 100.5 (s, 1JCP = 130.8 Hz), 153.1 (s), 154.8 (s); IR (nujol): max = 3478, 3281, 1762 
cm-1; MS m/z (%): 354 (M+) (5), 281 (17), 253 (34), 245 (23), 144 (85),; anal. calcd. for 
C12H23N2O6PS (354.3607): C 40.67, H 6.54, N 7.91; found: C 40.86, H 6.59, N 7.65. 
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CHAPTER 3 
General information 
All chemicals and solvents were purchased from commercial suppliers and used as received. 
Rhodanines 22ad were obtained as follows, according to the procedure reported in 
literature:43a a mixture of thioglycolic acid (0.92 g, 10 mmol) and ethyl, phenyl, 4-chlorophenyl 
or 4-methoxyphenyl isothiocyanates (12 mmol) in methanol (8 ml) and water (100 ml) was 
heated in an oil bath for 4 h at 100 °C. 1,2-Diaza-1,3-dienes 1ag were prepared as reported99 
and used as EE/EZ isomers mixtures. Melting points were determined in open capillary tubes 
and are uncorrected. FTIR spectra were obtained as Nujol mulls. All 1H NMR and 13C NMR 
spectra were recorded at 400 and 100 MHz, respectively. Proton and carbon spectra were 
referenced internally to solvent signals, using values of = 2.50 ppm for proton (middle peak) 
and  = 39.50 ppm for carbon (middle peak) in DMSOd6 and = 7.27 ppm for proton and  = 
77.00 ppm for carbon (middle peak) in CDCl3. All coupling constants (J) are given in Hz. All 
the NH exchanged with D2O. Precoated aluminium oxide plates 0.25 mm were employed for 
analytical thin layer chromatography. All new compounds showed satisfactory elemental 
analysis. Mass spectra were recorded in the ESI mode. The nomenclature was generated using 
ACD/IUPAC Name (version 3.50, 5 Apr. 1998), Advanced Chemistry Development Inc., 
Toronto, ON (Canada). 
General procedure for synthesis of dialkyl 2,2’-((3-substituted-4-oxo-2-
thioxothiazolidine-5,5-diyl)bis(4-alkoxy-4-oxobutan-3-yl-2-ylidene))bis(hydrazine-
carboxylates) (24af).  
To a magnetically stirred solution of 1,2-diaza-1,3-dienes 1a,c,d (4.2 mmol) and 3-ethyl or 3-
phenyl or 3-(4-chlorophenyl) or 3-(4-methoxyphenyl)-2-thioxothiazolidin-4-ones 22ad (2.0 
mmol) in THF (10 mL) at room temperature, potassium carbonate (2.0 mmol) was added. After 
the disappearance of the reagents (0.10.5 h) (TLC monitoring), K2CO3 was filtered, the 
reaction solvent was evaporated under reduced pressure and the crude mixture was purified by 
column chromatography on silica gel (cyclohexane : ethyl acetate mixtures) to afford the 
corresponding bis-hydrazone-functionalized rhodanines 24af, that were crystallized from 
diethyl ether-petroleum ether (b.p. 4060 °C). 
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Dimethyl 2,2’-((3-ethyl-4-oxo-2-thioxothiazolidine-
5,5-diyl)bis(4-ethoxy-4-oxobutan-3-yl-2-
ylidene))bis(hydrazinecar-boxylate) (24a). 
 White powder (887.2 mg, 79% yield); mp: 141143 
°C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 
1.131.23 (m, 9H, 2OCH2CH3, NCH2CH3), 1.87 (s, 
3H, CH3), 1.99 (s, 3H, CH3), 3.76 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 4.024.12 (m, 7H, 
CH, 2OCH2CH3, NCH2CH3), 4.51 (brs, 1H, CH), 8.24 (brs, 2H, 2NH); 
13C NMR (100 
MHz, CDCl3, 25 °C): δ = 11.0 (q), 13.8 (q), 13.9 (q), 14.8 (q), 17.2 (q), 39.6 (t), 52.8 
(q), 58.2 (s), 58.7 (d),61.0 (d), 61.8 (t), 62.1 (t), 146.0 (s), 146.3 (s), 154.1 (s), 154.7 (s), 
167.5 (s), 168.5 (s), 177.0 (s), 203.4 (s); ); IR (nujol): max = 3239, 1737, 1715, 1666 cm-
1; MS m/z (ESI): 562.70 (M + H+); anal. calcd. for C21H31N5O9S2 (561.6289): C 44.91, 
H 5.56, N 12.47; found: C 45.04, H 5.59, N 12.35. 
 
 
Dimethyl 2,2’-((4-oxo-3-phenyl-2-thioxothiazolidine-
5,5-diyl)bis(4-ethoxy-4-oxobutan-3-yl-2-
ylidene))bis(hydrazinecar-boxylate) (24b).  
White powder (1.03 g, 85% yield); mp: 145147 °C; 
1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.231.36 (m, 
6H, 2OCH2CH3), 1.84 (s, 3H, CH3), 2.08 (s, 3H, CH3), 
3.73 (brs, 3H, CH3), 3.73 (s, 3H, OCH3), 4.18 (s, 1H, CH), 4.194.30 (m, 4H, 
2OCH2CH3), 4.67 (brs, 1H, CH), 7.437.55 (m, 5H, Ar), 7.98 (brs, 1H, NH), 8.17 (brs, 
1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.4 (q), 14.4 (q), 14.6 (q), 17.5 (q), 
52.7 (q), 52.8 (q), 53.0 (q), 53.1 (q), 58.1 (s), 58.9 (d), 59.0 (d), 62.1 (t), 128.2 (d), 128.3 
(d), 129.3 (d), 136.0 (d), 145.4(s), 146.0 (s), 153.3 (s), 153.4 (s), 154.1 (s),168.4 (s), 
169.4 (s), 171.1 (s), 204.0 (s); IR (nujol): max = 3241, 3160, 1741, 1720, 1690 cm-1; MS 
m/z (ESI): 608.72 (M - H+); anal. calcd. for C25H31N5O9S2 (609.6717): C 49.25, H 5.13, 
N 11.49; found: C 49.14, H 5.10, N 11.65. 
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Diethyl 2,2’-((4-oxo-3-pheny-2-thioxothiazolidine-
5,5-diyl)bis(4-methoxy-4-oxobutan-3-yl-2-
ylidene))bis(hydrazinecarboxylate) (24c). 
 White powder (1.12 g, 92% yield); mp: 135137 °C; 1H 
NMR (400 MHz, CDCl3, 25 °C): δ = 1.281.37 (m, 
6H, 2OCH2CH3), 1.85 (s, 3H, CH3), 2.08 (s, 3H, 
CH3), 3.74 (s, 3H, OCH3), 3.74 (s, 3H, OCH3), 4.18 
(s, 1H, CH), 4.194.31 (m, 4H, 2OCH2CH3), 4.69 (brs, 1H, CH), 7.447.56 (m, 5H, Ar), 
7.80 (brs, 1H, NH), 7.95 (brs, H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.4 
(q), 14.6 (q), 15.2 (q), 17.5 (q), 52.8 (q), 53.1 (q), 58.2 (s), 62.1 (t), 62.3 (d), 65.8 (d), 
128.3 (d), 129.3 (d), 129.4 (d), 136.0 (s), 146.0(s), 153.1 (s), 153.9 (s), 168.4 (s), 169.4 
(s), 171.2 (s), 204.0 (s); IR (nujol): max = 3234, 3159, 3127, 1741, 1701 cm-1; HRMS (ESI) 
m/z [M+H]+ calcd. for C25H32N5O9S2: 610.1641; found: 610.1641; MS m/z (ESI): 610.55 
(M + H+); anal. calcd. for C25H31N5O9S2 (609.6717): C 49.25, H 5.13, N 11.49; found: 
C 49.12, H 5.11, N 11.62. 
 
 
Di-tert-butyl 2,2’-((4-oxo-3-pheny-2-
thioxothiazolidine-5,5-diyl)bis(4-ethoxy-4-
oxobutan-3-yl-2-ylidene))bis(hydrazinecar-
boxylate) (24d).  
White powder (1.29 g, 93% yield) mp: 138141 °C 
1H NMR (400 MHz, CDCl3, 25 °C): δ = 
1.231.27 (m, 6H, 2OCH2CH3), 1.51 (s, 9H, 
(CH3)3), 1.56 (s, 9H, (CH3)3), 1.84 (s, 3H, CH3), 2.09 (s, 3H, CH3), 4.11 (s, 1H, CH), 
4.174.23 (m, 4H, 2OCH2CH3), 4.67 (brs, 1H, CH), 7.457.56 (m, 5H, Ar), 7.65 (brs, 
1H, NH), 7.77 (brs, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 13.9 (q), 14.0 
(q), 14.5 (q), 17.6 (q), 28.2 (q), 28.4 (q), 58.2 (s), 59.1 (d), 59.2 (d), 61.9 (t), 62.1 (t), 
62.2 (t), 81.5 (s), 81.7 (s), 128.4 (d), 129.3 (d), 136.2 (s), 145.3(s), 151.9 (s), 152.6 (s), 
168.0 (s), 169.0 (s), 177.4 (s), 204.4 (s); IR (nujol): max = 3328, 3225, 1724, 1746, 1700 
cm-1; MS m/z (ESI): 694.00 (M + H+); anal. calcd. for C31H43N5O9S2 (693.8312): C 
53.66, H 6.25, N 10.09; found: C 53.78, H 6.29, N 10.02. 
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Diethyl 2,2’-((3-(4-chlorophenyl)-4-oxo-2-
thioxothiazolidine-5,5-diyl)bis(4-methoxy-4-
oxobutan-3-yl-2-ylidene))bis(hydra-zinecarboxlate) 
(24e).  
White powder (1.13 g, 88% yield); mp: 182184 °C; 1H 
NMR (400 MHz, CDCl3, 25 °C): δ = 1.291.37 (m, 
6H, 2OCH2CH3), 1.83 (s, 3H, CH3), 2.09 (s, 3H, 
CH3), 3.73 (s, 3H, OCH3), 3.74 (s, 3H, OCH3), 4.17 (s, 1H, CH), 4.204.33 (m, 4H, 
2OCH2CH3), 4.68 (s, 1H, CH), 7.40 (d, 2H, J = 8.4 Hz, Ar), 7.51 (d, 2H, J = 9.2 Hz, Ar), 
7.84 (brs, 1H, NH), 7.98 (brs, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.4 
(q), 14.4 (q), 14.5 (q), 15.2 (q), 17.6 (q), 52.9 (q), 53.2 (q), 58.2 (s), 59.0 (d), 62.1 (t), 
65.8 (d), 129.7 (d), 129.8 (d), 134.5 (s), 135.4 (s), 145.8(s), 153.1 (s), 155.8 (s), 168.5 
(s), 169.5 (s), 177.1 (s), 203.7 (s); IR (nujol): max = 3332, 3209, 1718, 1752, 1698 cm-1; 
MS m/z (ESI): 643.31 (M - H+); anal. calcd. for C25H30ClN5O9S2 (644.1168): C 46.62, 
H 4.69, N 10.87; found: C 46.75, H 4.71, N 10.73. 
 
 
 Di-tert-butyl 2,2’-((3-(4-methoxypheny)-4-oxo 2-
thioxothiazolidine-5,5-diyl)bis(4-ethoxy-4-
oxobutan-3-yl-2-ylidene))bis(hydrazinecar-
boxylate) (24f).  
White powder (1.34 g, 93% yield) mp: 169171 °C 
(dec.) 1H NMR (400 MHz, CDCl3, 25 °C): δ = 
1.211.77 (m, 6H, 2OCH2CH3), 1.51 (s, 9H, 
(CH3)3), 1.55 (s, 9H, (CH3)3), 1.83 (s, 3H, CH3), 
2.08 (s, 3H, CH3), 3.84 (s, 3H, OCH3), 4.09 (s, 1H, CH), 4.164.23 (m, 4H, 2OCH2CH3), 
4.66 (s, 1H, CH), 7.03 (d, 2H, J = 9.2 Hz, Ar), 7.37 (d, 2H, J = 8.4 Hz, Ar), 7.64 (brs, 
1H, NH), 7.75 (brs, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.0 (q), 14.0 
(q), 14.5 (q), 17.6 (q), 28.2 (q), 28.4 (q), 55.4 (q), 58.2 (s), 59.2 (d), 61.9 (t), 61.9 (t), 
62.2 (t), 65.8 (d), 81.5 (s), 81.7 (s), 114.6 (d), 128.7 (s), 129.4 (d), 145.4 (s), 151.8 (s), 
160.0 (s), 168.0 (s), 169.0 (s), 177.5 (s), 204.7 (s); IR (nujol): max = 3246, 3150, 3109, 
1754, 1693 cm-1; MS m/z (ESI): 724.67 (M + H+); anal. calcd. for C32H45N5O10S2 
(723.8572): C 53.10, H 6.27, N 9.68; found: C 53.01, H 6.26, N 9.78. 
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General procedure for synthesis of 2,3,5,6-tetrahydro-1H-pyrrolo[3,4-c]pyridine-
1,3,6-triones (26a,ce,j,l) starting from 24af (Path A).  
To a magnetically stirred solution of bis-hydrazone-functionalized rhodanines 4af (1.0 
mmol) in THF (5 mL) heated at 55 °C in an oil bath, potassium carbonate (5.0 mmol) 
was added. The flask was kept open in order to remove CS2 by evaporation (b.p. 49.3 
°C). After the disappearance of the products 24 (2.05.0 h) (TLC monitoring), K2CO3 
was filtered, the reaction solvent was evaporated under reduced pressure and the crude 
mixture was purified by column chromatography on silica gel (cyclohexane : ethyl 
acetate mixtures) to afford the corresponding 2,3,5,6-tetrahydro-1H-pyrrolo[3,4-
c]pyridine-1,3,6-triones (26a,ce,j,l), that were crystallized from diethyl ether-
petroleum ether (b.p. 4060 °C).  
General procedure for synthesis of 2,3,5,6-tetrahydro-1H-pyrrolo[3,4-c]pyridine-
1,3,6-triones (26al) in one-pot procedure (Path B). To a magnetically stirred solution 
of 1,2-diaza-1,3-dienes 1ag (2.1 mmol) and 3-ethyl or 3-phenyl or 3-(4-chlorophenyl) 
or 3-(4-methoxyphenyl)-2-thioxothiazolidin-4-ones 22ad (1.0 mmol) in THF (5 mL) 
heated at 55 °C in an oil bath, potassium carbonate (5.0 mmol) was added. The flask was 
kept open in order to remove CS2 by evaporation. After the disappearance of the reagents 
(1.05.0 h) (TLC monitoring), K2CO3 was filtered, the reaction solvent was evaporated 
under reduced pressure and the crude mixture was purified by column chromatography 
on silica gel (cyclohexane : ethyl acetate mixtures) to afford the corresponding 2,3,5,6-
tetrahydro-1H-pyrrolo[3,4-c]pyridine-1,3,6-triones (6al), that were crystallized from 
diethyl ether-petroleum ether (b.p. 460 °C).  
Methyl 2-(1-(2ethyl-5-((methoxycarbonyl)amino)-4-
methyl-1,3,6-trioxo-2,3,5,6-tetrahydro-1H-pyrrolo[3,4-
c]pyridin-7-yl)ethylidene)-hydrazinecarboxylate (26a). 
 Pale yellow powder (149.7 mg, 38% yield, path A; 239.8, 
61% yield, path B); mp: 235−237 °C (dec.); 1H NMR (400 
MHz, CDCl3, 25 °C): δ = 1.22 (t, J = 7.2 Hz, 3H, NCH2CH3), 
2.16 (s, 3H, CH3), 2.79 (s, 3H, CH3), 3.68 (q, J = 7.2 Hz, 2H, NCH2CH3), 3.83 (s, 6H, 2 OCH3), 
7.60 (brs, 1H, NH), 8.16 (brs, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 13.4 (q), 14.4 
(q), 15.6 (q), 33.4 (t), 53.2 (q), 54.2 (q), 105.7 (s), 125.4 (s), 137.2 (s), 142.5 (s), 152.2 (s), 156.2 
(s), 161.0 (s), 164.0 (s), 165.5 (s); IR (nujol): max = 3331, 3239, 1753, 1721, 1672 cm-1; HRMS 
(ESI) m/z [M+H]+ calcd. for C16H20N5O7: 394.1363; found: 394.1363; MS m/z (ESI): 
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394.11 (M + H+); anal. calcd. for C16H19N5O7 (393.1284): C 48.85, H 4.87, N 17.80; found: C 
48.94, H 4.85, N 17.68. 
Tert-butyl 2-(1-(5-((tert-butoxycarbonyl)amino)-2ethyl-
4-methyl-1,3,6-trioxo-2,3,5,6-tetrahydro-1H-
pyrrolo[3,4-c]pyridin-7-yl)ethy-
lidene)hydrazinecarboxylate (26b).  
Pale yellow powder (277.7, 58% yield, path B); mp: 
218220 °C (dec.);  1H NMR (400 MHz, CDCl3, 25 °C): δ 
= 1.22 (t, J = 7.2 Hz, 3H, NCH2CH3), 1.50 (s, 18H, 2 C(CH3)3), 2.13 (s, 3H, CH3), 2.76 (s, 3H, 
CH3), 3.67 (q, J = 7.2 Hz, 2H, NCH2CH3), 7.38 (brs, 1H, NH), 7.89 (s, 1H, NH); 
13C NMR 
(100 MHz, CDCl3, 25 °C): δ = 13.4 (q), 14.4 (q), 15.6 (q), 28.0 (q), 28.2 (q), 33.3 (t), 81.4 (s), 
83.8 (s), 105.1 (s), 125.6 (s), 136.7 (s), 141.4 (s), 152.1 (s), 154.5 (s), 160.9 (s), 164.2 (s), 165.7 
(s); IR (nujol): max = 3358, 3190, 1735, 1718, 1678 cm-1; MS m/z (ESI): 476.38 (M - H+); anal. 
calcd. for C22H31N5O7 (477.5108): C 55.34, H 6.54, N 14.67; found: C 55.22, H 6.50, N 14.78. 
 
 
 
Methyl 2-(1-(5-((methoxycarbonyl)amino)-4-methyl-1,3,6-
trioxo-2-phenyl-2,3,5,6-tetrahydro-1H-pyrrolo[3,4-
c]pyridin-7-yl)ethyli-dene)hydrazinecarboxylate (26c) 
 Pale yellow powder (209.3 mg, 37% yield, path A; 340.2, 
60% yield, path B); mp: 169172 °C; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 2.16 (s, 3H, CH3), 2.83 (s, 3H, CH3), 3.82 
and 3.85 (2s, 6H, 2 OCH3), 7.347.37 (m, 2H, Ph), 7.397.43 (m, 1H, Ph), 7.477.51 (m, 2H, 
Ph), 7.80 (brs, 1H, NH), 8.20 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.5 (q), 
14.6 (q), 15.5 (q), 15.6 (q), 53.3 (q), 54.1 (q), 54.2 (q), 105.1 (s), 125.8 (s), 126.5 (d), 126.6 (d), 
129.1 (d), 131.2 (s), 136.7 (s), 142.5 (s), 153.5 (s), 156.2 (s), 161.0 (s), 163.3 (s), 164.7 (s); δ = 
IR (nujol): max = 3352, 3195, 1738, 1722, 1681 cm-1; MS m/z (ESI): 442.27 (M + H+); anal. 
calcd. for C20H19N5O7 (441.3942): C 54.42, H 4.34, N 15.87; found: C 54.57, H 4.38, N 15.76. 
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Ethyl 2-(1-(5-((ethoxycarbonyl)amino)-4-methyl-1,3,6-
trioxo-2-phenyl-2,3,5,6-tetrahydro-1H-pyrrolo[3,4-
c]pyridin-7-yl)ethylide-ne)hydrazinecarboxylate (26d).  
Pale yellow powder (165.2 mg, 35% yield, path A; 258.6, 
55% yield, path B); mp: 182184 °C; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 1.281.34 (m, 6H, 2 OCH2CH3), 2.16 
(s, 3H, CH3), 2.84 (s, 3H, CH3), 4.254.33 (m, 4H, 2 OCH2CH3), 7.347.37 (m, 2H, Ph), 
7.397.42 (m, 1H, Ph), 7.477.51 (m, 2H, Ph), 7.58 (brs, 1H, NH), 8.04 (s, 1H, NH); 13C NMR 
(100 MHz, CDCl3, 25 °C): δ = 14.3 (q), 14.5 (q), 14.6 (q), 15.6 (q), 62.1 (t), 63.6 (t), 105.1 (s), 
125.8 (s), 126.5 (d), 128.5 (d), 129.1 (d), 131.2 (s), 136.7 (s), 142.4 (s), 153.6 (s), 155.8 (s), 
161.0 (s), 163.4 (s), 164.7 (s); IR (nujol): max = 3343, 3239, 1722, 1675, 1631 cm-1; MS m/z 
(ESI): 470.15 (M + H+); anal. calcd. for C22H23N5O7 (469.4473): C 56.29, H 4.94, N 14.92; 
found: C 56.36, H 4.96, N 14.81. 
 
 
Tert-butyl 2-(1-(5-((tert-butoxycarbonyl)amino)-4-
methyl-1,3,6-trioxo-2-phenyl-2,3,5,6-tetrahydro-1H-
pyrrolo[3,4-c]pyridin-7-
yl)ethylidene)hydrazinecarboxylate (26e). 
Pale yellow powder (216.2 mg, 41% yield, path A; 346.1, 
66% yield, path B); mp: 220222 °C (dec.); 1H NMR (400 
MHz, DMSOd6, 25 °C): δ = 1.45 and 1.48 (2s, 18H, 2 
C(CH3)3), 2.06 (s, 3H, CH3), 2.66 (s, 3H, CH3), 7.387.40 (m, 2H, Ph), 7.447.46 (m, 1H, Ph), 
7.497.53 (m, 2H, Ph), 9.93 (brs, 1H, NH), 10.23 (s, 1H, NH); 13C NMR (100 MHz, DMSOd6, 
25 °C): δ = 14.0 (q), 16.9 (q), 27.8 (q), 28.0 (q), 79.4 (s), 81.4 (s), 104.2 (s), 125.9 (s), 127.4 
(d), 128.3 (d), 128.7 (d), 131.7 (s), 135.6 (s), 142.7 (s), 152.4 (s), 152.7 (s), 154.2 (s), 160.0 (s), 
163.3 (s), 164.7; (s); IR (nujol): max = 3314, 3253, 1725, 1712, 1677 cm-1; HRMS (ESI) m/z 
[M+H]+ calcd. for C26H32N5O7: 526.2302; found: 526.2302; MS m/z (ESI): 524.38 (M - 
H+); anal. calcd. for C26H31N5O7 (525.5536): C 59.42, H 5.95, N 13.33; found: C 59.49, H 5.99, 
N 13.20. 
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Ethyl 2-(1-(4-butyl-5-((etoxycarbonyl)amino)-1,3,6-
trioxo-2-phenyl-2,3,5,6-tetrahydro-1H-pyrrolo[3,4-
c]pyridin-7-yl)pentyli-dene)hydrazinecarboxylate 
(26f).  
Pale yellow powder; (350.8, 63% yield, path B); mp: 
194196 °C (dec.); 1H NMR (400 MHz, CDCl3, 25 °C): δ 
= 0.850.98 (m, 8H, alkyl), 1.241.39 (m, 8H, alkyl), 
1.561.74 (m, 4H, alkyl), 2.482.63 (m, 2H, alkyl), 2.713.09 (m, 2H, alkyl), 4.214.32 (m, 
4H, 2 OCH2CH3), 7.08 (brs, 1H, NH), 7.377.41 (m, 3H, Ph), 7.477.50 (m, 2H, Ph), 8.06 and 
8.27 (2brs, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 13.6 (q), 13.7 (q), 14.3 (q), 14.5 
(q), 22.7 (t), 23.0 (t), 27.0 (t), 27.9 (t), 29.7 (t), 30.7 (t), 63.6 (t), 104.7 (s), 126.4 (s), 126.5 (d), 
128.5 (d), 129.1 (d), 131.2 (s), 137.5 (s), 139.3 (s), 156.0 (s), 157.6 (s), 161.5 (s), 163.4 (s), 
164.5 (s), 165.3; IR (nujol): max = 3348, 3192, 1729, 1721, 1680 cm-1; MS m/z (ESI): 552.37 
(M - H+); anal. calcd. for C28H35N5O7 (553.6068): C 60.75, H 6.37, N 12.65; found: C 60.62, H 
6.33, N 12.79. 
 
 
Benzyl 2-(1-(5-
(((benzyloxy)carbonyl)amino)-4-methyl-
1,3,6-trioxo-2-phenyl-2,3,5,6-tetrahydro-
1H-pyrrolo[3,4-c]pyridin-7-yl) 
ethylidene)hydrazinecarboxylate (26g).  
Pale yellow powder (253.8, 43% yield, path 
B); mp: 199201 °C (dec.); 1H NMR (400 
MHz, CDCl3, 25 °C): δ = 2.12 (s, 3H, CH3), 2.80 (s, 3H, CH3), 5.22 and 5.25 (2s, 4H, 2 
OCH2Ph), 7.347.51 (m, 15H, 3 Ph), 7.64 (s, 1H, NH), 8.12 (s, 1H, NH); 13C NMR (100 MHz, 
CDCl3, 25 °C): δ = 14.6 (q), 14.8 (q), 27.8 (q), 67.8 (T), 69.1 (s), 105.1 (s), 126.4 (s), 126.5 (d), 
128.3 (d), 128.5 (d), 128.6 (d), 128.6 (d), 128.7 (d), 128.8 (d), 129.1 (d), 129.2 (s), 131.2 (s), 
134.7 (s), 136.8 (s), 142.5 (s), 153.5 (s), 153.5 (s), 155.5 (s), 160.9 (s), 163.3 (s), 164.6 (s); IR 
(nujol): max = 3331, 3240, 1738, 1725, 1670; MS m/z (ESI): 592.12 (M + H+); anal. calcd. for 
C32H27N5O7 (593.5861): C 64.75, H 4.58, N 11.80; found: C 64.66, H 4.54, N 11.88. 
  
N
O
O N
NH
O
NNH
O
O
O
O
N
O
O N
NH
O
NNH
O
O
O
O
- 88 - 
 
Methyl 2-(1-(2-(4-chlorophenyl)-5-
((metoxycarbonyl)amino)-4-methyl-1,3,6-trioxo-
2,3,5,6-tetrahydro-1H-pyrrolo[3,4-c]py-ridin-7-
yl)ethylidene)hydrazinecarboxylate (26h). 
 Pale yellow powder (220.2, 46% yield, path B); mp: 
221222 °C (dec.); 1H NMR (400 MHz, CDCl3, 25 °C): δ 
= 2.13 (s, 3H, CH3), 2.80 (s, 3H, CH3), 3.79 and 3.83 (2s, 6H, 2 OCH3), 7.32 (d, J = 8.8 Hz, 
2H, Ph), 7.45 (d, J = 8.8 Hz, 2H, Ph), 8.34 (s, 1H, NH), 8.61 (brs, 1H, NH); 13C NMR (100 
MHz, CDCl3, 25 °C): δ = 14.6 (q), 14.7 (q), 15.5 (q), 15.6 (q), 53.1 (q), 53.3 (q), 54.1 (q), 54.3 
(q), 104.9 (s), 126.0 (s), 127.6 (d), 129.3 (d), 129.6 (s), 134.4 (s), 136.5 (s), 142.2 (s), 153.8 (s), 
156.2 (s), 160.9 (s), 163.0 (s), 164.4 (s); IR (nujol): max = 3325, 3239, 1752, 1735, 1718, 1670 
cm-1; HRMS (ESI) m/z [M+H]+ calcd. for C20H19ClN5O7: 476.0973; found: 476.0973; MS 
m/z (ESI): 476.10 (M + H+); anal. calcd. for C20H18ClN5O7 (475.8392): C 50.48, H 3.81, N 
14.72; found: C 50.59, H 3.82, N 14.65. 
 
 
Tert-butyl 2-(1-(5-((tert-butoxycarbonyl)amino)-2-(4-
chlorophenyl)-4-methyl-1,3,6-trioxo-2,3,5,6-
tetrahydro1H-pyr-rolo[3,4-c]pyridin-7-
yl)ethylidene)hydrazinecarboxylate (26i). 
 Pale yellow solid; (284.8, 51% yield, path B); mp: 
171173 °C (dec.); 1H NMR (400 MHz, CDCl3, 25 °C): δ 
= 1.49 (s, 18H, 2 C(CH3)3), 2.13 (s, 3H, CH3), 2.82 (s, 3H, 
CH3), 7.33 (d, J = 8.8 Hz, 2H, Ph), 7.45 (d, J = 8.8 Hz, 2H, Ph), 7.48 (brs, 1H, NH), 7.86 (s, 
1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.5 (q), 14.7 (q), 15.5 (q), 15.7 (q), 27.9 
(q), 28.0 (q), 28.2 (q), 28.3 (q), 81.5 (s), 83.9 (s), 104.4 (s), 126.1 (s), 127.8 (d), 127.8 (d), 129.2 
(d), 129.3 (d), 129.8 (d), 134.2 (s), 136.1 (s), 141.7 (s), 152.1 (s), 153.7 (s), 154.4 (s), 160.9 (s), 
163.2 (s), 164.6 (s); IR (nujol): max = 3328, 3205, 1732, 1718, 1685 cm-1; MS m/z (ESI): 558.30 
(M - H+); anal. calcd. for C26H30ClN5O7 (559.9987): C 55.76, H 5.40, N 12.51; found: C 55.84, 
H 5.44, N 12.53. 
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Ethyl 2-(1-(2-(4-chlorophenyl)-5-
((ethoxycarbonyl)amino-4-methyl-1,3,6-trioxo-2,3,5,6-
tetrahydro-1H-pyrrolo[3,4-c]pyridin-7-
yl)ethylidene)hydrazinecarboxylate (26j).  
Pale yellow powder (194.8 mg, 39% yield, path A; 293.7, 
58% yield, path B); mp: 177180 °C (dec.); 1H NMR (400 
MHz, CDCl3, 25 °C): δ = 1.231.29 (m, 6H, 2 OCH2CH3), 2.13 (s, 3H, CH3), 2.80 (s, 3H, CH3), 
4.124.33 (m, 4H, 2 OCH2CH3), 7.32 (d, J = 8.0 Hz, 2H, Ph), 7.44 (d, J = 8.0 Hz, 2H, Ph), 
7.93, 8.03, 8.16 and 8.33 (4brs, 2H, 2NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14. 1(q), 
14.3 (q), 14.5 (q), 14.7 (q), 60.4 (t), 63.5 (t), 104.8 (s), 126.0 (s), 127.8 (d), 129.3 (d), 129.8 (s), 
134.3 (s), 136.4 (s), 142.6 (s), 153.9 (s), 155.8 (s), 158.8 (s), 161.0 (s), 163.2 (s), 164.5 (s); IR 
(nujol): max = 3325, 3200, 1731, 1714, 1680 cm-1; MS m/z (ESI): 502.76 (M - H+);  anal. calcd. 
for C22H22ClN5O7 (503.8924): C 52.44, H 4.40, N 13.90; found: C 52.51, H 4.38, N 14.01. 
 
 
Ethyl 2-(1-(5-((ethoxycarbonyl)amino)-2-(4-
methoxyphenyl)-4-methyl-1,3,6-trioxo-2,3,5,6-
tetrahydro1H-pyrrolo[3,4-c]pyridin-7-
yl)ethylidene)hydrazinecarboxylate (26k).  
Pale yellow oil; (295.4, 59% yield, path B); 1H NMR (400 
MHz, CDCl3, 25 °C): δ = 1.26 (q, 6H, J = 7.2 Hz, 2 
OCH2CH3), 2.12 (s, 3H, CH3), 2.78 (s, 3H, CH3), 3.81 (s, 
3H, OCH3), 4.22-4.28 (m, 4H, 2 OCH2CH3), 6.97 (d, J = 8.8 Hz, 2H, Ph), 7.25 (d, J = 8.8 Hz, 
2H, Ph), 8.14 (brs, 1H, NH), 8.30 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14. 
2(q), 14.4 (q), 14.4 (q), 15.6 (q), 60.4 (t), 55.4 (q), 60.3 (t), 63.3 (t), 105.0 (s), 114.4 (d), 123.8 
(s), 125.8 (s), 127.8 (d), 136.6 (s), 142.7 (s), 153.4 (s), 155.7 (s), 159.4 (s), 161.0 (s), 163.6 (s), 
165.0 (s); IR (nujol): max = 3305, 3148, 1737, 1720, 1701 cm-1; MS m/z (ESI): 498.44 (M - 
H+); anal. calcd. for C23H25N5O8 (499.4733): C 55.31, H 5.05, N 14.02; found: C 55.22, H 5.03, 
N 14.11. 
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Tert-butyl 2-(1-(5-((tert-butoxycarbonyl)amino)-2-(4-
methoxyphenyl)-4-methyl-1,3,6-trioxo-2,3,5,6-
tetrahydro1H-pyrrolo[3,4-c]pyridin-7-
yl)ethylidene)hydrazinecarboxylate (26l).  
Pale yellow solid; (338.9 mg, 61% yield, path A; 355.1, 
64% yield, path B); mp: 171173 °C (dec.); 1H NMR (400 
MHz, CDCl3, 25 °C): δ = 1.47 (s, 18H, 2 C(CH3)3), 2.12 (s, 
3H, CH3), 2.78 (s, 3H, CH3), 3.81 (s, 3H, OCH3), 6.97 (d, J = 9.2 Hz, 2H, Ph), 7.26 (d, J = 9.2 
Hz, 2H, Ph), 7.73 (brs, 1H, NH), 7.96 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 
14.4 (q), 15.7 (q), 27.9 (q), 28.2 (q), 55.4 (q), 81.3 (s), 83.4 (s), 104.6 (s), 114.3(d), 123.9 (s), 
125.7 (s), 127.8 (d), 136.4 (s), 141.8 (s), 152.2 (s), 153.3 (s), 154.5 (s), 159.4 (s), 161.0 (s), 
163.8 (s), 165.2 (s); IR (nujol): max = 3302, 3150, 2982, 1739, 1719, 1709 cm-1; HRMS (ESI) 
m/z [M+H]+ calcd. for C27H33N5O8: 556.2407; found: 556.2407; MS m/z (ESI): 554.44 (M 
- H+); anal. calcd. for C27H33N5O8 (555.5796): C 58.37, H 5.99, N 12.61; found: C 58.50, H 
6.01, N 12.52. 
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General procedure for synthesis of 7-acetyl-5-amino-4-methyl-2-phenyl-1H-pyrrolo[3,4-
c]pyridine-1,3,6(2H,5H)-trione 27a starting from 26e.  
To a magnetically stirred solution of tert-butyl 2-(1-(5-((tert-butoxycarbonyl)amino)-4-methyl-
1,3,6-trioxo-2-phenyl-2,3,5,6-tetrahydro-1H-pyrrolo[3,4-c]pyridin-7-yl)ethylidene)hydrazine-
carboxylate 26e (1.0 mmol) in acetone/water (4.5:0.5 mL) at room temperature, Amberlyst 15H 
(500 mg) was added. After the disappearance of the product 26e (3.0 h) (TLC monitoring), 
Amberlyst 15H was filtered, the reaction solvent was evaporated under reduced pressure and 
the crude mixture was purified by column chromatography on silica gel (cyclohexane : ethyl 
acetate mixtures) to afford the corresponding 7-acetyl-5-amino-4-methyl-2-phenyl-1H-
pyrrolo[3,4-c]pyridine-1,3,6(2H,5H)-trione 27a, that was crystallized from diethyl ether-
petroleum ether (b.p. 40-60 °C).  
 
 
7-Acetyl-5-amino-4-methyl-2-phenyl-1H-pyrrolo[3,4-
c]pyridine-1,3,6-(2H,5H)-trione (27a).  
White powder (257.8, 83% yield); mp: 171173 °C; 1H NMR (400 
MHz, CDCl3, 25 °C): δ = 2.62 (s, 3H, CH3), 2.96 (s, 3H, CH3), 
5.05 (brs, 2H, NH2), 7.36-7.51 (m, 5H, Ph); 
13C NMR (100 MHz, 
CDCl3, 25 °C): δ = 15. 1 (q), 31.0 (q), 104.2 (s), 126.4 (d), 128.6 (d), 129.1 (d), 131.7 (s), 131.1 
(s), 134.0 (s), 151.4 (s), 159.2 (s), 163.5 (s), 164.9 (s), 197.5 (s); IR (nujol): max = 3300, 3201, 
1720, 1685, 1615 cm-1; MS m/z (ESI): 312.14 (M + H+); anal. calcd. for C16H13N3O4 
(311.2921): C 61.73, H 4.21, N 13.50; found: C 61.85, H 4.25, N 13.39. 
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CHAPTER 4 
General experimental details. 
 
All the commercially available reagents and solvents were used without further purification. 
1,2-Diaza-1,3-dienes 1ag were synthesized as a mixture of E/Z isomers as previously 
reported.99 Chromatographic purification of compounds was carried out on silica gel (60–200 
μm). TLC analysis was performed on pre-loaded (0.25 mm) glass supported silica gel plates 
(Kieselgel 60); compounds were visualized by exposure to UV light and by dipping the plates 
in 1% Ce(SO4)·4H2O, 2.5% (NH4)6Mo7O24·4H2O in 10% sulphuric acid followed by heating 
on a hot plate. All 1H NMR and 13C NMR spectra were recorded at 400 and 100.56 MHz, 
respectively. Proton and carbon spectra were referenced internally to solvent signals, using 
values of δ = 2.49 ppm for proton (middle peak) and δ = 39.50 ppm for carbon (middle peak) 
in DMSO-d6 and δ = 7.27 ppm for proton and δ = 77.00 ppm for carbon (middle peak) in CDCl3. 
The following abbreviations are used to describe peak patterns where appropriate: s = singlet, 
d = doublet, t = triplet q = quartet, sep = septet, m = multiplet and brs = broad signal. All 
coupling constants (J) are given in Hz. FT-IR spectra were obtained as Nujol mulls. Mass 
spectra were recorded in the EI mode (70eV). Melting points were determined in open capillary 
tubes and are uncorrected. 
 
Experimental procedures and spectral data. 
 
 
General procedure for synthesis of 3-alkylamino-2-(carbamothioyl)but-2-enoates (ACTs) 
28a-n. 
Alkyl amines 1a,b (0.5 mmol) were added to -ketoesters 30a-i (0.55 mmol) or to ethyl 
phenylpropiolate 33a (0.55mmol) under solvent-free conditions at room temperature and 
vigorously stirred. After 0.5 h aryl isothiocyanates 31a-c (0.5mmol) in MeOH (1.5 mL) were 
added and the reactions were stirred until the disappearance of the enamino esters 32 (6.0-18.0 
h monitored by TLC). The compounds 28a-c,e-i,l crystallized directly from the reaction 
medium and were collected as pure products by filtration. In the other cases, the reaction solvent 
was evaporated under reduced pressure and the final ACTs 28d,j,k,m,n were purified by 
chromatography on silica gel column (elution mixture: cyclohexane: ethyl acetate). 
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Methyl 3-(butylamino)-2-(phenylcarbamothioyl)but-2-
enoate 28a. 
28a was isolated by precipitation in methanol in 72% yield. 
Light yellow solid; mp: 109-110 °C; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 0.93 (t, 3H, J=7,6 Hz, n-But), 1.33-1.64 
(m, 4H, n-But), 2.18 and 2.21 (2s, 3H, CH3), 3.20, 3.30 (2q, 2H, J=6,0 Hz, J=6,8 Hz, n-But), 
3.40, 3.71 (2s, 3H, OCH3), 7.02-7.60 (m, 5H, Ph), 9.54, 9.59, 10.40, 11.69 (4brs, 2H, NH); 
13C 
NMR (100 MHz, CDCl3, 25 °C): δ = 13.6 (q), 17.0 (t), 19.0 (t), 19.8 (t), 20.1 (t), 31.2 (q), 31.8 
(q), 43.0 (t), 43.6 (t), 50.3 (q), 51.00 (q), 97.5 (s), 100.3 (s), 122.4 (d), 124.6 (d), 126.1 (d), 
128.5 (d), 128.9 (d), 139.2 (s), 139.3 (s), 161.7 (s), 165.3 (s), 166.5 (s), 169.6 (s), 192.2 (s), 
192.3 (s), 201.5 (s), 201.5 (s); IR (nujol): max = 3277, 3246, 1629, 1594 cm-1; MS m/z (ESI): 
307.13 (M + H+); anal. calcd. for C16H22N2O2S (306.4231): C 62.71, H 7.24, N 9.14; found: C 
62.62, H 7.21, N 9.21. 
 
 
Methyl 3-(butylamino)-2-((4-methoxyphenyl)carbamothioyl)but-2-enoate 28b. 
28b was isolated by precipitation in methanol in 49% 
yield. Light yellow solid; mp: 107-109 °C; 1H NMR 
(400 MHz, CDCl3, 25 °C): δ = 0.89-0.95 (m, 3H, n-But), 
1.33-1.65 (m, 4H, n-But), 2.16, 2.21 (2s, 3H, CH3), 3.16-
3.22, 3.36 (m and q, 2H, J=5,2 Hz, n-But), 3.46, 3.60, 
3.72 (3s, 3H, OCH3), 3.76, 3.79, 3.80 (3s, 3H, OCH3), 6.78-7.46 (m, 5H, Ph), 9.46, 9.70, 10.26, 
11.67 (4brs, 2H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 13.6 (q), 16.9 (q), 18.9 (t), 19.8 
(q), 20.1 (q), 31.3 (t), 31.8 (t), 32.3 (t), 42.6 (t), 43.0 (t), 43.5 (t), 49.7 (q), 50.4 (q), 51.0 (q), 
55.3 (q), 55.4 (q), 81.2 (s), 97.2 (s), 100.1 (s), 113.8 (d), 114.0 (d), 114.7 (d), 124.3 (s), 126.4 
(d), 126.8 (d), 132.4 (s), 157.7 (s), 161.3 (s), 165.1 (s), 166.5 (s), 169.6 (s), 192.6 (s), 201.6 (s); 
IR (nujol): max = 3257, 3252, 1631, 1597 cm-1; MS m/z (ESI): 337.21 (M + H+); anal. calcd. 
for C17H24N2O3S (336.4491): C 60.69, H 7.19, N 8.33; found: C 60.79, H 7.18, N 8.48. 
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Ethyl 3-(butylamino)-2-(phenylcarbamothioyl)but-2-
enoate 28c. 
28c was isolated by precipitation in methanol in 58% yield. 
Light yellow solid; mp: 107-109 °C; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 0.95 (t, 3H, J=7,6 Hz, n-But), 1.30 (t, 3H, 
J=7,2 Hz, OCH2CH3), 1.37-1.69 (m, 4H, n-But), 2.23 and 2.25 (2s, 3H, CH3), 3.24, 3.33 (2q, 
2H, J=6,0 Hz, J=6,8 Hz, n-But), 3.87, 4.21 (2q, 2H, J=6,8 Hz, J=7,2 Hz, OCH2CH3), 7.03-7.56 
(m, 5H, Ph), 9.65, 9.70, 10.58, 12.07 (4brs, 2H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 
13.6 (q), 14.2 (q), 17.2 (t), 19.4 (t), 19.9 (t), 20.1 (t), 31.2 (q), 31.9 (q), 43.1 (t), 43.7 (t), 59.1 
(t), 60.00 (t), 97.8 (s), 100.3 (s), 122.0 (d), 125.0 (d), 125.7 (d), 126.1 (d), 128.6 (d), 129.0 (d), 
139.4 (s), 161.9 (s), 165.8 (s), 166.1 (s), 169.5 (s), 191.7 (s), 191.7 (s), 191.8 (s), 201.4 (s); IR 
(nujol): max = 3232, 3142, 1653, 1634 cm-1; MS m/z (ESI): 321.18 (M + H+); anal. calcd. for 
C17H24N2O2S (320.4497): C 63.72, H 7.55, N 8.74; found: C 63.84, H 7.57, N 8.68. 
 
Ethyl 3-(benzylamino)-2-(phenylcarbamothioyl)but-2-
enoate 28d. 
28d was isolated by precipitation in methanol in 35% yield. 
Light yellow solid; mp: 9798 °C; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 1.09 and 1.25-1.32 (t and m, 3H, J=7,2 Hz, 
OCH2CH3), 1.93, 2.19 and 2.26 (3s, 3H, CH3), 3.94, 4.11and 4.22 (3q, 2H, J=7,2 Hz, J=7,2 Hz, 
J=7,2 Hz, OCH2CH3), 7.04-7.42 (m, 9H,2Ph), 7.59 (d, 1H, J=8,0 Hz, Ph), 8.97, 9.55, 9.95, 
10.33, 12.14 (5brs, 2H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.3 (q), 14.6 (q), 17.2 
(q), 19.2 (q), 19.4 (q), 46.8 (t), 47.0 (t), 47.5 (t), 58.4 (t), 59.4 (t), 60.2 (t), 83.2 (s), 99.0 (s), 
101.6 (s), 122.4 (d), 124.8 (d), 125.7 (d), 126.3 (d), 126.6 (d), 126.7 (d), 127.1 (d), 127.3 (d), 
127.7 (d), 128.7 (d), 128.7 (d), 128.8 (d), 128.9 (d), 128.9 (d), 129.1 (d), 129.5 (d), 136.8 (s), 
138.7 (s), 139.4 (s), 161.4 (s), 161.8 (s), 165.2 (s), 166.2 (s), 169.2 (s), 170.6 (s), 192.7 (s), 
191.7 (s), 201.7 (s); IR (nujol): max = 3130, 3088, 1648, 1589 cm-1; MS m/z (ESI): 355.99 (M 
+ H+); anal. calcd. for C20H22N2O2S (354.1402): C 67.77, H 6.26, N 7.90; found: C 67.63, H 
6.22, N 7.96. 
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Ethyl 3-(butylamino)-2-((4-
chlorophenyl)carbamothioyl)but-2-enoate 28e. 
28e was isolated by precipitation in methanol in 51% 
yield. Light yellow solid; mp: 8992 °C; 1H NMR (400 
MHz, CDCl3, 25 °C): δ = 0.96 (t, 3H, J=7,2 Hz, n-But), 
1.31 (t, 3H, J=7,2 Hz, OCH2CH3),1.43-1.70 (m, 4H, n-But), 2.26 (s, 3H, CH3), 3.36 (q, 2H, 
J=5,6 Hz, n-But), 4.22 (q, 2H, OCH2CH3), 7.32 (d, 2H, J=8.4 Hz, Ph), 7.49 (d, 2H, J=8.4 Hz, 
Ph), 10.86, (brs, 1H, NH), 12.49 (brs, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 13.6 
(q), 13.7 (q), 14.2 (q), 14.6 (q), 19.3 (t), 20.0 (t), 20.2 (t), 31.2 (q), 32.4 (q), 42.7 (t), 43.8 (t), 
58.2 (t), 60.2 (t), 81.6 (s), 99.9 (s), 126.5 (d), 126.9 (d), 128.7 (d), 130.0 (d), 131.2 (s), 132.9 
(s), 138.0 (s), 161.9 (s), 166.7 (s), 169.9 (s), 170.6 (s), 195.9 (s), 206.9 (s); IR (nujol): max = 
3257, 3187, 1632, 1602 cm-1; MS m/z (ESI): 355.03 (M + H+); anal. calcd. for C17H23ClN2O2S 
(354.8947): C 57.53, H 6.53, N 7.89; found: C 57.62, H 6.52, N 7.83. 
 
 
Isopropyl 3-(butylamino)-2-(phenylcarbamothioyl)but-2-enoate 28f. 
28f was isolated 1by precipitation in methanol in 55% yield. 
Light yellow solid; mp: 9799 °C; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 0.75, 1.12, 1.28 (3d, 6H, J=5,2 Hz, J=6,0 
Hz, J=6,4 Hz, OCH(CH3)2), 0.94 (t, 3H, J=7,2 Hz, n-But), 
1.37-1.69 (m, 4H, n-But), 2.22 and 2.25 (2s, 3H, CH3), 3.23, 
3.33 (2q, 2H, J=6,0 Hz, J=6,8 Hz, n-But), 4.75 and 5.09 (2ep, 
2H, J=6,4 Hz, J=6,4 Hz, OCH(CH3)2), 7.03-7.54 (m, 5H, Ph), 9.61, 9.69, 10.70, 12.27 (4brs, 
2H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 13.6 (q), 19.7 (t), 20.2 (t), 21.9 (q), 31.2 (q), 
31.9 (q), 43.1 (t), 43.7 (t), 66.4 (d), 67.6 (d), 98.1 (s), 100.4 (s), 121.6 (d), 125.1 (d), 125.5 (d), 
126.0 (d), 128.5 (d), 129.0 (d), 139.5 (s), 161.7 (s), 165.5 (s), 165.9 (s), 169.2 (s), 191.2 (s), 
201.4 (s); IR (nujol): max = 3255, 3167, 1622, 1612 cm-1; MS m/z (ESI): 344.23 (M + H+); 
anal. calcd. for C18H26N2O2S (343.4762): C 64.64, H 7.84, N 8.38; found: C 64.73, H 7.86, N 
8.32. 
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Tert-butyl 3-(butylamino)-2-((4-
chlorophenyl)carbamothioyl)but-2-enoate 28g. 
28g was isolated by precipitation in methanol in 75% 
yield. Light yellow solid; mp: 9294 °C; 1H NMR (400 
MHz, CDCl3, 25 °C): δ = 0.94 (t, 3H, J=7,2 Hz, n-But), 
1.42-1.70 (m, 4H, n-But), 1.51 (s, 9H, C(CH3) 3), 2.24 (s, 
3H, CH3), 3.33 (q, 2H, J=6,8 Hz, n-But), 7.30 (d, 2H, 
J=8.4 Hz, Ph), 7.45 (d, 2H, J=8.4 Hz, Ph), 9.47, 9.61, 10.97, (3brs, 2H, NH); 13C NMR (100 
MHz, CDCl3, 25 °C): δ = 13.6 (q), 20.2 (t), 28.4 (q), 31.2 (t), 43.8 (t), 81.0 (s), 101.2 (s), 124.4 
(s), 124.5 (s), 126.6 (d), 128.6 (d), 131.0 (s), 132.9 (s), 138.1 (s), 166.3 (s), 169.6 (s), 190.0 (s), 
(s); IR (nujol): max = 3257, 3191, 1624, 1615  cm-1; MS m/z (ESI): 383.59 (M + H+); anal. 
calcd. for C19H27ClN2O2S (382.9479): C 59.59, H 7.11, N 7.32; found: C 59.67, H 7.08, N 7.37. 
 
 
Allyl 3-(butylamino)-2-(phenylcarbamothioyl)but-2-
enoate 28h. 
28h was isolated by precipitation in methanol in 40% yield. 
Light yellow solid; mp: 8890 °C; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 0.95 (t, 3H, J=7,6 Hz, n-But), 1.37-1.68 
(m, 4H, n-But), 2.22 and 2.26 (2s, 3H, CH3), 3.18-3.26, 3.33 
(m, q, 2H, J=6,0 Hz, n-But), 4.28-4.67 (m, 2H, 
OCH2CH=CH2), 5.06-5.37 (m, 2H, OCH2CH=CH2), 5.62-6.00 (m, 1H, OCH2CH=CH2), 7.02-
7.58 (m, 5H, Ph), 8.54, 9.58, 10.42, 11.88 (4brs, 2H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): 
δ = 13.6 (t), 13.7 (q), 19.3 (t), 19.4 (t), 19.9 (t), 20.2 (t), 31.3 (q), 32.4 (q), 42.7 (t), 43.7 (t), 63.1 
(t), 64.7 (d), 81.3 (s), 97.4 (s), 100.2 (s), 116.8 (t), 118.1 (t), 122.3 (d), 124.9 (d), 125.7 (d), 
126.2 (d), 127.2 (d), 128.6 (d), 129.0 (d), 129.5 (d), 132.4 (s), 133.6 (s), 139.4 (s), 162.0 (s), 
162.3 (s), 165.7 (s), 165.7 (s), 168.8 (s), 170.1 (s), 192.2 (s), 192.3 (s),201.5 (s); IR (nujol): max 
= 3240, 3141, 1654, 1626 cm-1; MS m/z (ESI): 333.12 (M + H+); anal. calcd. for C18H24N2O2S 
(332.4604): C 65, H 7.28, N 8.43; found: C 64.86, H 7.24, N 8.52. 
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Methyl 3-(butylamino)-2-((4-
chlorophenyl)carbamothioyl)pent-2-enoate 28i. 
28i was isolated by precipitation in methanol in 50% yield. 
Light yellow solid; mp: 102105 °C; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 0.95 (t, 3H, J=7,2 Hz, n-But), 1.27 (t, 
3H, J=7,2 Hz, CH2CH3),1.47 (sex, 2H, J=7,6 Hz, n-But),1.63-1.70 (m, 2H, n-But), 2.55 (q, 2H, 
J=7,2 Hz, CH2CH3), 3.37 (q, 2H, J=6,4 Hz, n-But), 3.74 (s, 3H, OCH3), 7.33 (d, 2H, J=8.4 Hz, 
Ph), 7.53 (d, 2H, J=8.4 Hz, Ph), 9.58, 9.63, 10.48, 11.90 (4brs, 2H, NH); 13C NMR (100 MHz, 
CDCl3, 25 °C): δ = 12.6 (q), 13.6 (q), 20.0 (t), 20.1 (t), 25.2 (t), 30.8 (q), 31.6 (q), 43.2 (t), 51.1 
(q), 51.2 (q), 99.8 (s), 123.4 (d), 126.1 (d), 126.3 (d), 128.6 (d), 130.0 (s), 131.2 (s), 137.9 (s), 
166.6 (s), 169.7 (s), 170.0 (s), 180.5 (s), 199.2 (s), 199.2 (s), 201.5 (s); IR (nujol): max = 3289, 
3267, 1654, 1632 cm-1; MS m/z (ESI): 355.58 (M + H+); anal. calcd. for C17H23ClN2O2S 
(354.8947): C 57.53, H 6.53, N 7.89; found: C 57.39, H 6.49, N 8.01. 
 
 
 
 
 
 
 
 
Ethyl 3-(butylamino)-2-(phenylcarbamothioyl)pent-2-enoate 28j (Ethyl 3-(butylimino)-2-
(phenylcarbamothioyl)pentanoate 28j’). 
28j is in tautomeric equilibrium between the enamino j (51%) and the imino j’ forms. g was 
isolated by precipitation in methanol in 76% yield. Light yellow solid; mp: 9495 °C; 1H NMR 
(400 MHz, CDCl3, 25 °C): δ = 0.92-0.98 (m, 3.3 H), 1.14 (t, 1.4 H, J=7,6 Hz), 1.24-1.33 (m, 
4.3 H), 1.39-1.68 (m, 4.4 H), 2.22 (q, 1.0 H, J=7,6 Hz), 2.59 (q, 1.0 H, J=7,6 Hz), 3.20 (q, 0.9 
H, J=6,4 Hz), 3.37 (q, 1.1 H, J=6,4 Hz), 4.09 (q, 0.9 H, J=7,2 Hz), 4.21 (q, 0.9 H, J=7,2 Hz), 
4.45 (s, 0.4 H), 7.06 (brs, 0.34 H), 7.21-7.57 (m, 4.9 H), 8.57 (brs, 0.34 H), 9.51, 9.67 (brs, 0.18 
H), 10.36 (brs, 0.37 H), 11.79 (brs, 0.37 H); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 12.2, 
13.7, 13.7, 14.6, 20.0, 20.2, 25.3, 32.4, 42.3, 43.2, 58.2, 60.1, 79.8, 100.2, 124.9, 125.6, 125.7, 
125.7, 126.2, 127.2, 128.6, 129.5, 129.5, 129.5, 139.5, 167.1, 171.0, 192.5, 201.7; IR (nujol): 
max = 3248, 3135, 1625, 1598 cm-1; MS m/z (ESI): 335.20 (M + H+); anal. calcd. for 
C18H26N2O2S (334.4762): C 64.64, H 7.84, N 8.38; found: C 64.76, H 7.82, N 8.45.  
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Ethyl 3-(butylamino)-2-(phenylcarbamothioyl)hex-2-
enoate 28k. 
28k was isolated by precipitation in methanol in 45% yield. 
Light yellow solid; mp: 8891 °C; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 0.95 (t, 3H, J=7,2 Hz, n-But), 1.01 (t, 3H, 
J=7,2 Hz, prop), 1.31 (t, 3H, J=7,2 Hz, OCH2CH3), 1.42-1.52 (m, 2H, prop), 1.56-1.74 (m, 4H, 
n-But), 2.51-2.55 (m, 2H, prop), 3.34 (q, 2H, J= 5.6 Hz, n-But), 3.81-3.84, 4.20 (m, and q, 2H, 
J=6,8 Hz, OCH2CH3), 7.04-7.57 (m, 5H, Ph), 9.57, 9.71, 10.27, 11.71 (4brs, 2H, NH); 
13C NMR 
(100 MHz, CDCl3, 25 °C): δ = 13.7 (q), 14.3 (q), 20.2 (q), 21.9 (t), 31.8 (t), 33.7 (t), 43.2 (t), 
60.1 (t), 97.1 (s), 100.4 (s), 121.6 (s), 124.9 (d), 126.2 (s), 128.6 (d), 129.0 (s), 139.4 (s), 165.7 
(s), 166.3 (s), 168.0 (s), 169.5 (s), 192.6 (s), 192.7 (s), 192.8 (s), 201.4 (s); IR (nujol): max = 
3282, 3214, 1649, 1616 cm-1; MS m/z (ESI): 349.09 (M + H+); anal. calcd. for C19H28N2O2S 
(348.5028): C 65.48, H 8.10, N 8.04; found: C 65.39, H 8.06, N 8.11. 
 
 
Benzyl 3-(butylamino)-2-(phenylcarbamothioyl)but-2-
enoate 28l. 
28lwas isolated by precipitation in methanol in 34% yield. 
Light yellow solid; mp: 120123 °C; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 2.23 and 2.24 (2s, 3H, CH3), 4.42, 4.48 (2d, 
2H, J=6,4 Hz, J=6,0 Hz, NCH2Ph), 5.20 (d, 2H, J=4,4 Hz, 
OCH2Ph), 7.32-7.40 (m, 14H, Ph), 7.58 (d, 1H, J=7,6 Hz, Ph), 
9.87, 9.94, 10.10, 11.50 (4brs, 2H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 16.8 (q), 18.5 
(t), 47.3 (t), 49.8 (t), 65.6 (t), 66.9 (t), 82.7 (s), 98.5 (s), 101.8 (s), 126.6 (d), 124.3 (d), 126.2 
(d), 126.3 (d), 126.9 (d), 127.4 (d), 127.5 (d), 127.8(d), 128.2(d), 128.2(d), 128.3(d), 128.3(d), 
128.4(d), 128.5(d), 128.7(d), 128.8(d), 135.1 (s), 136.1 (s), 136.5 (s), 136.7 (s), 137.5 (s), 138.9 
(s), 139.1 (s), 161.0 (s), 164.4 (s), 165.9 (s), 166.8 (s), 168.1 (s), 193.7 (s), 200.3 (s), 201.2(s); 
IR (nujol): max = 3319, 3193, 1634, 1611 cm-1; MS m/z (ESI): 417.27 (M + H+); anal. calcd. 
for C25H24N2O2S (416.5353): C 72.09, H 5.81, N 6.73; found: C 72.21, H 5.79, N 6.78. 
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Methyl 3-(benzylamino)-3-phenyl-2-
(phenylcarbamothioyl)acrylate 28m. 
28m was isolated by precipitation in methanol in 27% yield. 
Light yellow solid; mp: 110113 °C; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 0.58-0.68, 1.17-1.36 (2m, 3H, OCH2CH3), 
3.55-3.68, 4.14-4.20 (2m, 2H, OCH2CH3), 4.22-4.29 (m, 2H, CH2Ph), 7.17-7.99, (m, 15H, Ph, 
NHPh, Bn), 11.73 (brs, H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 13.0 (q), 14.0 (q), 
14.5 (q), 45.8 (t), 48.2 (t), 48.7 (t), 60.0 (t), 60.1 (t), 61.3 (t), 100.8 (s), 100.9 (s), 125.4 (d), 
125.9 (d), 126.7 (d), 127.0 (d), 127.0 (d), 127.0 (d), 127.3 (d), 127.3 (d), 127.7 (d), 128.2 (d), 
128.3 (d), 128.5 (d), 128.9 (d), 129.2 (d), 133.6 (s), 136.3 (s), 137.2 (s), 139.1 (s), 167.3 (s), 
168.3 (s), 170.1 (s), 170.8 (s), 188.4 (s), 192.3 (s), 199.7 (s); IR (nujol): max = 3317, 3298, 
1679, 1645 cm-1; MS m/z (ESI): 403.28 (M + H+); anal. calcd. for C24H22N2O2S (402.5087): C 
71.62, H 5.51, N 6.96; found: C 71.51, H 5.48, N 7.04. 
 
 
One-pot procedure for synthesis of 2,5-dihydrothiophenes 29a-x. 
Alkyl amines 31a,b (0.5 mmol) were added to -ketoesters 30a-i (0.55 mmol) or to ethyl 
phenylpropiolate 33a (0.55mmol) under solvent-free conditions at room temperature and 
vigorously stirred at room temperature. After 0.5 h aryl isothiocyanates 34a-c (0.5mmol) in 
MeOH (1.5 mL)  were added and the reactions were stirred until the disappearance of the 
enamino esters 32 (6-18h monitored by TLC). DDs 1a-j (1.0 mmol) in MeOH (1.5mL) were 
added to the reaction medium and magnetically stirred until the complete disappearance of the 
ACTs 28a-m (3.0-5.0 h monitored by TLC). Then, the reaction solvent was evaporated under 
reduced pressure and the desired 2,5-dihydrothiophenes 29a-x were purified by 
chromatography on silica gel column (elution mixture: cyclohexane: ethyl acetate).  
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Dimethyl 2-(1-(2-tertbutoxycarbonyl)hydrazono)ethyl)-3-
methyl-5-(phenylimino)-2,5-dihydrothiophene-2,4-
dicarboxylate 29a. 
29a was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 78% yield. Pale yellow solid; mp: 
151153 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.50 (s, 9H, C(CH3)3), 1.83 (s, 3H, CH3), 
2.24 (s, 3H, CH3), 3.80 (s, 3H, OCH3), 3.93 (s, 3H, OCH3), 7.04(d, 2H, J = 8.0 Hz, Ph), 7.15 (t, 
1H, J = 7.2 Hz, Ph), 7.35 (t, 2H, J = 7.6 Hz, Ph), 7.85 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 
25 °C): δ = 12.3 (q), 16.2 (q), 28.2 (q), 52.7 (q), 64.4 (q), 75.1 (s), 81.7 (s), 120.1 (d), 125.2 (d), 
129.1 (d), 136.0 (s), 144.6 (s), 150.7 (s), 152.2 (s), 157.7 (s), 163.8 (s), 164.2 (s), 168.1 (s); IR 
(nujol): max = 3231, 1740, 1698, 1629 cm-1; MS m/z (ESI): 462.30 (M + H+); anal. calcd. for 
C22H27N3O6S (461.5313): C 57.25, H 5.90, N 9.10; found: C 57.16, H 5.87, N 9.16. 
 
 
4-Ethyl-2-methyl 2-(1-(2-
tertbutoxycarbonyl)hydrazono)ethyl)-3-methyl-5-
(phenylimino)-2,5-dihydrothiophene-2,4-dicarboxylate 
29b. 
29b was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 83% yield. Pale yellow solid; mp: 136139 °C; 1H NMR (400 MHz, 
DMSOd6, 25 °C): δ = 1.30 (t, 3H, J = 7.2 Hz OCH2CH3), 1.45 (s, 9H, C(CH3)3), 1.84 (s, 3H, 
CH3), 2.13 (s, 3H, CH3), 3.73 (s, 3H, OCH3), 4.33 (q, 2H, J = 7.2 Hz, OCH2CH3), 6.97 (d, 2H, 
J = 7.2 Hz, Ph), 7.18 (t, 1H, J = 7.6 Hz, Ph), 7.40 (t, 2H, J = 7.6 Hz, Ph), 9.88 (s, 1H, NH); 13C 
NMR (100 MHz, DMSOd6, 25 °C): δ = 13.4 (q), 13.9 (q), 15.4 (q), 27.9 (q), 53.4 (q), 61.4 (t), 
75.4 (s), 79.7 (s), 119.6 (d), 125.2 (d), 129.3 (d), 135.7 (s), 145.9 (s), 150.2 (s), 152.6 (s), 156.5 
(s), 163.1 (s), 163.2 (s), 167.8 (s); IR (nujol): max = 3227, 1739, 1695, 1636 cm-1; MS m/z 
(ESI): 476.29 (M + H+); anal. calcd. for C23H29N3O6S (475.5579): C 58.09, H 6.15, N 8.84; 
found: C 58.21, H 6.17, N 8.70.  
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4-Ethyl-2-methyl 2-(1-(2-
tertbutoxycarbonyl)hydrazono)ethyl)-5-(phenylimino)-3-
propyl--2,5-dihydrothiophene-2,4-dicarboxylate 29c. 
29c was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 58% yield. Pale yellow solid; mp: 
142144 °C; 1H NMR (400 MHz, DMSOd6, 25 °C): δ = 0.95 (t, 
3H, J = 7.2 Hz CH2CH2CH3), 1.39 (t, 3H, J = 7.2 Hz OCH2CH3), 1.51 (s, 9H, C(CH3)3), 1.46-
1.60 (m, 2H, CH2CH2CH3), 1.83 (s, 3H, CH3), 2.54-2.68 (m, 2H, CH2CH2CH3), 3.80 (s, 3H, 
OCH3), 4.41 (q, 2H, J = 7.2 Hz, OCH2CH3), 7.04 (dd, 2H, J = 8.8 Hz, J = 1.2 Hz, Ph), 7.14 (t, 
1H, J = 7.2 Hz, Ph), 7.35 (t, 2H, J = 7.6 Hz, Ph), 7.72 (s, 1H, NH); 13C NMR (100 MHz, 
DMSOd6, 25 °C): δ = 12.7 (q), 14.1 (q), 14.7 (q), 22.2 (t), 28.2 (q), 32.1 (t), 53.3 (q), 53.4 (q), 
61.8 (t), 75.4 (s), 81.7 (s), 120.2 (d), 125.1 (d), 129.1 (d), 136.7 (s), 145.0 (s), 150.9 (s), 152.3 
(s), 160.1 (s), 164.0 (s), 164.2 (s), 168.4 (s); IR (nujol): max = 3237, 1745, 1695, 1636 cm-1; 
MS m/z (ESI): 504.45 (M + H+); anal. calcd. for C25H33N3O6S (503.6110): C 59.62, H 6.60, N 
8.34; found: C 59.49, H 6.56, N 8.48. 
 
 
2-Ethyl-4-methyl 2-(1-(2(tert-
butoxycarbonyl)hydrazono)ethyl)-3-methyl-5-
(phenylimino)-2,5-dihydrothiophene-2,4-dicarboxylate 29d. 
29d was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 88 % yield. Pale yellow solid; mp: 
152156 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.27 (t, 
3H, J = 7.2 Hz OCH2CH3), 1.47 (s, 9H, C(CH3)3), 1.82 (s, 3H, CH3), 2.22 (s, 3H, CH3), 3.89 
(s, 3H, OCH3), 4.23 (q, 2H, J = 7.2 Hz, OCH2CH3), 7.01 (dd, 2H, J = 8.4 Hz, J = 1.2 Hz, Ph), 
7.11 (t, 1H, J = 7.6 Hz Ph), 7.32 (t, 2H, J = 8.4 Hz, Ph), 8.35 (brs, 1H, NH); 13C NMR (100 
MHz, CDCl3, 25 °C): δ = 12.5 (q), 12.6 (q), 13.8 (q), 16.1 (q), 16.1 (q), 28.0 (q), 52.4 (q), .52.5 
(q), 62.6 (t), 75.1 (s), 81.3 (s), 119.9 (d), 125.0 (d), 129.0 (d), 135.7 (s), 135.7 (s), 144.8 (s), 
150.8 (s), 152.8 (s), 157.8 (s), 157.9 (s), 163.8 (s), 163.9 (s), 164.1 (s), 167.5 (s); IR (nujol): 
max = 3254, 1713, 1676, 1628 cm-1; MS m/z (ESI): 476.38 (M + H+); anal. calcd. for 
C23H29N3O6S (475.5579): C 58.09, H 6.15, N 8.84; found: C 57.95, H 6.11, N 8.98. 
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Diethyl 2-(1-(2(tert-butoxycarbonyl)hydrazono)ethyl)-3-
methyl-5-(phenylimino)-2,5-dihydrothiophene-2,4-
dicarboxylate 29e. 
29e was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 79 % yield. Pale yellow solid; mp: 
136139 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.31 (t, 
3H, J = 7.2 Hz OCH2CH3), 1.39 (t, 3H, J = 7.2 Hz OCH2CH3), 1.51 (s, 9H, C(CH3)3), 1.83 (s, 
3H, CH3), 2.25 (s, 3H, CH3), 4.27 (q, 2H, J = 7.2 Hz, OCH2CH3), 4.42 (q, 2H, J = 7.2 Hz, 
OCH2CH3), 7.06 (d, 2H, J = 8.4 Hz, Ph), 7.15 (t, 1H, J = 7.6 Hz Ph), 7.36 (t, 2H, J = 8.0 Hz, 
Ph), 7.64 (brs, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 12.4 (q), 14.0 (q), 14.2 (q), 
16.0 (q), 28.2 (q), 61.7 (t), .62.7 (t), 75.2 (s), 81.6 (s), 120.19 (d), 125.1 (d), 129.1 (d), 136.3 
(s), 144.9 (s), 150.9 (s), 152.5 (s), 156.9 (s), 163.7 (s), 163.9 (s), 167.6 (s); IR (nujol): max = 
3230,1731,1693,1622 cm-1; MS m/z (ESI): 490.29 (M + H+); anal. calcd. for C24H31N3O6S 
(489.5844): C 58.88, H 6.38, N 8.58; found: C 58.76, H 6.35, N 8.61. 
 
 
2-Ethyl-4-methyl 2-(1-(2(tert-
butoxycarbonyl)hydrazono)ethyl)-5-((4-
chlorophenyl)imino)-3-ethyl-2,5-dihydrothiophene-2,4-
dicarboxylate 29f. 
29f was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 63 % yield. Pale yellow solid; mp: 
107109 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.10 (t, 3H, J = 7.6 Hz CH2CH3), 1.30 (t, 
3H, J = 7.2 Hz OCH2CH3), 1.49 (s, 9H, C(CH3)3), 1.84 (s, 3H, CH3), 2.63-2.70 (m, 2H, 
CH2CH3), 3.92 (s, 3H, OCH3), 4.22-4.29 (m, 2H, OCH2CH3), 6.97 (d, 2H, J = 8.8 Hz, Ph), 7.30 
(d, 2H, J = 8.8 Hz Ph), 8.01 (brs, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 12.9 (q), 
13.0 (q), 13.9 (q), 22.4 (t), 28.2 (q), 52.7 (q), 62.8 (t), 75.8 (s), 81.6 (s), 121.6 (d), 129.2 (d), 
130.3 (s), 135.8 (s), 144.8 (s), 149.3 (s), 152.6 (s), 162.9 (s), 164.5 (s), 165.2 (s), 167.6 (s); IR 
(nujol): max = 3223,1717,1684,1621 cm-1; MS m/z (ESI): 524.81 (M + H+); anal. calcd. for 
C24H30ClN3O6S (524.0295): C 55.01, H 6.77, N 8.02; found: C 54.95, H 6.79, N 8.15. 
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4-Tert-butyl 2-ethyl 2-((1-(2(tert-
butoxycarbonyl)hydrazono)ethyl)-5-((4-
chlorophenyl)imino)--3-methyl-2,5-dihydrothiophene-
2,4-dicarboxylate 29g. 
29g was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 81 % yield. Pale yellow solid; mp: 
120124 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.28 (t, 3H, J = 7.2 Hz OCH2CH3), 1.47 
(s, 9H, C(CH3)3), 1.56 (s, 9H, C(CH3)3), 1.81 (s, 3H, CH3), 2.20 (s, 3H, CH3), 4.23 (q, 2H, J = 
7.2 Hz OCH2CH3), 6.96 (d, 2H, J = 8.8 Hz, Ph), 7.27 (d, 2H, J = 8.8 Hz Ph), 8.46 (brs, 1H, 
NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 12.4 (q), 13.9 (q), 15.8 (q), 28.1 (q), 62.6 (t), 
75.4 (s), 81.4 (s), 83.0 (s), 121.4 (d), 129.9 (d), 130.1 (d), 137.1 (s), 144.8 (s), 149.3 (s), 152.7 
(s), 155.9 (s), 162.8 (s), 164.4 (s), 167.5 (s); IR (nujol): max = 3255,1736,1685,1624 cm-1; MS 
m/z (ESI): 553.04 (M + H+); anal. calcd. for C26H34ClN3O6S (552.1890): C 56.56, H 6.21, N 
7.61; found: C 56.68, H 6.24, N 7.51. 
 
 
4-Benzyl-2-ethyl 2-(1-(2-
tertbutoxycarbonyl)hydrazono)ethyl)-3-methyl-5-
(phenylimino)-2,5-dihydrothiophene-2,4-
dicarboxylate 29h. 
29h was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 65% yield. Pale yellow solid; 
mp: 109113 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.30 (t, 3H, J = 7.2 Hz OCH2CH3), 
1.49 (s, 9H, C(CH3)3), 1.82 (s, 3H, CH3), 2.21 (s, 3H, CH3), 4.26 (q, 2H, J = 7.2 Hz, OCH2CH3), 
5.39 (s, 2H, OCH2Ph), 7.06 (dd, 2H, J = 8.4 Hz, J = 1.2 Hz, Ph), 7.16 (t, 1H, J = 7.6 Hz, Ph), 
7.34-7.39 (m, 5H, Ph), 7.48 (dd, 2H, J = 8.0 Hz, J = 1.6 Hz, Ph), 7.88 (s, 1H, NH); 13C NMR 
(100 MHz, CDCl3, 25 °C): δ = 12.4 (q), 14.0 (q), 16.1 (q), 28.2 (q), 62.7 (t), 67.4 (t), 75.3 (s), 
81.6 (s), 120.1 (d), 125.1 (d), 128.3 (d), 128.3 (d), 128.5 (d), 129.1 (d), 135.3 (s), 135.9 (s), 
144.7 (s), 150.7 (s), 152.3 (s), 157.6 (s), 163.5 (s), 163.7 (s), 167.55 (s); IR (nujol): max = 
3255,1751,1681,1643 cm-1; MS m/z (ESI): 552.37 (M + H+); anal. calcd. for C29H33N3O6S 
(551.6538): C 63.14, H 6.03, N 7.62; found: C 63.02, H 6.00, N 7.74. 
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Diethyl-2-methyl 2-(1-(2(tert-
butoxycarbonyl)hydrazono)ethyl)-3-phenyl-5-
(phenylimino)-2,5-dihydrothiophene-2,4-dicarboxylate 29i. 
29i was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 58 % yield. Pale yellow solid; mp: 
105110 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.00 (t, 
3H, J = 7.2 Hz OCH2CH3), 1.14 (t, 3H, J = 7.2 Hz OCH2CH3), 1.49 (s, 9H, C(CH3)3), 1.88 (s, 
3H, CH3), 4.10-4.18 (m, 4H, 2 OCH2CH3), 7.01-7.18 (m, 3H, Ph), 7.30-7.39 (m, 5H, Ph), 7.42-
7.44 (m, 2H, Ph), 7.92 (brs, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 13.6 (q), 13.7 
(q), 13.8 (q), 28.1 (q), 28.2 (q), 61.6 (t), 62.7 (t), 76.1 (s), 81.6 (s), 120.2 (d), 120.3 (d), 125.3 
(d), 125.4 (d), 127.9 (d), 129.1 (d), 129.1 (d), 133.4 (s), 139.0 (s), 144.7 (s), 150.7 (s), 152.5 
(s), 156.0 (s), 163.3 (s), 163.7 (s), 167.5 (s); IR (nujol): max = 3236,1747,1698,1623 cm-1; MS 
m/z (ESI): 552.42 (M + H+); anal. calcd. for C29H33N3O6S (551.6538): C 63.14, H 6.03, N 7.62; 
found: C 63.01, H 5.99, N 7.78. 
 
 
Dimethyl 2-(1-(2-tertbutoxycarbonyl)hydrazono)propyl)-3-
methyl-5-(phenylimino)-2,5-dihydrothiophene-2,4-
dicarboxylate 29j. 
29j was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 78% yield. Pale yellow solid; mp: 
120124 °C; 1H NMR (400 MHz, DMSOd6, 25 °C): δ = 0.96 (t, 3H, J = 7.6 Hz OCH2CH3), 
1.45 (s, 9H, C(CH3)3), 2.11 (s, 3H, CH3), 2.44 (q, 2H, J = 7.6 Hz OCH2CH3), 3.71 (s, 3H, 
OCH3), 3.85 (s, 3H, OCH3), 6.97(dd, 2H, J = 8.4 Hz, J = 0.8 Hz, Ph), 7.19 (t, 1H, J = 7.2 Hz, 
Ph), 7.41 (t, 2H, J = 7.6 Hz, Ph), 10.09 (s, 1H, NH); 13C NMR (100 MHz, DMSOd6, 25 °C): δ 
= 10.5 (q), 15.8 (q), 19.8 (t), 28.0 (q), 52.7 (q), 53.4 (q), 75.3 (s), 79.9 (s), 119.6 (d), 125.3 (d), 
129.5 (d), 135.6 (s), 140.8 (s), 150.4 (s), 152.6 (s), 157.2 (s), 163.4 (s), 163.7 (s), 167.9 (s); IR 
(nujol): max = 3220,1749,1715,1654  cm-1; MS m/z (ESI): 476.29 (M + H+); anal. calcd. for 
C22H27N3O6S (475.5579): C 58.09, H 6.15, N 8.84; found: C 57.96, H 6.12, N 8.96. 
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4-Allyl 2-tert-butyl-2-(1-(2(tert-
butoxycarbonyl)hydrazono)ethyl)-3-methyl-5-
(phenylimino)-2,5-dihydrothiophene-2,4-dicarboxylate 
29k. 
29k was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 86 % yield. Pale yellow solid; mp: 
121125 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.46 (s, 18H, 2 OC(CH3)3), 1.81 (brs, 
3H, CH3), 2.22 (s, 3H, CH3), 4.80 (d, 2H, J = 5.6 Hz, OCH2CH=CH2), 5.24 (dd, 1H, J = 10.4 
Hz, J = 1.2 Hz, OCH2CH=CH2), 5.43 (dd, 1H, J = 17.2 Hz, J = 1.6 Hz, OCH2CH=CH2), 5.75 
(brs, 2H, NH2), 5.92-6.01 (m, 1H, OCH2CH=CH2), 7.01 (dd, 2H, J = 8.4 Hz, J = 1.2 Hz, Ph), 
7.10 (t, 1H, J = 7.6 Hz, Ph), 7.31 (t, 2H, J = 8.0 Hz, Ph), 8.44 (brs, 1H, NH); 13C NMR (100 
MHz, CDCl3, 25 °C): δ = 16.1 (q), 26.7 (q), 27.6 (q), 65.9 (t), 75.9 (s), 118.7 (t), 120.0 (d), 
124.8 (d), 128.9 (d), 131.4 (d), 135.4 (s), 145.2 (s), 150.8 (s), 152.7 (s), 158.1 (s), 163.4 (s), 
163.9 (s), 166.2 (s); IR (nujol): max = 3235,1752,1727,1676  cm-1; MS m/z (ESI): 530.36 (M + 
H+); anal. calcd. for C27H35N3O6S (529.6483): C 61.23, H 6.66, N 7.93; found: C 61.10, H 6.64, 
N 8.02. 
 
 
2-Benzyl-4-methyl 2-(1-(2-
tertbutoxycarbonyl)hydrazono)ethyl)-3-methyl-5-
(phenylimino)-2,5-dihydrothiophene-2,4-dicarboxylate 29l. 
29l was isolated by column chromatography on silica gel 
(acet39ate/cyclohexane) in 86% yield. Pale yellow solid; mp: 
135124 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.49 (s, 9H, 
C(CH3)3), 1.82 (s, 3H, CH3), 2.22 (s, 3H, CH3), 3.92 (s, 3H, 
OCH3), 5.39 (s, 2H, OCH2Ph), 7.03 (dd, 2H, J = 8.4 Hz, J = 1.2 Hz, Ph), 7.14 (t, 1H, J = 7.6 
Hz, Ph), 7.32-7.37 (m, 7H, Ph), 7.97 and 8.38 (2 brs, 1H, NH); 13C NMR (100 MHz, CDCl3, 
25 °C): δ = 12.4 (q), 16.2 (q), 28.1 (q), 52.6 (q), 68.2 (t), 75.3 (s), 81.6 (s), 120.0 (d), 125.1 (d), 
128.2 (d), 128.3 (d), 128.4 (d), 129.1 (d), 135.0 (s), 136.0 (s), 144.6 (s), 150.8 (s), 152.6 (s), 
157.8 (s), 163.9 (s), 164.2 (s), 167.5 (s); IR (nujol): max = 3216,1735,1722,1634   cm-1; MS 
m/z (ESI): 538.19 (M + H+); anal. calcd. for C28H31N3O6S (537.6272): C 62.55, H 5.81, N 7.82; 
found: C 62.62, H 5.83, N 7.71. 
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4-Ethyl-2-methyl 5-((4-chlorophenyl)imino)-2-(1-
(2(methoxycarbonyl)hydrazono)ethyl)-3-methyl-2,5-
dihydrothiophene-2,4-dicarboxylate 29m. 
29m was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 84 % yield. Pale yellow solid; mp: 
106109 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.35 (t, 3H, J = 7.6 Hz, OCH2CH3), 1.84 
(s, 3H, CH3), 2.20 (s, 3H, CH3), 3.76 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 4.37 (q, 2H, J = 7.6 
Hz, OCH2CH3), 6.95 (d, 2H, J = 8.8 Hz, Ph), 7.28 (d, 2H, J = 8.8 Hz Ph), 8.08 (brs, 1H, NH); 
13C NMR (100 MHz, CDCl3, 25 °C): δ = 12.1 (q), 14.1 (q), 15.8 (q), 52.9 (q), 53.3 (q), 75.3 (s), 
121.5 (d), 129.1 (d), 130.4 (s), 136.3 (s), 146.0 (s), 149.1 (s), 154.4 (s), 156.9 (s), 163.5 (s), 
164.2 (s), 167.8 (s); IR (nujol): max = 3243,1747,1736,1684  cm-1; MS m/z (ESI): 468.64 (M + 
H+); anal. calcd. for C20H22ClN3O6S (467.9232): C 51.34, H 4.74, N 8.98; found: C 54.15, H 
4.69, N 9.13. 
 
 
4-Ethyl-2-methyl 3-ethyl-2-(1-
(2(metoxycarbonyl)hydrazono)ethyl)-5-(phenylimino)-2,5-
dihydrothiophene-2,4-dicarboxylate 29n. 
29n was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 63 % yield. Pale yellow solid; mp: 
136139 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.10 (t, 3H, 
J = 7.6 Hz CH2CH3), 1.37 (t, 3H, J = 7.2 Hz OCH2CH3), 1.85 (s, 3H, CH3), 2.64 (q, 2H, J = 7.6 
Hz CH2CH3), 3.76 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 4.39 (q, 2H, J = 7.6 Hz OCH2CH3), 7.01 
(dd, 2H, J = 8.8 Hz, J = 0.8 Hz, Ph), 7.12 (t, 1H, J = 7.2 Hz Ph), 7.33 (t, 2H, J = 7.6 Hz Ph), 
8.38 (brs, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 12.8 (q), 12.9 (q), 14.1 (q), 23.1 
(t), 26.9 (q), 53.0 (q), 53.3 (q), 61.9 (t), 75.4 (s), 120.1 (d), 125.2 (d), 129.1 (d), 136.6 (s), 146.5 
(s), 150.8 (s), 154.4 (s), 161.2 (s), 164.0 (s), 164.1 (s), 168.4 (s); IR (nujol): max = 3262, 1732, 
1624, 1598 cm-1; MS m/z (ESI): 448.24 (M + H+); anal. calcd. for C21H25N3O6S (447.5047): C 
56.36, H 5.63, N 9.39; found: C 56.45, H 5.66, N 9.32. 
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4-Tert-butyl 2-ethyl 5-((4-chlorophenyl)imino)-2-((1-
(2(methoxycarbonyl)hydrazono)ethyl)-3-methyl-2,5-
dihydrothiophene-2,4-dicarboxylate 29o. 
29o was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 86 % yield. Pale yellow solid; mp: 
132135 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ =  1.28 (t, 
3H, J = 7.2 Hz OCH2CH3), 1.56 (s, 9H, C(CH3)3), 1.81 (s, 3H, CH3), 2.18 (s, 3H, CH3), 3.75 
(s, 3H, OCH3), 4.16-4.34 (m, 2H, OCH2CH3), 6.95 (d, 2H, J = 8.4 Hz, Ph), 7.28 (d, 2H, J = 8.8 
Hz Ph), 8.43 (brs, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 12.0 (q), 13.9 (q), 15.7 
(q), 28.2 (q), 53.0 (q), 62.8 (t), 75.4 (s), 83.2 (s), 121.7 (d), 129.2 (s), 130.3 (d), 137.8 (s), 146.2 
(s), 149.3 (s), 154.3 (s), 155.4 (s), 162.9 (s), 164.2 (s), 167.4 (s); IR (nujol): max = 3243, 1741, 
1703, 1612 cm-1; MS m/z (ESI): 510.54 (M + H+); anal. calcd. for C23H28ClN3O6S (510.0029): 
C 54.17, H 5.53, N 8.24; found: C 54.30, H 5.57, N 8.11. 
 
 
4-Ethyl-2-methyl 2-(1-(2-carbomoylhydrazono)ethyl)-3-
methyl-5-(phenylimino)-2,5-dihydrothiophene-2,4-
dicarboxylate 29p. 
29p was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 78 % yield. Pale yellow solid; mp: 
165169 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.38 (t, 3H, 
J = 7.2 Hz OCH2CH3), 1.90 (s, 3H, CH3), 2.18 (s, 3H, CH3), 3.78 (s, 3H, OCH3), 4.41 (q, 2H, 
J = 7.2 Hz , OCH2CH3), 5.17 and 5.80 (2brs, 2H, NH2), 7.03 (dd, 2H, J = 8.4 Hz, J = 1.2 Hz,  
Ph), 7.15 (t, 1H, J = 7.6 Hz, Ph), 7.35 (t, 2H, J = 7.6 Hz, Ph), 9.06 (s, 1H, NH); 13C NMR (100 
MHz, CDCl3, 25 °C): δ = 12.7 (q), 14.2 (q), 15.6 (q), 53.3 (q), 61.9 (t), 75.1 (s), 120.1 (d), 125.3 
(d), 129.2 (d), 136.8 (s), 144.4 (s), 150.7 (s), 155.6 (s), 157.3 (s), 163.2 (s), 163.7 (s), 168.1 (s); 
IR (nujol): max = 3412, 3278, 3243, 1753, 1644, 1623 cm-1; MS m/z (ESI): 419.02 (M + H+); 
anal. calcd. for C19H22N4O5S (418.4668): C 54.53, H 5.30, N 13.39; found: C 54.63, H 5.33, N 
13.27. 
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2-Ethyl 4-iso-propyl 2-((1-(2-carbamoylhydrazono)ethyl)-3-
methyl-5-((phenyl)imino)-2,5-dihydrothiophene-2,4-
dicarboxylate 29q. 
29q was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 75 % yield. Pale yellow solid; mp: 
170174 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.27 (t, 3H, 
J = 7.2 Hz OCH2CH3), 1.35 (d, 6H, J = 6.4 Hz, CH(CH3)2), 1.90 (s, 3H, CH3), 2.16 (s, 3H, 
CH3), 4.23 (q, 2H, J = 7.2 Hz OCH2CH3), 5.29 (hept, 1H, J = 6.4 Hz, CH(CH3)2),5.60 and 5.82 
(2 brs, 2H, NH2), 7.04 (dd, 2H, J = 8.8 Hz, J = 1.2 Hz, Ph), 7.13 (t, 1H, J = 7.2 Hz, Ph), 7.34 
(d, 2H, J = 8.4 Hz Ph), 9.40 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 12.8 (q), 
14.0 (q), 15.4 (q), 27.8 (q), 62.6 (t), 69.7 (d), 75.3 (s), 120.1 (d), 125.1 (d), 129.1 (d), 136.9 (s), 
144.7 (s), 150.6 (s), 155.0 (s), 157.9 (s), 163.1 (s), 163.3 (s), 167.5 (s); IR (nujol): max = 3421, 
3264, 3257, 1742, 1613, 1606cm-1; MS m/z (ESI): 446.87 (M + H+); anal. calcd. for 
C21H26N4O5S (446.1624): C 56.49, H 5.87, N 12.55; found: C 56.37, H 5.89, N 12.68. 
 
 
4-Allyl 2-tert-butyl-2-(1-(2(carbamoylhydrazono)ethyl)-3-
methyl-5-(phenylimino)-2,5-dihydrothiophene-2,4-
dicarboxylate 29r. 
29r was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 63 % yield. Pale yellow solid; mp: 
155158 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.26 (t, 
3H, J = 7.2 Hz OCH2CH3), 1.89 (s, 3H, CH3), 2.18 (s, 3H, CH3), 4.22 (q, 2H, J = 7.2 Hz, 
OCH2CH3), 4.83 (d, 2H, J = 5.2 Hz, OCH2CH=CH2), 5.29 (dd, 1H, J = 10.4 Hz, J = 1.2 Hz, 
OCH2CH=CH2), 5.46 (dd, 1H, J = 17.2 Hz, J = 1.6 Hz, OCH2CH=CH2), 5.75 (brs, 2H, NH2), 
5.94-6.02 (m, 1H, OCH2CH=CH2), 7.03 (d, 2H, J = 7.6 Hz, Ph), 7.13 (t, 1H, J = 7.6 Hz Ph), 
7.34 (t, 2H, J = 7.6 Hz, Ph), 9.48 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 12.8 
(q), 13.9 (q), 15.7 (q), 62.6 (t), .66.2 (t), 75.3 (s), 119.0 (t), 120.0 (d), 125.2 (d), 129.0 (d), 131.3 
(d), 136.2 (s), 144.5 (s), 150.6 (s), 156.4 (s), 157.9 (s), 163.2 (s), 163.3 (s), 167.4 (s); IR (nujol): 
max = 3476, 3316, 3197, 1739, 1732, 1695 cm-1; MS m/z (ESI): 445.13 (M + H+); anal. calcd. 
for C21H24N4O5S (444.5041): C 56.74, H 5.44, N 12.60; found: C 56.63, H 5.40, N 12.71. 
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2-Ethyl-4-methyl 2-(1-(2(carbamoylhydrazono)ethyl)-5-
((4-chlorophenyl)imino)-3-ethyl-2,5-dihydrothiophene-
2,4-dicarboxylate 29s. 
29s was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 78 % yield. Pale yellow solid; mp: 
158162 °C; 1H NMR (400 MHz, DMSOd6, 25 °C): δ = 1.00 
(t, 3H, J = 7.6 Hz CH2CH3), 1.19 (t, 3H, J = 7.2 Hz OCH2CH3), 1.84 (s, 3H, CH3), 2.48-2.58 
(m, 2H, CH2CH3), 3.85 (s, 3H, OCH3), 4.17-4.26 (m, 2H, OCH2CH3), 6.23 (brs, 2H, NH2), 7.02 
(d, 2H, J = 8.8 Hz, Ph), 7.45 (d, 2H, J = 8.8 Hz Ph), 9.62 (s, 1H, NH); 13C NMR (100 MHz, 
DMSOd6, 25 °C): δ = 12.6 (q), 13.5 (q), 13.7 (q), 22.7 (t), 52.7 (q), 62.6 (t), 75.8 (s), 81.6 (s), 
121.6 (d), 129.4 (s), 129.4 (d), 135.4 (s), 142.2 (s), 149.0 (s), 156.3 (s), 162.2 (s), 163.8 (s), 
164.8 (s), 167.2 (s); IR (nujol): max = 3446, 3321, 3223, 1747, 1730, 1684 cm-1; MS m/z (ESI): 
467.63 (M + H+); anal. calcd. for C20H23ClN4O5S (466.9384): C 51.44, H 4.96, N 12.00; found: 
C 51.36, H 4.97, N 12.11. 
 
 
4-benzyl 2-ethyl 2-((1-(2-carbamoylhydrazono)ethyl)-3-
methyl-5-((phenyl)imino)-2,5-dihydrothiophene-2,4-
dicarboxylate 29t. 
29t was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 63 % yield. Pale yellow solid; mp: 
148151 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.27 (t, 
3H, J = 7.2 Hz OCH2CH3), 1.88 (s, 3H, CH3), 2.14 (s, 3H, CH3), 4.22 (dq, 2H, J = 7.2 Hz, J = 
1.6 Hz,OCH2CH3), 5.38 (AB system, 2H, J = 12.4 Hz, OCH2Ph), 5.78 ( brs, 2H, NH2), 7.05 
(dd, 2H, J = 8.4 Hz, J = 1.2 Hz, Ph), 7.16 (t, 1H, J = 7.2 Hz, Ph), 7.34-7.40 (m, 5H, Ph), 7.46 
(dd, 2H, J = 8.0 Hz, J = 1.6 Hz, Ph), 9.32 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ 
= 12.9 (q), 14.0 (q), 15.7 (q), 62.6 (t), 67.5 (t), 75.3 (s), 120.1 (d), 125.2 (d), 128.3 (d), 128.4 
(d), 128.5 (d), 129.1 (d), 135, 2 (s), 136.2 (s), 144.5 (s), 150.6 (s), 156.5 (s), 157.7 (s), 163.1 
(s), 163.6 (s), 167.4 (s); IR (nujol): max = 3470, 3361, 3196, 1732, 1697, 1682 cm-1; MS m/z 
(ESI): 494.96 (M + H+); anal. calcd. for C25H26N4O5S (494.1624): C 60.71, H 5.30, N 11.33; 
found: C 60.86, H 5.34, N 11.21. 
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Dimethyl 3-methyl 2-(1-
(2(phenylcarbamoyl)hydrazono)ethyl)-5-(phenylimino)-
2,5-dihydrothiophene-2,4-dicarboxylate 29u. 
29u was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 65% yield. Pale yellow solid; mp: 
126128 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 2.01 (s, 3H, CH3), 2.24 (s, 3H, CH3), 
3.86 (s, 3H, OCH3), 3.97 (s, 3H, OCH3), 7.05-7.11 (m, 3H, Ph), 7.16 (t, 1H, J = 7.6 Hz, Ph), 
7.31-7.39 (m, 4H, Ph), 7.45 (d, 2H, J = 8.4 Hz, Ph), 7.97 (s, 1H, NH), 9.46 (s, 1H, NH); 13C 
NMR (100 MHz, CDCl3, 25 °C): δ = 13.2 (q), 15.9 (q), 52.8 (q), .53.5 (q), 75.2 (s), 119.0 (d), 
120.1 (d), 123.6 (d), 125.4 (d), 129.1 (d), 129.2 (d), 136.6 (s), 137.7 (s), 144.3 (s), 150.6 (s), 
153.4 (s), 156.5 (s), 163.2 (s), 164.1 (s), 168.1 (s); IR (nujol): max = 3335, 3215, 1712, 1684, 
1677 cm-1; MS m/z (ESI): 481.22 (M + H+); anal. calcd. for C24H24N4O5S (480.5362): C 59.99, 
H 5.03, N 11.66; found: C 60.10, H 5.06, N 11.55. 
 
 
4-Ethyl-2-methyl 3-methyl-2-(1-(2-
phenylcarbomoyl)hydrazono)ethyl)-5-(phenylimino)-2,5-
dihydrothiophene-2,4-dicarboxylate 29v. 
29v was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 60 % yield. Pale yellow solid; mp: 
137141 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.42 (t, 
3H, J = 7.2 Hz OCH2CH3), 2.07 (s, 3H, CH3), 2.53 (s, 3H, CH3), 3.87 (s, 3H, OCH3), 4.46 (q, 
2H, J = 7.2 Hz, OCH2CH3), 7.07-7.12 (m, 3H, Ph), 7.17 (t, 1H, J = 7.6 Hz, Ph), 7.32-7.40 (m, 
4H, Ph), 7.46 (dd, 2H, J = 8.4 Hz, J = 1.2 Hz, Ph), 8.03 (s, 1H, NH), 10.15 (s, 1H, NH); 13C 
NMR (100 MHz, CDCl3, 25 °C): δ = 13.2 (q), 14.2 (q), 15.6 (q), 53.4 (q), 61.9 (t), 75.2 (s), 
118.8 (d), 120.2 (d), 123.4 (d), 125.2 (d), 129.0 (d), 129.1 (d), 136.8 (s), 137.6 (s), 144.6 (s), 
150.6 (s), 153.8 (s), 155.5 (s), 163.1 (s), 163.7 (s), 168.2 (s); IR (nujol): max = 3357, 3241, 
1707, 1698, 1653  cm-1; MS m/z (ESI): 494.76 (M + H+); anal. calcd. for C25H26N4O5S 
(494.1624): C 60.71, H 5.30, N 11.33; found: C 60.57, H 5.26, N 11.45.  
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4-Ethyl 2-methyl 5-((4-methoxyphenyl)imino)-3methyl-
1-(2-(phenylcarbamoyl)hydrazono)ethyl)-2,5-
dihydrothiophene-2,4-dicarboxylate 29w. 
29w was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 60 % yield. Pale yellow solid; mp: 
133139 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.34 
(t, 3H, J = 7.2 Hz OCH2CH3), 2.01 (s, 3H, CH3), 2.23 (s, 
3H, CH3), 3.81 (s, 3H, OCH3), 3.97 (s, 3H, OCH3), 4.26-4.39 (q, 2H, J = 7.2 Hz OCH2CH3), 
6.91 (d, 2H, J = 8.8 Hz, Ph), 7.06-7.11 (m, 3H, Ph), 7.33 (t, 2H, J = 7.6 Hz, Ph), 7.45 (dd, 2H, 
J = 8.8 Hz, J = 1.2 Hz, Ph), 7.98 (s, 1H, NH), 9.29 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 
25 °C): δ = 13.2 (q), 14.1 (q), 15.8 (q), 52.8 (q), 55.4 (q), 62.8 (t), 75.4 (s), 114.3 (d), 119.1 (d), 
121.9 (d), 123.6 (d), 129.1 (d), 136.8 (s), 137.7 (d), 143.5 (s), 144.6 (s), 153.4 (s), 155.4 (s), 
157.4 (s), 162.0 (s), 164.3 (s), 167.8 (s); IR (nujol): max = 3349, 3208, 1733, 1675, 1649  cm-
1; MS m/z (ESI): 524.79 (M + H+); anal. calcd. for C26H28N4O6S (524.1730): C 59.53, H 5.38, 
N 10.68; found: C 59.38, H 5.34, N 10.79. 
 
 
Ethyl 5-(dimethylcarbamoyl)-4-methyl-5-(-1-
(2(phenylcarbamoyl)hydrazono)ethyl)-2-(phenylimino)-
2,5-dihydrothiophene-3-carboxylate 29x 
29x was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 77 % yield. Pale yellow solid; mp: 
125131 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.39 (t, 
3H, J = 7.2 Hz, OCH2CH3), 2.04 (s, 3H, CH3), 2.23 (s, 3H, CH3), 2.81 (s, 3H, NCH3), 3.05 (s, 
3H, NCH3), 4.42 (q, 2H, J = 7.2 Hz, OCH2CH3),7.05 (d, 2H, J = 7.6 Hz, Ph), 7.10 (t, 1H, J = 
7.2 Hz, Ph), 7.17 (t, 1H, J = 7.2 Hz, Ph), 7.32-7.40 (m, 4H, Ph), 7.43 (d, 2H, J = 7.6 Hz, Ph), 
8.01 (s, 1H, NH), 9.48 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 13.3 (q), 14.2 (q), 
16.6 (q), 36.8 (q), .39.0 (q), 61.9 (t), 73.8 (s), 119.0 (d), 120.1 (d), 123.7 (d), 125.3 (d), 129.2 
(d), 129.2 (d), 135.6 (s), 137.5 (s), 144.7 (s), 150.8 (s), 153.4 (s), 159.2 (s), 163.0 (s), 163.8 (s), 
167.2 (s); IR (nujol): max = 3374, 3239, 1754, 1636, 1625 cm-1; MS m/z (ESI): 507.72 (M + 
H+); anal. calcd. for C26H29N5O4S (507.1940): C 61.52, H 5.76, N 13.80; found: C 61.64, H 
5.79, N 13.72.  
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General procedure for synthesis of 5-amino thiophene-2,4-dicarboxylates 9a-i. 
To a solution of 2,5-dihydrothiophenes 29a-c,e-g,l,m,r,t (0.5 mmol) in acetone/water (90/10, 
5.0mL) were added Amberlyst 15 H (4 equiv) and the reaction mixture was softly stirred at 
room temperature. At the disappearance of the starting 2,5-dihydrothiophenes 29 (2.0-4.0 h 
monitored by TLC) the reaction solvent was evaporated under reduced pressure and the desired 
2,5-5-amino thiophene-2,4-dicarboxylates 35a-j were purified by chromatography on silica gel 
column (elution mixture: cyclohexane: ethyl acetate). 
 
Dimethyl 3-methyl-5-(phenylamino)thiophene-2,4-dicarboxylate 
35a. 
35a was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 82% yield. White solid; mp: 135137 °C; 1H 
NMR (400 MHz, CDCl3, 25 °C): δ =  2.75 (s, 3H, CH3), 3.81 (s, 3H, 
OCH3), 3.90 (s, 3H, OCH3),  7.15 (t, 1H, J = 7.2 Hz, Ph), 7.34 (d, 2H, 
J = 7.6 Hz, Ph), 7.40 (t, 2H, J = 7.2 Hz, Ph), 10.58 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 
25 °C): δ = 15.9 (q), 51.3 (q), 51.5 (q), 108.2 (s), 109.0 (s), 120.0 (d), 124.4 (d), 129.6 (d), 139.8 
(s), 147.7 (s), 162.6 (s), 163.1 (s), 167.3 (s); IR (nujol): max = 3225, 1700, 1662  cm-1; MS m/z 
(ESI): 306.09 (M + H+); anal. calcd. for C15H15NO4S (305.3489): C 59.00, H 4.95, N 4.95; 
found: C 58.88, H 4.92, N 4.99.  
 
 
4-Ethyl-2-methyl 3-methyl-5-(phenylamino)thiophene-2,4-
dicarboxylate 35b. 
35b was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 80% yield. White solid; mp: 136139 °C; 
1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.42 (t, 3H, J = 7.2 Hz 
OCH2CH3), 2.77 (s, 3H, CH3), 3.81 (s, 3H, OCH3), 4.36 (q, 2H, J = 
7.2 Hz, OCH2CH3), 7.15 (t, 1H, J = 7.2 Hz, Ph), 7.33-7.42 (m, 4H, Ph), 10.62 (s, 1H, NH); 
13C 
NMR (100 MHz, CDCl3, 25 °C): δ = 14.3 (q), 16.0 (q), 51.5 (q), 60.4 (t), 108.1 (s), 109.2 (s), 
119.9 (d), 124.3 (d), 129.6 (d), 139.8 (s), 147.8 (s), 162.4 (s), 163.2 (s), 166.9 (s); IR (nujol): 
max = 3217, 1714, 1650  cm-1; MS m/z (ESI): 320.04 (M + H+); anal. calcd. for C16H17NO4S 
(319.3755): C 60.17, H 5.37, N 4.39; found: C 60.26, H 5.39, N 4.32.  
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4-Ethyl 2-methyl 5-((4-chlorophenyl)amino) 3-
methylthiophene-2,4-dicarboxylate 35c. 
35c was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 82% yield. White solid; mp: 140141 °C; 
1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.42 (t, 3H, J = 7.6 Hz 
OCH2CH3), 2.77 (s, 3H, CH3), 3.82 (s, 3H, O CH3), 4.37 (q, 2H, J = 
7.6 Hz, OCH2CH3), 7.28 (d, 2H, J = 9.6 Hz, Ph), 7.36 (d, 2H, J = 9.6 
Hz, Ph), 10.62 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.3 (q), 16.0 (q), 51.6 
(q), 60.6 (t), 108.6 (s), 109.6 (s), 121.2 (d), 129.4 (s), 129.6 (d), 138.4 (s), 147.8 (s), 162.0 (s), 
163.1 (s), 166.9 (s); IR (nujol): max = 3160, 1704, 1652 cm-1; MS m/z (ESI): 354.55 (M + H+); 
anal. calcd. for C16H16ClNO4S (353.8205): C 54.31, H 4.56, N 3.96; found: C 54.42, H 4.58, N 
3.88.  
2-Ethyl-4-methyl 3-methyl-5-(phenylamino)thiophene-2,4-
dicarboxylate 35d. 
35d was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 78% yield. White solid; mp: 128131 
°C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.35 (t, 3H, J = 7.2 
Hz OCH2CH3), 2.76 (s, 3H, CH3), 3.91 (s, 3H, OCH3), 4.29 (q, 2H, J = 7.2 Hz, OCH2CH3), 
7.16 (t, 1H, J = 7.2 Hz, Ph), 7.35-7.44 (m, 4H, Ph), 10.55 (s, 1H, NH); 13C NMR (100 MHz, 
CDCl3, 25 °C): δ = 14.4 (q), 15.9 (q), 51.3 (q), 60.5 (t), 108.8 (s), 109.1 (s), 120.1 (d), 124.5 
(d), 129.6 (d), 139.9 (s), 147.4 (s), 162.6 (s), 162.8 (s), 167.4 (s); IR (nujol): max = 3163, 1698, 
1667 cm-1; MS m/z (ESI): 320.05 (M + H+); anal. calcd. for C16H17NO4S (319.3755): C 60.17, 
H 5.37, N 4.39; found: C 60.05, H 5.34, N 4.43.  
Diethyl 3-methyl-5-(phenylamino)thiophene-2,4-
dicarboxylate 35e. 
35e was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 78% yield. White solid; mp: 106111 
°C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.34 (t, 3H, J = 7.2 
Hz OCH2CH3), 1.41 (t, 3H, J = 7.2 Hz OCH2CH3), 2.76 (s, 3H, CH3), 4.28 (q, 2H, J = 7.2 Hz, 
OCH2CH3), 4.35 (q, 2H, J = 7.2 Hz, OCH2CH3), 7.12-7.41 (m, 5H, Ph), 10.62 (s, 1H, NH); 
13C 
NMR (100 MHz, CDCl3, 25 °C): δ = 14.0 (q), 14.2 (q), 15.7 (q), 60.2 (t), 108.4 (s), 108.9 (s), 
119.6 (d), 124.0 (d), 129.3 (d), 139.6 (s), 147.2 (s), 162.0 (s), 162.6 (s), 166.1 (s); IR (nujol): 
max = 3224, 1693, 1655 cm-1; MS m/z (ESI): 334.07 (M + H+); anal. calcd. for C17H19NO4S 
(333.4021): C 61.24, H 5.74, N 4.20; found: C 61.39, H 5.79, N 4.12.  
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2-Ethyl 4-methyl 5-((4-chlorophenyl)amino) 3-ethylthiophene-
2,4-dicarboxylate 35f. 
35f was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 78% yield. White solid; mp: 149151 °C; 
1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.19 (t, 3H, J = 7.6 Hz 
CH2CH3), 1.35 (t, 3H, J = 7.2 Hz OCH2CH3), 3.31 (q, 2H, J = 7.2 
Hz, CH2CH3), 3.91 (s, 3H, O CH3), 4.30 (q, 2H, J = 7.2 Hz, OCH2CH3), 7.30 (d, 2H, J = 8.8 
Hz, Ph), 7.37 (d, 2H, J = 8.8 Hz, Ph), 10.58 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): 
δ = 14.4 (q), 14.8 (q), 22.3 (t), 51.5 (q), 60.6 (t), 108.5 (s), 108.8 (s), 121.4 (d), 129.5 (s), 129.7 
(d), 138.5 (s), 153.7 (s), 162.3 (s), 162.6 (s), 167.1 (s); IR (nujol): max = 3223, 1696, 1664 cm-
1; MS m/z (ESI): 368.42 (M + H+); anal. calcd. for C17H18ClNO4S (367.8471): C 55.51, H 4.93, 
N 3.81; found: C 55.40, H 4.95, N 3.86.  
4-Benzyl 2-Ethyl 3-methyl-5-(phenylamino)thiophene-2,4-
dicarboxylate 35g. 
35g was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 81% yield. White solid; mp: 117119 
°C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.34 (t, 3H, J = 
7.2 Hz OCH2CH3), 2.77 (s, 3H, CH3), 4.28 (q, 2H, J = 7.2 Hz, 
OCH2CH3), 5.38 (s, 2H, OCH2Ph), 7.16 (t, 1H, J = 7.2 Hz, Ph), 7.33-7.46 (m, 9H, Ph), 10.54 
(s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.4 (q), 16.2 (q), 60.5 (t), 66.2 (t), 108.8 
(s), 108.9 (s), 120.2 (d), 124.5 (d), 128.1 (d), 128.3 (d), 128.7 (d), 129.6 (d), 135.9 (s), 139.8 
(s), 147.4 (s), 162.8 (s), 166.6 (s); IR (nujol): max = 3242, 1701, 1648 cm-1; MS m/z (ESI): 
395.98 (M + H+); anal. calcd. for C22H21NO4S (395.4714): C 66.82, H 5.35, N 3.54; found: C 
66.95, H 5.38, N 3.59.  
4-Allyl 2-tert-butyl 3-methyl-5-(phenylamino)thiophene-2,4-
dicarboxylate 35h. 
35h was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 70% yield. White solid; mp: 7779 °C; 
1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.56 (s, 9H, OC(CH3)3), 
2.75 (s, 3H, CH3), 4.82 (d, 2H, J = 5.2 Hz, OCH2CH=CH2), 5.31 (dd, 1H, J = 10.4 Hz, J = 0.8 
Hz, OCH2CH=CH2), 5.42 (dd, 1H, J = 17.2 Hz, J = 1.2 Hz, OCH2CH=CH2), 6.00-6.10 (m, 1H, 
OCH2CH=CH2), 7.15 (t, 1H, J = 7.2 Hz, Ph), 7.34-7.42 (m, 4H, Ph), 10.54 (s, 1H, NH); 
13C 
NMR (100 MHz, CDCl3, 25 °C): δ = 15.9 (q), 28.4 (q), 65.0 (s), 81.3 (s), 108.9 (s), 110.6 (s), 
118.2 (t), 120.0 (d), 124.3 (d), 129.6 (d), 132. 2 (s), 139.9 (s), 146.2 (s), 162.3 (s), 162.3 (s), 
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166.6 (s); IR (nujol): max = 3188, 1704, 1664 cm-1; MS m/z (ESI): 374.08 (M + H+); anal. calcd. 
for C20H23NO4S (373.4659): C 64.32, H 6.21, N 3.75; found: C 64.39, H 6.22, N 3.75.  
2-Benzyl 4-methyl 3-methyl-5-
(phenylamino)thiophene-2,4-dicarboxylate 35i. 
35i was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 81% yield. White solid; mp: 
116118 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ =  2.78 
(s, 3H, CH3), 3.91 (s, 3H, OCH3), 5.29 (s, 2H, OCH2Ph), 7.16 (t, 1H, J = 7.2 Hz, Ph), 7.34-7.43 
(m, 9H, Ph), 10.59 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 16.0 (q), 51.4 (q), 
66.0 (t), 108.2 (s), 109.2 (s), 120.1 (d), 124.5 (d), 128.0 (d), 128.1 (d), 128.5 (d), 129.6 (d), 
136.2 (s), 139.8 (s), 148.1 (s), 162.6 (s), 162.8 (s), 167.3 (s); IR (nujol): max = 3221, 1695, 
1666 cm-1; MS m/z (ESI): 382.04 (M + H+); anal. calcd. for C21H19NO4S (381.4449): C 66.12, 
H 5.02, N 3.67; found: C 65.98, H 4.98, N 3.72. 
 
4-Allyl 2-ethyl 3-methyl-5-(phenylamino)thiophene-2,4-
dicarboxylate 35j. 
35j was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 67% yield. White solid; mp: 7073 °C; 
1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.35 (t, 3H, J = 7.2 Hz 
OCH2CH3), 2.79 (s, 3H, CH3), 4.29 (q, 2H, J = 7.2 Hz, 
OCH2CH3), 4.83 (dt, 2H, J = 5.6 Hz, J = 1.2 Hz, OCH2CH=CH2), 5.31 (dd, 1H, J = 10.4 Hz, J 
= 1.2 Hz, OCH2CH=CH2), 5.46 (dd, 1H, J = 17.2 Hz, J = 1.2 Hz, OCH2CH=CH2), 6.00-6.10 
(m, 1H, OCH2CH=CH2), 7.16 (t, 1H, J = 7.2 Hz, Ph), 7.34-7.43 (m, 4H, Ph), 10.56(s, 1H, NH); 
13C NMR (100 MHz, CDCl3, 25 °C): δ = 16.4 (q), 16.1 (q), 60.5 (t), 65.1 (t), 108.8 (s), 108.9 
(s), 118.4 (t), 120.1 (d), 124.5 (d), 129.6 (d), 132.2 (d), 139.8 (s), 147.4 (s), 162.7 (s), 162.8 (s), 
166.5 (s); IR (nujol): max = 3283, 1708, 1663 cm-1; MS m/z (ESI): 346.11 (M + H+); anal. calcd. 
for C18H19NO4S (345.4128): C 62.59, H 5.54, N 4.06; found: C 62.46, H 5.51, N 4.12.  
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General procedure for the synthesis of 2-arylamino 5-hydrazono thiophene-3 
carboxylates 41a-g by basic treatment of DHT 29. 
To a solution of 2,5-dihydrothiophenes 29a,b,d-f,h,j,m,n (0.5 mmol) in THF (5.0mL) 
NaH ( 2.0 equiv.) were added and the reaction mixture was softly stirred at room 
temperature. At the disappearance of the starting 2,5-dihydrothiophenes 29 (3.0-5.0 h 
monitored by TLC) the reaction solvent was evaporated under reduced pressure and the desired 
2-arylamino 5-hydrazono thiophene-3 carboxylates 41a-g were purified by chromatography on 
silica gel column (elution mixture: cyclohexane: ethyl acetate). 
 
 Tert-butyl 2-(1-(4-(methoxycarbonyl)-3-methyl-5-
(phenylamino)thiophen-2-
yl)ethylidene)hydrazinecarboxylate 41a. 
41a was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 71% yield. Pale yellow solid; mp: 
123125 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.49 and 
1.52 (brs and s, 9H, OC(CH3) 3), 2.16 and 2.48 (2s, 3H, CH3), 2.19 and 2.23 (2s, 3H, CH3), 3.86 
and 3.88 (2s, 3H, OCH3), 7.04-7.14 (m, 1H, Ph), 7.27-7.39 (m, 4H, Ph), 7.73 and 7.83 (2brs, 
1H, NH), 10.28 and 10.35 (2s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 16.6 (q), 16.8 
(q), 25.4 (q), 28.2 (s), 28.3 (s), 51.1 (q), 51.3 (q), 81.2 (s), 107.0 (s), 108.6 (s), 109.7 (s), 119.4 
(s), 119.5 (d), 119.6 (d), 123.5 (d), 124.1 (d), 129.5 (d), 129.6 (d), 135.2 (s), 135.2 (s), 140.2 
(s), 140.3 (s), 142.9 (s), 152.5 (s), 159.9 (s), 161.5 (s), 167.0(s), 167.2 (s); IR (nujol): max = 
3288, 3167, 1743, 1653 cm-1; MS m/z (ESI): 403.68 (M + H+); anal. calcd. for C20H25N3O4S 
(403.1566): C 59.53, H 6.25, N 10.41; found: C 59.68, H 6.28, N 10.31. 
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Tert-butyl 2-(1-(4-(ethoxycarbonyl)-3-methyl-5-
(phenylamino)thiophen-2-
yl)ethylidene)hydrazinecarboxylate 41b. 
41b was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 78% yield. Pale yellow solid; mp: 
170172 °C; 1H NMR (400 MHz, DMSOd6, 25 °C): δ = 1.31 (t, 
3H, J = 7.2 Hz OCH2CH3), 1.41 and 1.45 (2s, 9H, OC(CH3) 3), 2.05 and 2.43 (2s, 3H, CH3), 
2.10 and 2.18 (2s, 3H, CH3), 4.29 (q, 2H, J = 7.2 Hz, OCH2CH3), 7.12 (t, 1H, J = 7.2 Hz, Ph), 
7.35-7.43 (m, 4H, Ph), 9.16 and 9.77 (2s, 1H, NH), 10.00 (s, 1H, NH); 13C NMR (100 MHz, 
DMSOd6, 25 °C): δ = 14.2 (q), 14.2 (q), 16.4 (q), 16.4 (q), 17.5 (q), 25.2 (q), 28.0 (s), 28.1 (s), 
59.9 (t), 79.3 (s), 79.4 (s), 107.6 (s), 108.9 (s), 111.6 (s), 119.5 (d), 119.7 (d), 120.4 (s), 123.7 
(d), 123.8 (d), 129.6 (d), 129.6 (d), 134.1 (s), 134.3(s), 140.4 (s), 140.7 (s), 147.2 (s), 152.6 (s), 
152.8 (s), 158.4 (s), 159.9 (s), 165.4(s), 165.4 (s); IR (nujol): max = 3281, 3221, 1740, 1653 
cm-1; MS m/z (ESI): 418.13 (M + H+); anal. calcd. for C21H27N3O4S (417.5288): C 60.41, H 
6.52, N 10.06; found: C 60.28, H 6.47, N 10.22.  
 
 
Tert-butyl 2-(1-(5-((4-chlorophenyl)amino)-3-ethyl--4-
(methoxycarbonyl)thiophen-2-
yl)ethylidene)hydrazinecarboxylate 41c. 
41c was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 77% yield. Pale yellow solid; mp: 
150152 °C; 1H NMR (400 MHz, CDCl3,, 25 °C): δ = 1.09 and 
1.21 (2t, 3H, J = 7.6 Hz, J = 7.2 Hz, CH2CH3), 1,48 and 1.53 
(2s, 9H, OC(CH3) 3), 2.20 and 2.24 (2s, 3H, CH3), 2.58 and 2.96 (2q, 2H, J = 7.2 Hz, J = 7.2 
Hz, CH2CH3), 3.88 and 3.90 (2s, 3H, OCH3), 4.29-4.37 (m, 2H, OCH2CH3), 7.22-7.34 (m, 4H, 
Ph), 7.68 and 7.82 (2brs, 1H, NH), 10.31 and 10.41 (2s, 1H, NH); 13C NMR (100 MHz, CDCl3,, 
25 °C): δ = 15.0 (q), 15.3 (q), 16.2 (q), 22.7 (t), 23.1 (t), 25.8 (q), 28.2 (s), 28.2 (s), 51.1 (q), 
51.4 (q), 81.3 (s), 106.5 (s), 108.0 (s), 109.1 (s), 119.4 (s), 120.7 (d), 120.8 (d), 128.4 (s), 129.0 
(s), 129.4 (d), 129.6 (d), 138.8 (s), 139.0 (s), 141.4 (s), 141.7 (s), 142.8 (s), 152.2 (s), 152.3 ( s), 
159.7 (s), 161.4 (s), 166.6(s), 167.0 (s); IR (nujol): max = 3291, 3210, 1746, 1702 cm-1; MS 
m/z (ESI): 452.57 (M + H+); anal. calcd. for C21H26ClN3O4S (451.9668): C 55.81, H 5.80, N 
9.30; found: C 55.73, H 5.78, N 9.37. 
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Tert-butyl 2-(1-(4-((benzyloxy)carbonyl)-3-methyl-5-
(phenylamino)thiophen-2-
yl)ethylidene)hydrazinecarboxylate 41d. 
41d was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 73% yield. Pale yellow solid; mp: 
126128 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.50 
and 1.53 (2s, 9H, OC(CH3) 3), 2.18 and 2.52 (2s, 3H, CH3), 2.20 and 2.23 (2s, 3H, CH3), 5.35and 
5.37 (2s, 2H, J = 7.2 Hz, OCH2Ph), 7.08-7.14 (m, 1H, J = 7.2 Hz, Ph), 7.30-7.45 (m, 9H, Ph), 
7.63 and 7.81 (2brs, 1H, NH), 10.28 and 10.36 (2s, 1H, NH); 13C NMR (100 MHz, CDCl3,, 
25 °C): δ = 16.6 (q), 16.8 (q), 17.2 (q), 25.5 (q), 28.2 (s), 28.3 (s), 66.0 (t), 66.2 (t), 81.3 (s), 
106.8 (s), 108.5 (s), 109.6 (s), 119.6 (d), 119.7 (d), 120.4 (s), 123.7 (d), 124.2 (d), 128.1 (d), 
128.2 (d), 128.2 (d), 128.3 (d), 128.6 (d), 128.7 (d), 129.5 (d), 129.6 (d), 135.2 (s), 135.9(s), 
136.1 (s), 140.2 (s), 140.2 (s), 152.5 (s), 152.5 (s), 160.3 (s), 161.8 (s), 166.2(s), 166.4 (s); IR 
(nujol): max = 3296, 3145, 1745, 1624 cm-1; MS m/z (ESI): 480.13 (M + H+); anal. calcd. for 
C26H29N3O4S (479.5912): C 65.11, H 6.09, N 8.76; found: C 65.24, H 6.11, N 8.71.  
 
 
Tert-butyl 2-(1-(4-(methoxycarbonyl)-3-methyl-5-
(phenylamino)thiophen-2-
yl)propylidene)hydrazinecarboxylate 41e. 
41e was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 78% yield. Pale yellow solid; mp: 
136138 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.08 (t, 
3H, J = 7.6 Hz, CH2CH3), 2.16 (s, 3H, CH3), 2.54 (q, 2H, J = 7.6 Hz, CH2CH3), 3.90 (s, 3H, 
OCH3), 7.13 (t, 1H, J = 7.2 Hz, J = 8.4 Hz, J = 0.8 Hz, Ph), 7.39 (t, 2H, J = 7.6 Hz, Ph), 7.82 
(brs, 1H, NH), 10.30 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 11.0 (q), 16.6 (q), 
28.2 (q), 32.3 (t), 25.7 (q), 51.3 (q), 81.2 (s), 107.0 (s), 108.5 (s), 119.6 (d), 124.1 (d), 129.6 (d), 
135.8 (s), 140.2 (s), 144.5 (s), 147.6 (s), 152.6 (s), 161.5 (s), 167.0 (s); IR (nujol): max = 3296, 
3220, 1745, 1653 cm-1; MS m/z (ESI): 417.85 (M + H+); anal. calcd. for C21H27N3O4S 
(417.1722): C 60.41, H 6.52, N 10.06; found: C 60.33, H 6.50, N 10.12.  
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Methyl 2-(1-(5-((4-chlorophenyl)amino)-4-
(ethoxycarbonyl)-3-methylthiophen-2-
yl)ethylidene)hydrazinecarboxylate 41f. 
41f was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 69% yield. Pale yellow solid; mp: 
136139 °C; 1H NMR (400 MHz, CDCl3,, 25 °C): δ = 1.36-1.40 
(m, 3H, OCH2CH3), 2.17 and 2.46 (2s, 3H, CH3), 2.22 and 2.24 (2s, 3H, CH3), 3.80 and 3.83 
(brs and s, 3H, OCH3), 4.29-4.37 (m, 2H, OCH2CH3), 7.20-7.33 (m, 4H, Ph), 7.97 (brs, 1H, 
NH), 10.32 and 10.38 (2s, 1H, NH); 13C NMR (100 MHz, CDCl3,, 25 °C): δ = 14.3 (q), 16.7 
(q), 16.7 (q), 16.9 (q), 25.3 (q), 53.0 (q), 60.2 (t), 60.4 (t), 107.5 (s), 109.1 (s), 109.5 (s), 119.1 
(s), 120.5 (d), 120.7 (d), 128.3 (s), 129.0 (s), 129.4 (d), 129.6 (d), 135.5 (s), 135.6 (s), 138.7 (s), 
138.9 (s), 143.9 (s), 153.9 (s), 154.2 ( s), 159.1 (s), 160.8 (s), 166.4(s), 166.7 (s); IR (nujol): 
max = 3293, 3191, 1736, 1653 cm-1; MS m/z (ESI): 410.47 (M + H+); anal. calcd. for 
C18H20ClN3O4S (409.8871): C 52.74, H 4.92, N 10.25; found: C 52.58, H 4.89, N 10.34. 
 
 
 (Methyl 2-(1-(4-(ethoxycarbonyl)-3-ethyl-5-
(phenylamino)thiophen-2-
yl)ethylidene)hydrazinecarboxylate 41g. 
41g was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 68% yield. Pale yellow solid; mp: 
128130 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.03 and 1.16 ( 2t, 3H, J = 7.2 Hz, J = 
7.2 Hz, CH2CH3), 1.33 (t, 3H, J = 7.2 Hz OCH2CH3), 2.14 and 2.18 (2s, 3H, CH3), 2.51 and 
2.90 ( 2q, 2H, J = 7.2 Hz, J = 7.2 Hz, CH2CH3), 3.73 and 3.76 (brs and s, 3H, OCH3), 4.29 (q, 
2H, J = 7.2 Hz, OCH2CH3), 6.99-7.07 (m, 1H, Ph), 7.19-7.33 (m, 4H, Ph), 7.89 and 7.96 (brs 
and s, 1H, NH), 10.27 and 10.38 (2s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.2 
(q), 15.2 (q), 15.4 (q), 16.4 (q), 17.5 (q), 22.8 (t), 23.3 (q), 25.7 (q), 53.3 (q), 60.2 (t), 60.4 (t), 
79.3 (s), 106.1 (s), 107.8 (s), 108.2 (s), 118.4 (s), 119.6 (d), 119.8 (d), 123.6 (d), 124.2 (d), 
129.5 (d), 129.6 (d), 140.3 (s), 140.4 (s), 141.7(s), 142.3 (s), 144.5 (s), 144.6 (s), 153.8 (s), 
153.9 (s), 160.4 (s), 162.1 (s), 166.2 (s), 166.6 (s); IR (nujol): max = 3288, 3120, 1756, 1654 
cm-1; MS m/z (ESI): 390.03 (M + H+); anal. calcd. for C19H23N3O4S (389.4686): C 58.59, H 
5.95, N 10.79; found: C 58.71, H 5.99, N 10.67.  
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One pot sequential synthesis of 2-arylamino 5-hydrazono thiophene-3-carboxylates 
(AHTs) 41h-r starting from in situ generated 4-unsubstituted DDs. 
Alkyl amines 31a,b (0.5 mmol) were added to -ketoesters 30a,b,i (0.55 mmol) under solvent-
free conditions at room temperature and vigorously stirred at room temperature. After 0.5 h aryl 
isothiocyanates 34a (0.5mmol) in CH2Cl2 (1.5 mL) were added and the reactions were stirred 
until the disappearance of the enamino esters 32 (5-20h monitored by TLC). -Halo hydrazones 
15a-g (1.0 mmol) in CH2Cl2 (2.0 mL) and potassium carbonate (4.0 mmol) were added to the 
reaction medium and magnetically stirred until the complete disappearance of the ACTs 28a,c,i 
(5.0-7.0 h monitored by TLC). Then, the reaction solvent was evaporated under reduced 
pressure and the desired 2-arylamino 5-hydrazono thiophene-3-carboxylates (AHTs) 41h-r 
were purified by chromatography on silica gel column (elution mixture: cyclohexane: ethyl 
acetate). 
 
Methyl 2-((4-(methoxycarbonyl)-3-methyl-5-
(phenylamino)thiophen-2-
yl)(phenyl)methylene)hydrazinecarboxylate (41h).  
41h was isolated by column chromatography on silica gel 
(acetate/cyclohexane 20:80) in 80% yield. White solid; mp: 
169172 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 2.17 (s, 
3H, CH3), 3.87 (brs, 3H, OCH3), 3.92 (s, 3H, OCH3), 7.11 (t, 
1H, J = 7.2 Hz, Ph), 7.29-7.38 (m, 7H, Ph), 7.63-7.68 (m, 2H, Ph), 8.22 (brs, 1H, NH), 
10.39 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 16.5 (q), 51.3 (q), 53.1 (q), 
106.0 (s), 106.9 (s), 119.6 (d), 124.1 (d), 127.3 (d), 128.4 (d), 129.6 (d), 129.7 (s), 136.6 
(s), 137.8 (s), 140.1 (s), 144.1 (s), 153.6 (s), 162.2 (s), 166.9 (s); IR (nujol): max = 
3218, 3113, 1699, 1660 cm-1; MS m/z (ESI): 424.05 (M + H+); anal. calcd. for 
C22H21N3O4S (423.4848): C 62.40, H 5.00, N 9.92; found: C 62.34, H 4.98, N 9.96. 
Tert-butyl 2-((4-(methoxycarbonyl)-3-methyl-5-
(phenylamino)thiophen-2-
yl)(phenyl)methylene)hydrazinecarboxylate (41i).  
41i was isolated by column chromatography on silica gel 
(acetate/cyclohexane 20:80) in 81% yield. White solid; mp: 
162166 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.55 (s, 
9H, OC(CH3)3), 2.18 (s, 3H, CH3), 3.93 (s, 3H, OCH3), 7.11 
(t, 1H, J = 7.2 Hz, Ar), 730-7.38 (m, 7H, Ph), 7.67-7.69 (m, 2H, Ph), 8.07 (brs, 1H, NH), 
10.42 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 16.4 (q), 28.2 (q), 51.3 (q), 
81.7 (s), 106.3 (s), 107.0 (s), 119.5 (d), 124.0 (d), 127.1 (d), 128.3 (d), 129.4 (d), 129.6 
(d), 136.9 (s), 137.5 (s), 140.2 (s), 142.8 (s), 152.3 (s), 162.0 (s), 167.0 (s); IR (nujol): 
max = 3287, 3178, 1751, 1663 cm-1; MS m/z (ESI): 466.18 (M + H+); anal. calcd. for 
C25H27N3O4S (465.5646): C 64.50, H 5.85, N 9.03; found: C 64.44, H 5.86, N 9.09.  
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Tert-butyl 2-((4-bromophenyl)(4-(methoxycarbonyl)-3-
methyl-5-(phenylamino)thiophen-2-
yl)methylene)hydrazinecarboxylate (41j). 
41j was isolated by column chromatography on silica gel 
(acetate/cyclohexane 20:80) in 87% yield. White solid; mp: 
168171 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.54 
(s, 9H, OC(CH3)3), 2.15 (s, 3H, CH3), 3.93 (s, 3H, OCH3), 
7.12 (t, 1H, J = 7.2 Hz, Ph), 7.31 (dd, J = 8.8 Hz, J = 1.2 
Hz, 2H, Ph), 7.37 (t, 2H, J = 7.2 Hz, Ph), 7.46 (d, 2H, J = 
8.8 Hz, Ph), 7.54 (d, 2H, J = 8.8 Hz, Ph), 8.05 (brs, 1H, NH), 10.40 (s, 1H, NH); 13C 
NMR (100 MHz, CDCl3, 25 °C): δ = 16.4 (q), 28.2 (q), 51.3 (q), 81.9 (s), 105.6 (s), 
107.0 (s), 119.6 (d), 123.9 (s), 124.2 (d), 128.6 (d), 129.6 (d), 131.4 (d), 135.9 (s), 137.8 
(s), 140.1 (s), 141.8 (s), 152.2 (s), 162.2 (s), 167.0 (s); IR (nujol): max = 3343, 3173, 
1754, 1659 cm-1; MS m/z (ESI): 545.08 (M + H+); anal. calcd. for C25H26BrN3O4S 
(544.4606): C 55.15, H 4.81, N 7.72; found: C 55.02, H 4.78, N 7.74. 
 
 
Methyl 5-((2-
isonicotinoylhydrazono)(phenyl)methyl)-4-methyl-
2-(phenylamino)thiophene-3-carboxylate (41k). 
41k was isolated by column chromatography on silica 
gel (acetate/cyclohexane 20:80) in 53% yield. White 
solid; mp: 160163 °C; 1H NMR (400 MHz, CDCl3, 25 
°C): δ = 2.22 (s, 3H, CH3), 3.93 (s, 3H, OCH3), 7.13 (t, 
1H, J = 7.2 Hz, Ar), 7.30-7.42 (m, 7H, Ar), 7.51-7.62 
(m, 2H, Ar), 7.76-7.83 (m, 2H, Ar), 7.67-8.79 (m, 2H, 
Ar), 9.17 and 9.48 (2brs, 1H, NH), 10.39 and 10.45 (2s, 1H, NH); 13C NMR (100 MHz, 
CDCl3, 25 °C): δ = 14.1 (q), 16.6 (q), 51.1 (q), 51.3 (q), 51.4 (q), 105.0 (s), 105.7 (s), 
107.0 (s), 119.6 (d), 119.8 (d), 119.9 (s), 120.0 (s), 123.7 (s), 124.4 (s), 127.3 (d), 128.0 
(d), 128.1 (d), 129.5 (d), 129.6 (d), 130.2 (d), 130.2 (d), 130.6 (s), 130.6 (s), 136.2 (s), 
138.5 (s), 139.8 (s), 140.0 (s), 145.2 (s), 149.6 (s), 150.7 (s), 162.4 (s), 162.5 (s), 166.8 
(s), 167.8 (s); IR (nujol): max = 3355, 3241, 1661, 1593 cm-1; MS m/z (ESI): 471.13 
(M + H+); anal. calcd. for C26H22N4O3S (470.5429): C 66.37, H 4.71, N 11.91; found: C 
66.48, H 4.73, N 11.82. 
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Methyl 2-((4-(ethoxycarbonyl)-3-methyl-5-
(phenylamino)thiophen-2-yl)(4-
nitrophenyl)methylene)hydrazinecarboxylate (41l).  
41l was isolated by column chromatography on silica gel 
(acetate/cyclohexane 20:80) in 57% yield. White solid; mp: 
164165 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.43 
(q, 3H, J = 7.2 Hz, OCH2CH3), 2.17 (s, 3H, CH3), 3.90 (s, 
3H, OCH3), 4.41 (q, 2H, J = 7.2 Hz, OCH2CH3), 7.14 (t, 1H, 
J = 7.2 Hz, Ph), 7.30 (d, 2H, J = 7.6 Hz, Ph),7.38 (t, 2H, J = 7.6 Hz, Ph), 7.84 (d, 2H, J 
= 8.8 Hz, Ph), 8.20 (d, 2H, J = 8.4 Hz, Ph), 8.34 (brs, 1H, NH), 10.36 (brs, 1H, NH); 13C 
NMR (100 MHz, CDCl3, 25 °C): δ = 14.4 (q), 16.7 (q), 55.4 (q), 60.6 (t), 104.3 (s), 107.2 
(s), 119.8 (d), 123.7 (d), 124.5 (d), 128.0 (d), 129.7 (d), 138.8 (s), 140.0 (s), 141.9 (s), 
142.7 (s), 148.3 (s), 153.7 (s), 162.5 (s), 166.4 (s); IR (nujol): max = 3327, 3222, 1763, 
1652 cm-1; MS m/z (ESI): 483.10 (M + H+); anal. calcd. for C23H22N4O6S (482.5090): 
C 57.25, H 4.60, N 11.61; found: C 57.16, H 4.63, N 11.74. 
 
 
Ethyl 2-((4-(ethoxycarbonyl)-3-methyl-5-
(phenylamino)thiophen-2-
yl)(phenyl)methylene)hydrazinecarboxylate (41m).  
41m was isolated by column chromatography on silica gel 
(acetate/cyclohexane 20:80) in 79% yield. White solid; 
mp: 155157 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 
1.31-1.39 (m, 3H, OCH2CH3), 1.42 (t, 3H, J = 7.2 Hz, 
OCH2CH3), 2.19 (s, 3H, CH3), 4.27-4.32 (m, 2H, OCH2CH3), 4.40 (q, 2H, J = 7.2 Hz, 
OCH2CH3), 7.10 (t, 1H, J = 7.2 Hz, Ph), 7.29-7.38 (m, 7H, Ph), 7.67-7.69 (m, 2H, Ph), 
8.20 (brs, 1H, NH), 10.44 (s, 1H, 2NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.4 
(q), 14.5 (q), 16.6 (q), 60.4 (t), 62.1 (t), 106.1 (s), 107.1 (s), 119.4 (d), 124.0 (s), 127.3 
(d), 128.3 (d), 129.6 (d), 129.7 (d), 136.8 (s), 137.8 (s), 140.2 (s) 153.6 (s), 162.0 (s), 
166.6 (s); IR (nujol): max = 3209, 3131, 1697, 1650 cm-1; MS m/z (ESI): 452.12 (M 
+ H+); anal. calcd. for C24H25N3O4S (451.5380): C 63.84, H 5.58, N 9.31; found: C 
63.96, H 5.61, N 9.20. 
 
 
Tert-butyl 2-((4-(ethoxycarbonyl)-3-methyl-5-
(phenylamino)thiophen-2-
yl)(phenyl)methylene)hydrazinecarboxylate (41n).  
41n was isolated by column chromatography on silica gel 
(acetate/cyclohexane 20:80) in 85% yield. White solid; mp: 
149151 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.42 
(t, 3H, J = 7.2 Hz, OCH2CH3), 1.55 (s, 9H, OC(CH3)3), 2.19 
(s, 3H, CH3), 4.39 (q, 2H, J = 7.2 Hz, OCH2CH3), 7.10 (t, 1H, J = 7.2 Hz, Ph), 730-7.38 
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(m, 7H, Ph), 7.67-7.70 (m, 2H, Ph), 8.09 (brs, 1H, NH), 10.46 (s, 1H, NH); 13C NMR 
(100 MHz, CDCl3, 25 °C): δ = 14.3 (q), 16.5 (q), 28.2 (q), 60.3 (t), 81.7 (s), 106.2 (s), 
107.1 (s), 119.3 (d), 123.9 (d), 127.1 (d), 128.2 (d), 129.4 (d), 129.5 (d), 136.8 (s), 137.6 
(s), 140.2 (s), 143.0 (s), 152.2 (s), 161.7 (s), 166.6 (s); IR (nujol): max = 3277, 3226, 
1750, 1652 cm-1; MS m/z (ESI): 480.16 (M + H+); anal. calcd. for C26H29N3O4S 
(479.5912): C 65.11, H 6.09, N 8.76; found: C 65.24, H 6.12, N 8.69. 
 
 
Ethyl 5-((2-(benzoylhydrazono)(phenyl)methyl)-4-methyl-2-
(phenylamino)thiophene-3-carboxylate (41o).  
41o was isolated by column chromatography on silica gel 
(acetate/cyclohexane 20:80) in 62% yield. White solid; mp: 
142144 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.43 
(q, 3H, J = 7.2 Hz, OCH2CH3), 2.25 (s, 3H, CH3), 4.41 (q, 
2H, J = 7.2 Hz, OCH2CH3), 7.11 (t, 1H, J = 7.2 Hz, Ph), 
7.31-7.77 (m, 14H, Ph), 8.03, 9,02 (2brs, 1H, NH), 10.48 (s, 
1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.3 (q), 16.8 (q), 60.4 (t), 60.1 (t), 
106.1 (s), 107.2 (s), 119.5 (d), 124.2 (d), 127.2 (d), 127.8 (d), 128.2 (d), 128.4 (d), 128.8 
(d), 129.6 (d), 130.0 (d), 133.1 (s), 136.6 (s), 138.3 (s), 140.1 (s), 147.7 (s), 162.1 (s), 
163.2 (s), 166.5 (s); IR (nujol): max = 3326, 3310, 1693, 1651 cm-1; MS m/z (ESI): 
483.99 (M + H+); anal. calcd. for C28H25N3O3S (483.5814): C 69.54, H 5.21, N 8.69; 
found: C 69.66, H 5.24, N 8.60. 
 
 
Methyl 2-((3-ethyl-4-(methoxycarbonyl)--5-
(phenylamino)thiophen-2-
yl)(phenyl)methylene)hydrazinecarboxylate (41p).  
41p was isolated by column chromatography on silica gel 
(acetate/cyclohexane 20:80) in 87% yield. White solid; mp: 
129130 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 0.85 and 
1.04 (2t, 3H, J = 7.2 Hz, J = 7.2 Hz, CH2CH3), 2.46 and 2.57 
(q and brs, 2H, J = 7.2 Hz, CH2CH3), 3.79, 3.84, and 3.92 (brs and 2s, 6H, 2OCH3), 
7.08-7.70 (m, 10H, 2Ph), 7.76 and 8.25 (2brs, 1H, NH), 10.40 and 10.48 (2brs, 1H, NH); 
13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.8 (q), 15.0 (q), 51.0 (q), 51.2 (q), 52.8 (q), 
52.9 (q), 105.3 (s), 106.0 (s), 107.7 (s), 119.7 (s), 119.8 (d), 123.8 (d), 124.1 (d), 127.2 
(d), 128.0 (d), 128.3 (d), 129.4 (d), 129.5 (d), 129.7 (s), 129.7 (d), 130.1 (s), 132.4 (s), 
136.6 (s), 140.1 (s), 140.1 (s), 143.9 (s), 144.3 (s), 153.5 (s), 153.9 (s), 161.5 (s), 162.7 
(s), 166.6 (s), 166.9 (s); IR (nujol): max = 3321, 3217, 1774, 1668 cm-1; MS m/z (ESI): 
438.01 (M + H+); anal. calcd. for C23H23N3O4S (437.5114): C 63.14, H 5.30, N 9.60; 
found: C 63.23, H 5.34, N 9.55. 
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Tert-butyl 2-((4-bromophenyl)(-3-ethyl-4-
(methoxycarbonyl)-5-(phenylamino)thiophen-2-
yl)methylene)hydrazinecarboxylate (41q). 
41q was isolated by column chromatography on silica gel 
(acetate/cyclohexane 20:80) in 91% yield. White solid; mp: 
163164 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.03 (t, 
2H, J = 7.2 Hz, CH2CH3), 1.53 (s, 9H, OC(CH3)3), 2.55 (q, 
2H, CH2CH3), 3.94 (s, 3H, OCH3), 7.12 (t, 1H, J = 7.2 Hz, 
Ph), 7.31 (dd, J = 8.8 Hz, J = 1.2 Hz, 2H, Ph), 7.37 (t, 2H, J 
= 7.2 Hz, Ph), 7.45 (d, 2H, J = 8.8 Hz, Ph), 7.56 (d, 2H, J = 8.4 Hz, Ph), 8.07 (brs, 1H, 
NH), 10.42 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.8 (q), 23.3 (t), 28.2 
(q), 51.4 (q), 81.9 (s), 104.9 (s), 106.1 (s), 119.7 (d), 123.9 (s), 124.2 (d), 128.6 (d), 129.6 
(d), 131.4 (d), 136.0 (s), 140.1 (s), 142.1 (s), 144.0 (s), 152.1 (s), 162.7 (s), 166.7 (s); IR 
(nujol): max = 3336, 3233, 1754, 1665 cm-1; MS m/z (ESI): 559.14 (M + H+); anal. 
calcd. for C26H28BrN3O4S (558.4872): C 55.92, H 5.05, N 7.52; found: C 55.82, H 5.03, 
N 7.53. 
 
 
Methyl 4-methyl-5-((2-
isonicotinoylhydrazono)(phenyl)methyl)-2-
(phenylamino)thiophene-3-carboxylate (41r). 
41r was isolated by column chromatography on silica gel 
(acetate/cyclohexane 20:80) in 73% yield. White solid; mp: 
162165 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.06-
1.09 (m, 3H, CH2CH3), 2.51-2.71 (m, 2H, CH2CH3), 3.94 
(s, 3H, OCH3), 7.13 (t, 1H, J = 7.2 Hz, Ar), 7.33-7.43 (m, 
7H, Ar), 7.53-7.59 (m, 2H, Ar), 7.79-7.82 (m, 2H, Ar), 7.66-8.90 (m, 2H, Ar), 9.22 and 
9.51 (2brs, 1H, NH), 10.40 and 10.47 (2brs, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 
°C): δ = 14.9 (q), 15.1 (q), 23.4 (t), 23.4 (t), 51.1 (q), 51.3 (q), 51.4 (q), 104.2 (s), 104.9 
(s), 106.0 (s), 119.7 (d), 120.0 (d), 120.1 (s), 120.8 (s), 123.7 (s), 124.4 (d), 127.2 (d), 
127.9 (d), 128.4 (d), 128.5 (d), 129.6 (d), 130.0 (d), 130.2 (d), 130.6 (s), 136.2 (s), 139.9 
(s), 140.1 (s), 144.6 (s), 145.4 (s), 149.3 (s), 149.6 (s), 150.7 (s), 161.2 (s), 162.9 (s), 
163.1 (s), 166.5 (s), 167.6 (s); IR (nujol): max = 3226, 3161, 1692, 1650 cm-1; MS m/z 
(ESI): 485.04 (M + H+); anal. calcd. for C27H24N4O3S (484.5695): C 66.92, H 4.99, N 
11.56; found: C 67.05, H 5.03, N 11.43. 
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General Procedure for the synthesis of 2-(phenylamino)-5-(1,2,3-thiadiazol-4-
yl)thiophene-3-carboxylates (ATTs) 43a-d starting from 2-arylamino 5-hydrazono 
thiophene-3-carboxylates (AHTs) 41a-c,g. 
To a solution of 2-arylamino 5-hydrazono thiophene-3-carboxylates (AHTs) 41a-c,g. 
(0.5 mmol) in CH2Cl2 (4.0 mL) thionyl chloride (5.0 mmol) were added and the reaction 
mixture was softly stirred at room temperature. At the disappearance of the starting 2-
arylamino 5-hydrazono thiophene-3-carboxylates (AHTs) 41 (1.0-1.5 h monitored by 
TLC) 
the crude was neutralized by adding saturated aqueous solution of sodium hydrogen carbonate 
until pH ~ 7 and then extracted with fresh CH2Cl2 (5.0 mL x 3). The organic layer was washed 
with water and dried on sodium sulphate. The reaction solvent was evaporated under reduced 
pressure and the desired 2-(phenylamino)-5-(1,2,3-thiadiazol-4-yl)thiophene-3-carboxylates 
(ATTs) 43a-d were purified by chromatography on silica gel column (elution mixture: 
cyclohexane: ethyl acetate). 
 
Methyl 4-methyl-2-(phenylamino)-5-(1,2,3-thiadiazol-4-
yl)thiophene-3-carboxylate 43a. 
43a was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 63% yield. Pale brown solid; mp: 
120121 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 2.60 (s, 3H, 
CH3), 3.94 (s, 3H, OCH3), 7.12-7.15 (m, 1H, Ph), 7.37-7.42 (m, 4H, Ph), 8.38 (s, 1H, SCH), 
10.42 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 16.5 (q), 51.3 (q), 108.2 (s), 
109.5 (s), 119.6 (d), 123.9 (d), 129.3 (d), 129.6 (d), 133.6 (s), 140.3 (s), 156.7 (s), 160.6 (s), 
167.2 (s); IR (nujol): max = 3109, 1668 cm-1; MS m/z (ESI): 33.97 (M + H+); anal. calcd. for 
C15H13N3O2S2 (331.4126): C 54.36, H 3.95, N 12.68; found: C 54.47, H 3.97, N 12.82.  
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Ethyl 4-methyl-2-(phenylamino)-5-(1,2,3-thiadiazol-4-
yl)thiophene-3-carboxylate 43b. 
43b was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 57% yield. Pale brown solid; mp: 
99102 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.44 (t, 3H, J 
= 7.2 Hz, OCH2CH3), 2.61 (s, 3H, CH3), 4.40 (q, 2H, J = 7.2 Hz, OCH2CH3), 7.09-7.14 (m, 
1H, Ph), 7.36-7.42 (m, 4H, Ph), 8.37 (s, 1H, SCH), 10.45 (s, 1H, NH); 13C NMR (100 MHz, 
CDCl3, 25 °C): δ = 14.4 (q), 16.5 (q), 60.3 (q), 108.3 (s), 109.5 (s), 119.5 (d), 123.8 (d), 129.2 
(d), 129.6 (d), 135.6 (s), 140.3 (s), 156.7 (s), 160.4 (s), 166.8 (s); IR (nujol): max = 3115, 
1654 cm-1; MS m/z (ESI): 346.01 (M + H+); anal. calcd. for C16H15N3O2S2 (345.4392): C 
55.63, H 4.38, N 12.16; found: C 55.51, H 4.36, N 12.27.  
Ethyl 4-ethyl-2-(phenylamino)-5-(1,2,3-thiadiazol-4-
yl)thiophene-3-carboxylate 43c. 
43c was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 60% yield. Pale brown solid; mp: 
105107 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.32 (t, 3H, J 
= 7.6 Hz, CH2CH3), 1.45 (t, 3H, J = 7.2 Hz, OCH2CH3), 3.08 (q, 
2H, J = 7.6 Hz, CH2CH3), 4.42 (q, 2H, J = 7.2 Hz, OCH2CH3), 7.10-7.17 (m, 1H, Ph), 7.34-
7.42 (m, 4H, Ph), 8.36 (s, 1H, SCH), 10.50 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): 
δ = 14.2 (q), 14.5 (q), 22.8 (t), 60.3 (t), 107.4 (s), 109.3 (s), 119.6 (d), 123.9 (d), 128.5 (d), 129.6 
(d), 140.4 (s), 142.0 (s), 156.5 (s), 161.0 (s), 166.6 (s); IR (nujol): max = 3114, 1647 cm-1; MS 
m/z (ESI): 360.16 (M + H+); anal. calcd. for C17H17N3O2S2 (359.4658): C 56.80, H 4.77, N 
11.69; found: C 56.96, H 4.79, N 11.59.  
Methyl -2-((4-chlorophenyl)amino)-4-ethyl-5-(1,2,3-thiadiazol-
4-yl)thiophene-3-carboxylate 43d. 
43d was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 63% yield. Pale brown solid; mp: 
120124 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.30 (t, 3H, J 
= 7.6 Hz, CH2CH3), 3.06 (q, 2H, J = 7.6 Hz, CH2CH3), 3.95 (s, 3H, 
OCH3), 7.30-7.37 (m, 4H, Ph), 8.37 (s, 1H, SCH), 10.45 (s, 1H, NH); 
13C NMR (100 MHz, 
CDCl3, 25 °C): δ = 14.4 (q), 22.8 (t), 51.4 (q), 107.7 (s), 109.7 (s), 120.9 (d), 128.7 (d), 128.9 
(s), 129.6 (d), 138.9 (s), 142.0 (s), 156.3 (s), 160.6 (s), 167.0 (s); IR (nujol): max = 3180, 1686 
cm-1; MS m/z (ESI): 380.43 (M + H+); anal. calcd. for C16H14ClN3O2S2 (379.8843): C 50.59, H 
3.71, N 11.06; found: C 50.68, H 3.70, N 11.00.   
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General Procedure for the synthesis of 2-(phenylamino)-5-(1,2,3-thiadiazol-4-
yl)thiophene-3-carboxylates (ATTs) 43e-h starting from 2-arylamino 5-hydrazono 
thiophene-3-carboxylates (AHTs) 41a,b,d,f. 
To a solution of 2-arylamino 5-hydrazono thiophene-3-carboxylates (AHTs) 41a,b,d,f. 
(0.5 mmol) in CH2Cl2 (4.0 mL) thionyl chloride (5.0 mmol) were added and the reaction 
mixture was softly stirred at room temperature. At the disappearance of the starting 2-
arylamino 5-hydrazono thiophene-3-carboxylates (AHTs) 41 (15 h – 18h  monitored by 
TLC). Then, the crude was neutralized by adding saturated aqueous solution of sodium 
hydrogen carbonate until pH ~ 7 and then extracted with fresh CH2Cl2 (5.0 mL x 3). The 
organic layer was washed with water and dried on sodium sulphate. The reaction solvent was 
evaporated under reduced pressure and the desired 2-(phenylamino)-5-(1,2,3-thiadiazol-4-
yl)thiophene-3-carboxylates (ATTs) 43e-h were purified by chromatography on silica gel 
column (elution mixture: cyclohexane: ethyl acetate). 
 
Ethyl 4-(chloromethyl)-2-(phenylamino)-5-(1,2,3-thiadiazol-4-
yl)thiophene-3-carboxylate 43e. 
43e was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 56% yield. Dark green solid; mp: 
9898 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.49 (t, 3H, J = 
7.2 Hz, OCH2CH3), 4.46 (q, 2H, J = 7.2 Hz, OCH2CH3), 5.06 (s, 2H, CH2Cl), 7.16 (t, 1H, J = 
7.2 Hz, Ph), 7.36-7.44 (m, 4H, Ph), 8.79 (s, 1H, SCH), 10.40 (s, 1H, NH); 13C NMR (100 MHz, 
CDCl3, 25 °C): δ = 14.2 (q), 39.6 (t), 60.8 (t), 106.0 (s), 114.5 (s), 120.0 (d), 124.5 (d), 129.7 
(d), 130.9 (d), 133.5 (s), 140.0 (s), 155.0 (s), 161.2 (s), 165.9 (s); IR (nujol): max = 3193, 1661 
cm-1; MS m/z (ESI): 380.49 (M + H+); anal. calcd. for C16H14ClN3O2S2 (379.8843): C 50.59, H 
3.71, N 11.06; found: C 50.72, H 3.76, N 10.92.  
 
Methyl 4-(chloromethyl)-2-(phenylamino)-5-(1,2,3-thiadiazol-4-yl)thiophene-3-
carboxylate 43f. 
43f was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 58% yield. Dark green solid; mp: 
9798 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ =  4.00 (s, 3H, 
OCH3), 5.00 (s, 2H, CH2Cl), 7.18 (t, 1H, J = 6.8 Hz, Ph), 7.37-7.44 
(m, 4H, Ph), 8.79 (s, 1H, SCH), 10.34 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 
14.2 (q), 14.4 (q), 38.9 (t), 39.4 (t), 60.9 (t), 61.0 (t), 106.5 (s), 106.6 (s), 113.9 (s), 114.9 (s), 
121.0 (d), 121.0 (d), 129.3 (s),  
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129.4 (s), 129.7 (d), 129.7 (d), 131.0 (d), 131.6 (d), 132.0 (s), 133.5 (s), 138.6 (s), 154.8 (s), 
154.9(s), 160.6 (s), 160.7 (s), 165.8 (s), 165.8 (s) IR (nujol): max = 3154, 1675 cm-1; MS m/z 
(ESI): 366.26 (M + H+); anal. calcd. for C15H12ClN3O2S2 (365.8577): C 49.24, H 3.31, N 11.49; 
found: C 49.11, H 3.27, N 11.57.  
 
Benzyl 4-(chloromethyl)-2-(phenylamino)-5-(1,2,3-
thiadiazol-4-yl)thiophene-3-carboxylate 43g. 
43g was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 62% yield. Dark green solid; mp: 
116121 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 4.97 (s, 
2H, OCH2Ph), 5.44 (s, 2H, CH2Cl), 7.17 (t, 1H, J = 7.2 Hz, Ph), 
7.34-7.45 (m, 7H, Ph),7.55 (d, 2H, J = 6.8 Hz, Ph), 8.78 (s, 1H, SCH), 10.35 (s, 1H, NH); 13C 
NMR (100 MHz, CDCl3, 25 °C): δ = 39.5 (t), 66.7 (t), 105.6 (s), 114.6 (s), 120.1 (d), 124.6 (d), 
128.4 (d), 128.4 (d), 128.7 (d), 129.7 (d), 130.9 (d), 133.5 (s), 135.7 (s), 139.9 (s), 154.9 (s), 
161.5 (s), 165.5 (s); IR (nujol): max = 3128, 1654 cm-1; MS m/z (ESI): 442.58 (M + H+); anal. 
calcd. for C21H16ClN3O2S2 (441.9536): C 57.07, H 3.65, N 9.51; found: C 57.21, H 3.68, N 
9.42.  
 
Ethyl 4-(chloromethyl)-2-((4-chlorophenyl)amino)-5-(1,2,3-
thiadiazol-4-yl)thiophene-3-carboxylate 43h. 
43h was isolated by column chromatography on silica gel 
(acetate/cyclohexane) in 64% yield. Dark green solid; mp: 
101103 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.46-1.50 (m, 
3H, OCH2CH3), 4.42-4.47 (m, 2H, OCH2CH3), 4.72 and 4.98 (2s, 
2H, CH2Cl), 7.28-7.31 (m, 2H, Ph), 7.34-7.37 (m, 2H, Ph), 8.79 and 8.84 (2s, 1H, SCH), 10.42 
(s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.2 (q), 14.4 (q), 38.9 (t), 39.4 (t), 60.9 
(t), 61.0 (t), 106.5 (s), 106.6 (s), 113.9 (s), 114.9 (s), 121.0 (d), 121.0 (d), 129.3 (s), 129.4 (s), 
129.7 (d), 129.7 (d), 131.0 (d), 131.6 (d), 132.0 (s), 133.5 (s), 138.6 (s), 154.8 (s), 154.9(s), 
160.6 (s), 160.7 (s), 165.8 (s), 165.8 (s) IR (nujol): max = 3119, 1657 cm-1; MS m/z (ESI): 
415.88 (M + H+); anal. calcd. for C16H13Cl2N3O2S2 (414.3293): C 46.38, H 3.16, N 10.14; 
found: C 46.25, H 3.19, N 10.05.   
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CHAPTER 5 
Experimental Section 
All chemicals and solvents were purchased from commercial suppliers and used as received. 
1,2-Diaza-1,3-dienes were prepared as reported[99] and used as EE/EZ isomer mixtures. Melting 
points were determined in open capillary tubes and are uncorrected. FTIR spectra were obtained 
as Nujol mulls. All 1H NMR and 13C NMR spectra were recorded at 400 and 100 MHz, 
respectively. Proton and carbon spectra were referenced internally to solvent signals, using 
values of  = 7.26 ppm for proton and  = 77.00 ppm for carbon (middle peak) in CDCl3. 
Precoated silica gel plates 0.25 mm were employed for analytical thin layer chromatography. 
All new compounds showed satisfactory elemental analysis. Mass spectra were recorded in the 
EI mode (70eV). The nomenclature was generated using ACD/IUPAC Name (version 3.50, 5 
Apr. 1998), Advanced Chemistry Development Inc., Toronto, ON (Canada). 
General Procedure for the Synthesis of the γ-adduct 3as. 
To a magnetically stirred solution of tetrahydropyridazine 18 (0.1 mmol 1.0 eq) in DCM (2 mL) 
at room temperature, a nucleophile 44a-i  (0.1 eq), and BF3(OEt)2 (1.2 eq) as promoter, was 
added consequentially. After the disappearance of the reagents (0.10.5 h) (TLC monitoring), 
the reaction solvent was evaporated under reduced pressure and the crude mixture was purified 
by column chromatography on silica gel (ethyl acetate/cyclohexane mixtures) to afford the 
corresponding adduct. 
 
hyl 5-(but-3-enyl)-3-phenylpyridazine-1(4H)-carboxylate (45a): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 1:9) in 80% yield. oil; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 1.40 (t, 3H, OCH2CH3), 2.172.21 (m, 2H 
CH2CH2CH=CH2), 2.252.31 (m, 2H CH2CH2CH=CH2), 3.17 (s, 2H, 
CCH2C), 4.344.40 (q, 2H, OCH2CH3), 4.995.10 (m, 2H, CH2CH2CH=CH2), 5.785.88 (m, 
1H, CH2CH2CH=CH2), 6.99 (s, 1H, NCH), 7.407.42 (m, 3H, Ph), 7.827.84 (m, 2H, Ph); 13C 
NMR (100 MHz, CDCl3, 25 °C): δ = 14.5 (q), 26.3 (t), 30.7 (t), 33.3 (t), 62.9 (t), 113.7 (s), 
116.0 (t), 117.6 (s), 125.9 (d), 128.3 (d), 129.8 (d), 136.4 (s), 137.4 (d), 146.5 (s), 152.6 (s); IR 
(nujol): max = 1697 cm-1; MS m/z (ESI): 285.03 (M + H+); anal. calcd. for C17H20N2O2 (284,35): 
C 71.81, H 7.09, N 9.85; found: C 71.68, H 5.05, N 9.96. 
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Methyl 5-(but-3-en-1-yl)-3-phenylpyridazine-1(4H)-carboxylate 
(45b): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 1:9) in 69% yield. oil; 1H NMR (400 MHz, 
CDCl3, 25 °C δ = 2.172.21 (m, 2H CH2CH2CH=CH2), 2.252.31 (m, 
2H CH2CH2CH=CH2), 3.17 (s, 2H, CCH2C), 3.92 (s, 3H, OCH3), 4.995.10 (4m, 2H, 
CH2CH2CH=CH2), 5.775.87 (m, 1H, CH2CH2CH=CH2), 7.00 (s, 1H, NCH), 7.407.41 (m, 
3H, Ph), 7.817.83 (m, 2H, Ph); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 26.5 (t), 30.7 (t), 33.3 
(t), 53.8 (q), 113.9 (s), 115.4 (t), 117.6 (s), 126.0 (d), 128.4 (d), 129.9 (d), 136.4 (s), 137.4 (d), 
146.4 (s), 152.6 (s); IR (nujol): max = 1717 cm-1; MS m/z (ESI): 271.01 (M + H+); anal. calcd. 
for C16H18N2O2 (270,33): C, 71.09; H, 6.71; N, 10.36; found: C, 71.22; H, 6.64; N, 10.25;  
 
 
Ethyl 3-(4-bromophenyl)-5-(but-3-en-1-yl)pyridazine-1(4H)-
carboxylate (45c): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 1:9) in 75% yield. oil; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 1.38 (t, 3H, OCH2CH3), 2.162.20 (m, 2H 
CH2CH2CH=CH2), 2.242.28 (m, 2H CH2CH2CH=CH2), 3.13 (s, 2H, CCH2C), 4.344.40 (q, 
2H, OCH2CH3), 5.005.09 (4m, 2H, CH2CH2CH=CH2), 5.785.84 (m, 1H, CH2CH2CH=CH2), 
6.98 (s, 1H, NCH), 7.54 (d, 2H, PhBr), 7.70 (d, 2H, PhBr); 13C NMR (100 MHz, CDCl3, 25 
°C): δ = 14.5 (q), 26.2 (t), 30.6 (t), 33.3 (t), 63.0 (t), 113.6 (s), 115.4 (t), 117.6 (s), 124.1 (d), 
127.5 (d), 131.5 (s), 135.3 (s), 137.4 (d), 144.8 (s), 152.6 (s); IR (nujol): max = 1723 cm-1; MS 
m/z (ESI): 363.89 (M + H+); anal. calcd. for C17H19BrN2O2 (363,25): C, 56.21; H, 5.27; Br, 
22.00; N, 7.71; found: C, 56.36; H, 5.19; Br, 22.05; N, 7.63  
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Ethyl 5-(but-3-enyl)-3-(4-nitrophenyl)pyridazine-1(4H)-
carboxylate (45d): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 1:9) in 79% yield. oil; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 1.40 (t, 3H, OCH2CH3), 2.182.22 (m, 2H 
CH2CH2CH=CH2), 2.262.35 (m, 2H CH2CH2CH=CH2), 3.19 (s, 2H, CCH2C), 4.364.40 (q, 
2H, OCH2CH3), 5.015.10 (4m, 2H, CH2CH2CH=CH2), 5.815.83 (m, 1H, CH2CH2CH=CH2), 
6.99 (s, 1H, NCH), 7.98 (d, 2H, PhNO2), 8.25 (d, 2H, Ph NO2); 
13C NMR (100 MHz, CDCl3, 
25 °C): δ = 14.5 (q), 26.2 (t), 30.5 (t), 33.2 (t), 63.3 (t), 114.0 (s), 115.6 (t), 117.5 (s), 123.6 (d), 
126.7 (d), 136.4 (s), 137.2 (d), 142.3 (s), 148.3 (s), 152.0 (s); IR (nujol): max = 1689cm-1; MS 
m/z (ESI): 330.96 (M + H+); anal. calcd. for C17H19N3O4 (329,35): C, 62.00; H, 5.81; N, 12.76; 
found: C, 62.14; H, 5.85; N, 12.66 
   
 
3-Ethyl 1-methyl 5-(but-3-en-1-yl)pyridazine-1,3(4H)-dicarboxylate 
(45e): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 1:9) in 26% yield. oil; 1H NMR (400 MHz, CDCl3, 
25 °C δ = 1.38 (t, 3H OCH2CH3), 2.102.14 (m, 2H CH2CH2CH=CH2), 
2.202.23 (m, 2H CH2CH2CH=CH2), 3.04 (s, 2H, CCH2C), 3.91 (s, 3H, OCH3), 4.334.37 (q, 
2H OCH2CH3) 5.015.07 (4m, 2H, CH2CH2CH=CH2), 5.745.81 (m, 1H, CH2CH2CH=CH2), 
6.85 (s, 1H, NCH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.1 (q), 25.3 (t), 30.3 (t), 33.0 (t), 
54.4 (q), 62.2 (t), 115.6 (s), 116.1 (t), 117.0 (s), 137.4 (d), 139.8 (s), 152.4 (s) 164.0 (s); IR 
(nujol): max = 1756, 1723 cm-1; MS m/z (ESI): 266.91 (M + H+); anal. calcd. for C13H18N2O4 
(266,29): C, 58.63; H, 6.81; N, 10.52; found: C, 58.74; H, 6.75; N, 10.59;  
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Ethyl 5-(but-3-enyl)-1-(phenylcarbamoyl)-1,4-
dihydropyridazine-3-carboxylate (45f): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 1:9) in 31% yield. oil; 1H NMR (400 
MHz, CDCl3, 25 °C δ = 1.39 (t, 3H OCH2CH3), 2.122.16 (m, 
2H CH2CH2CH=CH2), 2.222.27 (m, 2H CH2CH2CH=CH2), 3.11 (s, 2H, CCH2C), 4..38 
(q, 2H OCH2CH3) 4.995.09 (4m, 2H, CH2CH2CH=CH2), 5.795.80 (m, 1H, 
CH2CH2CH=CH2), 7.087.12 (m, 2H, NCH and NHph), 7.317.35 (m, 2H, NHph), 7.517.53 
(m, 2H, NHph), 8.62 (s, H, NHph);13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.2 (q), 25.5 (t), 
30.2 (t), 33.2 (t), 61.9 (t), 114.9 (s), 115.4 (t), 115.5 (s), 119.7 (d), 123.8 (s), 129.0 (d), 136.6 
(s), 137.2 (d), 137.5 (s), 149.6 (s) 163.7 (s); IR (nujol): max = 3266, 1669, 1624 cm-1; MS m/z 
(ESI): 328.01 (M + H+); anal. calcd. for C18H21N3O3 (327,38): C, 66.04; H, 6.47; N, 12.84; 
found: C, 66.19; H, 6.41; N, 12.76  
 
 
Ethyl 3-(4-bromophenyl)-5-(2,2-dimethyl-3-
oxopropyl)pyridazine-1(4H)-carboxylate (45g): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 1:9) in 65% yield. oil; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 1.12 (s, 6H CH2C(CH3)2COH) 1.39 (t, 3H, 
OCH2CH3), 2.32 (s, 2H CH2C(CH3)2COH), 3.01 (s, 2H, CCH2C), 4.344.39 (q, 2H, 
OCH2CH3), 6.98 (s, 1H, NCH), 7.52 (d, 2H, PhBr), 7.64 (d, 2H, PhBr), 9.58 (s, 1H 
CH2C(CH3)2COH); 
13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.5 (q), 22.1 (q), 27.6 (t), 41.6 
(t), 46.2 (s), 63.2 (t), 110.2 (s), 120.4 (s), 120.7 (d), 124.4 (s), 127.6 (d), 131.6 (d), 135.0 (s), 
139.4 (s), 144.9 (s), 205.6 (d); IR (nujol): max = 1742, 1620 cm-1; MS m/z (ESI): 538.69 (M + 
H+); anal. calcd. for C18H21BrN2O3 (393,27): C, 54.97; H, 5.38; Br, 20.32; N, 7.12; found: C, 
54.82; H,  
  
- 133 - 
 
Ethyl 5-(2-benzoyl-3-oxobutyl)-3-phenylpyridazine-1(4H)-
carboxylate (45h): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 1:9) in 95% yield. oil; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 1.37 (t, 3H, OCH2CH3), 2.17 (s, 3H CH3CO), 
2.81 (d, 2H CCH2CH), 3.15 (s, 2H, CCH2C), 4.314.39 (q, 2H, 
OCH2CH3), 4.70 (t, 1H, CCH2CH), 7.01 (s, 1H, NCH), 7.49 (5m, 10H, Ph and COPh); 
13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.5 (q), 26.4 (q), 28.0 (t), 33.0 (t), 61.0 (d), 63.0 (t), 
110.5 (d), 119.4 (s), 126.0 (d), 128.4 (d), 128.7 (d), 129.0 (d), 130.0 (d), 134.0 (d), 136.0 (s), 
136.1 (s), 145.9 (s), 153.9 (s), 195.4 (s), 203.0 (s); IR (nujol): max = 1751, 1744, 1692 cm-1; 
MS m/z (ESI): 405.12 (M + H+); anal. calcd. for C24H24N2O4 (404,46): C, 71.27; H, 5.98; N, 
6.93; found: C, 71.10; H, 5.92; N, 6.8575.  
 
 
Ethyl 5-(2-benzoyl-3-oxobutyl)-3-(4-
bromophenyl)pyridazine-1(4H)-carboxylate (45i): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 1:9) in 86% yield. oil; 1H NMR (400 
MHz, CDCl3, 25 °C): δ = 1.36 (t, 3H, OCH2CH3), 2.17 (s, 
3H CH3CO), 2.80 (d, 2H CCH2CH), 3.10 (s, 2H, CCH2C), 
4.304.38 (q, 2H, OCH2CH3), 4.69 (t, 1H, CCH2CH), 6.99 (s, 1H, NCH), 7.49 (3m, 9H, 
PhBr and COPh); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.5 (q), 26.2 (q), 28.0 (t), 32.9 (t), 
61.0 (d), 63.1 (t), 110.5 (d), 119.4 (s), 124.3 (d), 127.5 (d), 128.7 (d), 129.0 (d), 131.5 (d), 134.0 
(s), 134.9 (s), 136.1 (s), 144.7 (s), 152.2 (s), 195.3 (s), 202.9 (s); IR (nujol): max = 1741, 1733, 
1679 cm-1; MS m/z (ESI): 538.69 (M + H+); anal. calcd. for C24H23BrN2O4 (483,35): C, 59.64; 
H, 4.80; Br, 16.53; N, 5.80; found: C, 59.51; H, 4.75; Br, 16.62; N, 5.89.  
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Methyl 5-(2-acetyl-3-oxobutyl)-3-phenylpyridazine-
1(4H)-carboxylate (45j): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 1:9) in 42% yield. oil; 1H NMR (400 
MHz, CDCl3, 25 °C): δ = 2.14 (2s, 6H, COCH3 enol form), 
and 2.22 (2s, 6H, COCH3), 2.64 (d 2H CCH2CH ) 2.99 (s 2H 
CCH2C= enol form), 3.14 (2s, 2H, CCH2C), 3.19 (2s, 2H, CCH2C enol form), 3.92 (s, 3H, 
OCH3), 3.953.99 (m, 1H, CCH2CH), 6.89 (2s, 1H, NCH enol form)  7.01 (2s, 1H, NCH), 
7.40 and 7.80 (2m, 5H, Ph); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 23.07 (q), 
26.4 (t) 26.8 (t, enol form), 29.1 (t, enol form) 29.7 (t), 32.0 (t), 54.0 (t), 66.1 (s), 104.9 (s, enol 
form) 112.7 (d, enol form), 117.8 (s) 119.4 (s), 125.9 and 126.0 (d), 128.4 (d), 136.0 and 136.1 
(s), 145.9 (s), 153.0 (s), 191.8 (s), 202.9 (s); IR (nujol): max = 1736, 1672, 1657 cm-1; MS m/z 
(ESI): 328.88 (M + H+); anal. calcd. for C18H20N2O4 (328,36): C, 65.84; H, 6.14; N, 8.53; found: 
C, 65.71; H, 6.19; N, 8.47. 
 
 
Ethyl 5-(furan-2-ylmethyl)-3-phenylpyridazine-1(4H)-
carboxylate (45k): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 1:4) in 58% yield. oil; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 1.40 (t, 3H, OCH2CH3), 3.15 (s, 2H, CCH2C), 
3.43 (s, 2H, CCH2C4H4O), 4.354.40 (q, 2H, OCH2CH3), 6.12 
(dd, 1H, CCHCHCHO), 6.31 (dd, 1H, CCHCHCHO), 7.11 (s, 1H, NCH), 7.34 (dd, 1H, 
CCHCHCHO), 7.347.40 and 7.797.81 (2m, 5H, Ph); 13C NMR (100 MHz, CDCl3, 25 °C): δ 
= 14.5 (q), 26.0 (t), 32.9 (t), 63.0 (t), 106.9 (d), 110.4(d), 110.8 (s), 118.9 (d), 126.0 (d), 128.3 
(d), 129.8 (d), 136.4 (s), 141.8 (d), 146.5 (s), 151.6 (s), 152.6 (s); IR (nujol): max = 1673 cm-1; 
MS m/z (ESI): 311.03 (M + H+); anal. calcd. for C18H18N2O3 (310,35): C, 69.66; H, 5.85; N, 
9.03; found: C, 69.73; H, 5.81; N, 9.09. 
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Diethyl 5,5'-[furan-2,5-
diylbis(methylene)]bis(3-phenylpyridazine-
1(4H)-carboxylate) (45l): 
Isolated by column chromatography on silica gel 
(ethyl acetate/cyclohexane, 2:3) in 39% yield. oil; 
1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.39 (t, 
6H, OCH2CH3), 3.15 (s, 4H, CCH2C), 3.38 (s, 4H, CCH2C4H4O), 4.334.38 (q, 4H, OCH2CH3), 
6.03 (s, 2H, -CCHCHC), 7.09 (s, 2H, NCH), 7.377.40 and 7.777.80 (2m, 10H, Ph); 13C NMR 
(100 MHz, CDCl3, 25 °C): δ = 14.5 (q), 26.0 (t), 32.9 (t), 63.0 (t), 106.9 (d), 110.4(d), 110.8 
(s), 118.9 (d), 126.0 (d), 128.3 (d), 129.8 (d), 136.4 (s), 141.8 (d), 146.5 (s), 151.6 (s), 152.6 
(s); IR (nujol): max = 1710, 1688 cm-1; MS m/z (ESI): 553.27 (M + H+); anal. calcd. for 
C32H32N4O5 (552,62): C, 69.55; H, 5.84; N, 10.14; found: C, 69.49; H, 5.91; N, 10.08. 
 
 
Ethyl 5-((5-methylfuran-2-yl)methyl)-1-(phenylcarbamoyl)-
1,4-dihydropyridazine-3-carboxylate (45m): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 1:4) in 30 % yield. oil; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 1.38 (t, 3H, OCH2CH3), 2.25 (s, 3H, CCH3), 
3.09 (s, 2H, CCH2C), 3.31 (s, 2H, CCH2C4H3O), 4.314.36 (q, 2H, OCH2CH3), 5.87 (d, 1H, 
CCHCHCOCH3), 5.98 (d, 1H, CCHCHCOCH3), 7.10 (t, 1H NHph),7.17 (s, 1H, NCH), 
7.34and 7.52 (t,d, 4H, NHPh), 8.61 (s, 1H NHph); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 
13.6 (q),14.5 (q), 25.3 (t), 32.9 (t), 61.9 (t), 106.2 (d), 107.9 (d), 112.6 (s), 116.5 (d), 119.7 (d), 
123.9 (d), 129.0 (d), 137.0 (s), 137.4 (s), 148.7 (s), 149.6 (s), 151.5 (s), 163.6 (s); IR (nujol): 
max = 3265, 1733, 1645 cm-1; MS m/z (ESI): 368.06 (M + H+); anal. calcd. for C20H21N3O4 
(367,40): C, 65.38; H, 5.76; N, 11.44; found: C, 65.25; H, 5.74; N, 11.54. 
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Ethyl 5-((5-methylfuran-2-yl)methyl)-3-phenylpyridazine-
1(4H)-carboxylate (45n): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 1:4) in 94% yield. oil; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 1.40 (t, 3H, OCH2CH3), 2.26 (s, 3H, CCH3), 
3.15 (s, 2H, CCH2C), 3.37 (s, 2H, CCH2C4H3O), 4.354.40 (q, 2H, OCH2CH3), 5.87 (d, 1H, 
CCHCHCOCH3), 5.98 (d, 1H, CCHCHCOCH3), 7.10 (s, 1H, NCH), 7.397.40 and 7.797.82 
(2m, 5H, Ph); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 13.5 (q) 14.5 (q), 25.9 (t), 33.0 (t), 63.0 
(t), 106.1 (d), 107.6 (d), 111.1 (s), 118.8 (d), 126.0 (d), 128.3 (d), 129.8 (d), 136.3 (s), 146.2 
(d), 149.5 (s), 151.3 (s), 152.4 (s); IR (nujol): max = 1716 cm-1; MS m/z (ESI): 324.89 (M + 
H+); anal. calcd. for C19H20N2O3 (324,37): C, 70.35; H, 6.21; N, 8.64; found: C, 70.20; H, 6.25; 
N, 8.58. 
 
 
Methyl 5-[(1H-indol-3-yl)methyl]-3-phenylpyridazine-
1(4H)-carboxylate (45o): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 2:3) in 50% yield. oil; 1H NMR (400 
MHz, CDCl3, 25 °C): δ = 3.15 (s, 2H, CCH2C), 3.57 (s, 2H, 
CCH2C8H7N), 3.94 (s, 3H, OCH3), 7.03 (d, 1H, Indole), 7.137.21, (m, 3H, NCH, Indole) 
7.357.37 (m, 4H, Ph, Indole) 7.64(d, 1H, Indole) 7.737.75 (m, 2H, Ph) 8.14 (s, 1H NH 
Indole); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 26.2 (t), 30.1 (t), 53.8 (q), 111.2 (d), 111.4 
(s), 114.0 (s), 117.8 (d), 118.8 (d), 119.5 (d), 122.1 (d), 122.5 (d), 126.0 (d), 127.5 (s), 128.3 
(d), 129.8 (d), 136.3 (s), 136.4 (s), 146.9 (s), 153.3 (s); IR (nujol): max = 3241, 1698 cm-1; MS 
m/z (ESI): 346.01 (M + H+); anal. calcd. for C21H19N3O2 (345,39): C, 73.03; H, 5.54; N, 12.17; 
found: C, 73.17; H, 5.58; N, 12.10. 
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Ethyl 5-[(1H-indol-3-yl)methyl]-3-phenylpyridazine-
1(4H)-carboxylate (45p): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 2:3) in 39% yield. oil; 1H NMR (400 
MHz, CDCl3, 25 °C): δ = 1.41 (s, 3H OCH2CH3) 3.15 (s, 2H, 
CCH2C), 3.57 (s, 2H, CCH2C8H7N), 4.364.42 (q, 2H, 
OCH2CH3), 7.04 (d, 1H, Indole), 7.137.26, (2m, 3H, NCH, Indole) 7.327.38 (m, 4H, Ph, 
Indole) 7.64(d, 1H, Indole) 7.747.76 (m, 2H, Ph) 8.12 (s, 1H NH Indole); 13C NMR (100 
MHz, CDCl3, 25 °C): δ = 15.5 (q), 26.1 (t), 30.2 (t), 62.9 (t), 111.2 (d), 111.6 (s), 113.7(s), 
117.9 (d), 118.9 (d), 119.5 (d), 122.1 (d), 122.5 (d), 126.0 (d), 127.5 (s), 128.2 (d), 129.7 (d), 
136.4 (s), 136.4 (s), 146.4 (s), 152.5 (s); IR (nujol): max = 3232, 1724, cm-1; MS m/z (ESI): 
360.07 (M + H+); anal. calcd. for C22H21N3O2 (359,42): C, 73.52; H, 5.89; N, 11.69; found: C, 
73.67; H, 5.96; N, 11.74. 
 
 
4-Methoxybenyl 5-[(1H-indol-3-yl)methyl]-3-
phenylpyridazine-1(4H)-carboxylate (45r): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 2:3) in 47% yield. oil; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 3.14 (s, 2H, CCH2C), 3.55 (s, 2H, 
CCH2C8H7N), 3.81 (s, 3H, OCH3), 5.39 (s, 2H, OCH2ph), 6.90 
(dd, 2H OphO), 7.04 (d, 1H, Indole), 7.107.20, (m, 3H, NCH, 
Indole) 7.357.30 (m, 6H, Ph, OphO, Indole) 7.62(d, 1H, 
Indole) 7.737.75 (m, 2H, Ph) 8.07 (s, 1H NH Indole); 13C NMR 
(100 MHz, CDCl3, 25 °C): δ = 26.1 (t), 29.7 (t), 30.1 (t), 55.3 (q), 68.1 (t), 111.2 (d), 111.6 (s), 
113.9 (s), 117.9 (d), 118.9 (d), 119.6 (d), 122.2 (d), 122.5 (d), 126.0 (d), 127.5 (s), 128.2 (d), 
128.2 (d), 128.6 (s), 129.7 (d), 130.0 (d), 136.3 (s), 136.4 (s), 146.6 (s), 152.7 (s), 159.6 (s); IR 
(nujol): max = 3219, 1685, cm-1; MS m/z (ESI): 452.17 (M + H+); anal. calcd. for C28H25N3O3 
(451,52): C, 74.48; H, 5.58; N, 9.31; found: C, 74.31; H, 5.52; N, 9.39. 
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Ethyl 5-[(1-methyl-1H-indol-3-yl)methyl]-3-
phenylpyridazine-1(4H)-carboxylate (45q): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 2:3) in 38% yield. oil; 1H NMR (400 
MHz, CDCl3, 25 °C): δ = 1.40 (s, 3H OCH2CH3) 3.15 (s, 2H, 
CCH2C), 3.56 (s, 2H, CCH2C8H7N), 3.76 (s, 3H NCH3) 4.354.40 (q, 2H, OCH2CH3), 6.91 (s, 
1H, Indole), 7.097.31, (2m, 4H, NCH, Indole) 7.357.37 (m, 3H, Ph) 7.62(d, 1H, Indole) 
7.747.76 (m, 2H, Ph); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.6 (q), 26.1 (t), 30.1 (t), 32.7 
(q), 62.9 (t), 109.2 (d), 110.0 (s), 113.9 (s), 117.8 (d), 118.9 (d), 119.0 (d), 121.7 (d), 126.0 (d), 
127.2 (d), 127.9 (s), 128.2 (d), 129.7 (d), 136.4 (s), 137.2 (s), 146.4 (s), 152.7 (s); IR (nujol): 
max = 1732 cm-1; MS m/z (ESI): 374.10 (M + H+); anal. calcd. for C23H23N3O2 (373,45): C, 
73.97; H, 6.21; N, 11.25; found: C, 73.79; H, 6.25; N, 11.31. 
 
 
Ethyl 5-methyl-3-phenylpyridazine-1(4H)-carboxylate (45s): 
Isolated by column chromatography on silica gel (ethyl 
acetate/cyclohexane, 1:9) in 53% yield. oil; 1H NMR (400 MHz, 
CDCl3, 25 °C): δ = 1.40 (s, 3H OCH2CH3) 1.78 (s, 3H, CCH3), 3.15 (s, 
2H, CCH2C), 4.344.39 (q, 2H, OCH2CH3), 6.97 (s, 1H, NCH), 
7.407.42 (m, 3H, Ph), 7.83 (m, 2H, Ph); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 14.6 (q), 
19.8 (q), 27.9 (t), 62.9 (t), 110.7 (s), 117.2 (d), 125.9 (d), 128.3 (d), 129.8 (d), 136.4 (s), 145.9 
(s), 152.6 (s); IR (nujol): max = 1674 cm-1; MS m/z (ESI): 245.65 (M + H+); anal. calcd. for 
C14H16N2O2 (244,29): C, 68.83; H, 6.60; N, 11.47; found: C, 68.96; H, 6.65; N, 11.40. 
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CHAPTER 6 
1. General experimental details. 
All chemicals and solvents were purchased from commercial suppliers and used as received, 
with the exception of berberine chloride. In fact, commercial berberine contains ca. 15% w/w 
H2O; the anhydrous product is obtained by heating it at 50 °C under vacuum for 8 hours. 1,2-
Diaza-1,3-dienes were prepared as reported99 and used as EE/EZ isomers mixtures. Melting 
points were determined in open capillary tubes and are uncorrected. FTIR spectra were obtained 
as Nujol mulls. All 1H NMR and 13C NMR spectra were recorded at 400 and 100 MHz, 
respectively. Proton and carbon spectra were referenced internally to solvent signals, using 
values of  = 2.50 ppm for proton (middle peak) and  = 39.50 ppm for carbon (middle peak) 
in DMSO-d6 and  = 7.27 ppm for proton and  = 77.00 ppm for carbon (middle peak) in CDCl3. 
All coupling constants (J) are given in Hz. All the NH exchanged with D2O. Precoated 
aluminium oxide plates 0.25 mm were employed for analytical thin layer chromatography. All 
new compounds showed satisfactory elemental analysis. Mass spectra were recorded in the ESI 
and EI modes. The nomenclature was generated using ACD/IUPAC Name (version 3.50, 5 Apr. 
1998), Advanced Chemistry Development Inc., Toronto, ON (Canada). 
 
2. Experimental procedures and spectral data. 
General procedure for synthesis of 7,8-dihydroberberine 47. 
To a solution of berberine chloride (3.718 g, 10 mmol) in pyridine (30 mL) sodium borohydride 
(450 mg, 12 mmol) was added portion wise and the mixture was stirred at room temperature 
for 30 min. More sodium borohydride (450 mg, 12 mmol) was added and stirring was continued 
for 1 h. The reduction reaction was monitored by TLC (elution: dichloromethane-ethyl acetate-
methanol 4:4:2). The mixture was poured onto ice water. The precipitate was filtered, the 
residue washed with water and then dried under vacuum over calcium chloride to give 2.860 g 
of 7,8-DHB in about 85% yield. 
 
General procedure for synthesis of 8-acetonyl-7,8-dihydroberberine 47’. 
 To a stirred solution of berberine chloride (3.846 g, 10 mmol) in 5 N Na OH (18 mL) acetone 
(3.8 mL) was added drop wise. The stirring was continued for 2 h and then filtered and washed 
with 80% methanol to give 8-acetonyl-7,8-DHB 47’ as dark yellow crystals in about 60% yield. 
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General procedure for synthesis of fused pyrrolino-tetrahydroberberine derivatives 
49an  
A solution of 1,2-diaza-1,3-dienes 1a-n (0.5 mmol) as a mixture of EE/EZ isomers99 and 7,8-
dihydroberberines 1,2 (0.5 mmol) was stirred in acetonitrile (1.5 mL) at room temperature for 
0.25 h, until the disappearance of the reagents and the formation of compounds 49 (TLC 
monitoring). Products 49d,d’e,e’,l directly precipitated from the reaction medium, while, in 
the other cases, the solvent was evaporated under reduced pressure at 25 °C and the crude 
mixtures were then purified by column chromatography on aluminum oxide (elution with 
cyclohexane-ethyl acetate mixtures) to afford products 49a-d,f-k,m,n, that were crystallized 
by concentration under vacuum at 25 °C of the corresponding column fractions. 
 
Methyl 15-[(ethoxycarbonyl)amino]-9,10-dimethoxy-14-
methyl-5,6,12b,15-tetrahydro-8H-[1,3]dioxo[4,5-
g]pyrrolo[2’,3’:3,4]isoquino[3,2-a]isoquinoline-13-
carboxylate (49a). 
49a was isolated by column chromatography on aluminum 
oxide (acetate/cyclohexane 20:80) in 61% yield. White solid; 
mp: 120124 °C; 1H NMR (400 MHz, DMSOd6, 25 °C): δ = 1.151.26 (m, 3H, OCH2CH3), 2.12 
and 2.16 (2s, 3H, CH3), 2.182.30 and 2.552.65 (2m, 2H, C(5)H2), 2.342.43 and 2.672.78 
(2m, 2H, C(6)H2), 3.48 and 3.53 (2s, 3H, CO2CH3), 3.69 and 3.70 (2s, 3H, OCH3), 3.76 (s, 3H, 
OCH3), 3.813.88 and 4.424.46 (2m, 2H, C(8)H2), 4.004.09 (m, 2H, OCH2CH3), 4.12 and 
4.15 (2s, 1H, C(12b)H), 5.97 and 5.99 (2s, 2H,OC(2)H2O), 6.50 and 6.61 (brs and s, 1H, 
C(16)H), 6.64 and 6.84 (s and brs, 1H, C(4)H), 6.78-6.81 (m, 1H, C(11)H), 7.04 and 7.10 (2d, 
1H, J = 8.4 Hz, J = 8.4 Hz, C(12)H), 8.34, 8.84 and 8.98 (3s, 1H, NH); 13C NMR (100 MHz, 
DMSOd6, 25 °C): δ = 11.5 (CH3), 14.3 (OCH2CH3), 28.5 (C(5)), 45.7 (C(8)), 46.6 (C(6)), 49.7 
and 49.8 (C(12b)), 59.7 (CO2CH3), 55.4 (OCH3), 60.3 and 60.5 (OCH3), 60.5 and 60.7 
(OCH2CH3), 86.3 (C(15a)), 95.5 and 97.9 (C(13)), 100.9 (C(2)), 105.3 (C(16)), 107.1 (C(4)), 
109.9 and 109.9 (C(11)), 125.3 and 125.6 (C(12)), 127.7 (C(8a)), 128.3 (C(12a)), 128.8 
(C(15b)), 131.8 (C(4a)), 145.1 and 145.4 (C(9)), 146.3 (C(16a)), 146.5 and 146.7 (C(3a)), 
150.1 (C(10)), 156.6 (NCOO), 160.1 (C(14)), 165.5 and 165.6 (CCOO); IR (nujol): max = 3257, 
1749, 1686 cm-1; MS m/z (ESI): 538.19 (M + H+); anal. calcd. for C28H31N3O8 (537.5612): C 
62.56, H 5.81, N 7.82; found: C 62.74, H 5.85, N 7.64. 
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Ethyl 15-[(methoxycarbonyl)amino]-9,10-dimethoxy-14-
methyl-5,6,12b,15-tetrahydro-8H-[1,3]dioxo[4,5-
g]pyrrolo[2’,3’:3,4]isoquino[3,2-a]isoquinoline-13-
carboxylate (49b). 
49b was isolated by column chromatography on aluminum 
oxide (acetate/cyclohexane 40:60) in 83% yield 1H NMR 
(400 MHz, DMSOd6, 25 °C): δ = 1.20 (m, 3H, OCH2CH3), 2.14 and 2.18 (2s, 3H, CH3), 
2.222.25 and 2.622.72 (2m, 2H, C(5)H2), 2.382.42 and 2.682.75 (2m, 2H, C(6)H2), 3.61 
(s, 3H, OCH3), 3.70 (s, 3H, OCH3) 3.76 (s, 3H, OCH3), 3.844.90 and 4.434.47 (2m, 2H, 
C(8)H2), 3.914.04 (m, 2H, OCH2CH3), 4.13 (s, 1H, C(12b)H), 5.97 and 6.00 (2s, 2H, 
,OC(2)H2O), 6.50 and 6.60 (brs and s, 1H, C(16)H), 6.65 and 6.86 (s and brs, 1H, C(4)H), 
6.786.81 (m, 1H, C(11)H), 7.06 and 7.13 (2d, 1H, J = 8.4 Hz, J = 8.4 Hz, C(12)H), 8.38, 8.88 
and 9.07 (3s, 1H, NH); 13C NMR (100 MHz, DMSOd6, 25 °C): δ = 11.5 (CH3), 14.3 
(OCH2CH3), 28.5 (C(5)), 45.7 (C(8)), 46.6 (C(6)), 50.0 (C(12b)), 52.1 (COOCH3), 55.4 
(OCH3), 58.2 and 58.3 (OCH2CH3), 60.3 and 60.5 (OCH3), 86.3 (C(15a)), 97.9 (C(13)), 100.9 
(C(2)), 105.3 (C(16)), 107.2 (C(4)), 109. 8 (C(11)), 125.6 (C(12)), 127.7 (C(8a)), 128.2 
(C(12a)), 128.9 (C(15b)), 131.8 (C(4a)), 145.2 (C(9)), 146.3 (C(16a)), 146.7 (C(3a)), 150.2 
(C(10)), 157.2 (NCOO), 160.0 (C(14)), 165.3 (CCOO); IR (nujol): max = 3235, 1721, 1678 
cm-1; MS m/z (ESI): 538.03 (M + H+); anal. calcd. for C28H31N3O8 (537.56): C, 62.56; H, 5.81; 
N, 7.82; found: C, 62.49; H, 5.86; N, 7.88. 
  
O
O
N
O
O
NHN
O
O
O
O
1
2
3
3a
4
4a
5
6
8
8a
9
10
11
12
12a
12b
13
14
15
15a
15b
16
16a
- 142 - 
 
Benzyl 15-[(ethoxycarbonyl)amino]-9,10-dimethoxy-14-
methyl-5,6,12b,15-tetrahydro-8H-[1,3]dioxo[4,5-
g]pyrrolo[2’,3’:3,4]isoquino[3,2-a]isoquinoline-13-
carboxylate (49c).  
49c was isolated by column chromatography on aluminum 
oxide (acetate/cyclohexane 40:60) in 92% yield. White solid; 
mp: 156159 °C; 1H NMR (400 MHz, DMSOd6, 25 °C): δ = 
1.19 (t, J = 7.2 Hz, 3H, OCH2CH3), 2.14 and 2.17 (2s, 3H, 
CH3), 2.202.26 and 2.562.64 (2m, 2H, C(5)H2), 2.332.42 and 2.672.89 (2m, 2H, C(6)H2), 
3.463.58 and 4.424.46 (2m, 2H, C(8)H2), 3.69 and 3.70 (2s, 3H, OCH3), 3.76 (s, 3H, OCH3), 
3.934.01 (m, 2H, OCH2CH3), 4.16 and 4.18 (2s, 1H, C(12b)H), 4.895.24 (m, 2H, OCH2Ph), 
5.90, 5.96, and 5.98 (3s, 2H, ,OC(2)H2O), 6.52 and 6.60 (brs and s, 1H, C(16)H), 6.67 and 6.89 
(s and brs, 1H, C(4)H), 6.756.82 (m, 1H, C(11)H), 7.09 and 7.14 (2d, 1H, J = 8.0 Hz, J = 8.4 
Hz, C(12)H), 7.287.45 (m, 5H, OCH2Ph), 8.49, 9.04 and 9.24 (3s, 1H, NH); 13C NMR (100 
MHz, DMSOd6, 25 °C): δ = 11.5 (CH3), 14.2 (OCH2CH3), 28.5 (C(5)), 45.0 and 45.7 (C(8)), 
46.7 and 47.0 (C(6)), 49.1 (C(12b)), 55.4 (OCH3), 58.2 and 58.3 (OCH2CH3), 60.3 and 60.5 
(OCH3), 65.9 (OCH2Ph), 86.3 (C(15a)), 97.8 (C(13)), 100.8 and 100.9 (C(2)), 105.4 (C(16)), 
107.1 (C(4)), 109.8 (C(11)), 125.7 and 126.0 (C(12)), 127.1 and 127.4 (OCH2Ph), 127.7 and 
127.9 (OCH2Ph), 127.8 (C(8a)), 128.2 (C(12a)), 128.2 and 128.3 (OCH2Ph), 129.0 (C(15b)), 
131.8 (C(4a)), 136.6 (OCH2Ph), 145.2 and 145.4 (C(9)), 146.3 (C(16a)), 146.6 and 146.8 
(C(3a)), 150.2 (C(10)), 156.1 and 156.7 (NCOO), 159.9 (C(14)), 165.2 and 165.3 (CCOO); IR 
(nujol): max = 3281, 1758, 1725, 1665 cm-1; MS m/z (ESI): 614.22 (M + H+); anal. calcd. for 
C34H55N3O8 (613.6571): C 66.55, H 5.75, N 6.85; found: C 66.63, H 5.77, N 6.68. 
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Methyl 15-[(tert-butoxycarbonyl)amino]-9,10-
dimethoxy-14-methyl-5,6,12b,15-tetrahydro-8H-
[1,3]dioxo[4,5-g]pyrrolo[2’,3’:3,4]isoquino[3,2-
a]isoquinoline-13-carboxylate (49d). 
49d was isolated by column chromatography on 
aluminum oxide (acetate/cyclohexane 40:60) in 60% 
yield. White solid; mp: 186188 °C; 1H NMR (400 MHz, DMSOd6, 25 °C): δ = 1.20, 1.40 and 
1.46 (3s, 9H, OC(CH3)3), 2.032.26 and 2.542.67 (2m, 2H, C(5)H2), 2.12 and 2.15 (2s, 3H, 
CH3), 2.322.44 and 2.682.80 (2m, 2H, C(6)H2), 3.48 and 3.53 (2s, 3H, CO2CH3), 3.69 (s, 
3H, OCH3), 3.76 (s, 3H, OCH3), 3.813.88 and 4.444.48 (2m, 2H, C(8)H2), 4.12 and 4.18 (2s, 
1H, C(12b)H), 5.915.99 (m, 2H, OC(2)H2O), 6.50 and 6.61 (brs and s, 1H, C(16)H), 6.65 and 
6.76 (s and brs, 1H, C(4)H), 6.786.84 (m, 1H, C(11)H), 7.037.11 (m, 1H, C(12)H), 7.95, 
8.20 and 8.53 (3s, 1H, NH); 13C NMR (100 MHz, DMSOd6, 25 °C): δ = 11.4 and 11.6 (CH3), 
28.0 (OC(CH3)3), 28.6 and 28.6 (C(5)), 45.7 (C(8)), 46.6 (C(6)), 49.0 and 49.6 (C(12b)), 55.4 
and 55.4 (OCH3), 60.3 (CO2CH3), 60.5 (OCH3), 79.4 (OC(CH3)3), 86.2 (C(15a)), 95.2 and 97.8 
(C(13)), 100.7 and 100.8 (C(2)), 105.4 and 105.4 (C(16)), 107.2 (C(4)), 109.9 (C(11)), 125.2 
and 125.7 (C(12)), 127.8 (C(8a)), 128.4 (C(12a)), 128.8 (C(15b)), 131.8 (C(4a)), 145.0 (C(9)), 
146.2 (C(16a)), 146.5 and 146.7 (C(3a)), 150.0 (C(10)), 155.0 (NCOO), 160.3 (C(14)), 165.5 
and 165.6 (CCOO); IR (nujol): max = 3234, 1718, 1673 cm-1; MS m/z (ESI): 566.29 (M + H+); 
anal. calcd. for C30H35N3O8 (565.6143): C 63.70, H 6.24, N 7.43; found: C 63.58, H 6.19, N 
7.52. 
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Methyl 15-[(tert-butoxycarbonyl)amino]-9,10-
dimethoxy-14-methyl-8-(2-oxopropyl)-5,6,12b,15-
tetrahydro-8H-[1,3]dioxo[4,5-
g]pyrrolo[2’,3’:3,4]isoquino[3,2-a]isoquinoline-13-
carboxylate (49d’). 
49d’ was isolated by precipitation in 49% yield. White 
solid; mp: 166168 °C; 1H NMR (400 MHz, DMSOd6, 25 °C): δ = 1.50 (3s, 9H, OC(CH3)3), 
1.59 (s, 3H, CH2COCH3), 1.98 and 2.00 (2s, 3H, CH3), 2.36 (dd, 1H, J = 15.6 Hz, J = 3.2 Hz, 
CH2COCH3), 2.672.69 (m, 2H, C(5)H2), 3.06 (dd, 1H, J = 15.6 Hz, J = 8.0 Hz, CH2COCH3), 
3.273.41 (m, 2H, C(6)H2), 3.72 (s, 3H, CO2CH3), 3.84 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 
5.13 (s, 1H, C(12b)H), 5.30 (dd, 1H, J = 8.0 Hz, J = 3.2 Hz, C(8)H2), 5.945.96 (m, 2H, 
OC(2)H2O), 6.64 (s, 1H, C(16)H), 6.77 (d, 1H, J = 9.2 Hz, C(11)H), 7.00 (s, 1H, C(4)H), 7.17 
(d, 1H, J = 8.8 Hz, C(12)H), 7.44 (s, 1H, NH); 13C NMR (100 MHz, CDCl3, 25 °C): δ = 13.8 
(CH2COCH3), 28.2 and 28.3 (OC(CH3)3), 30.9 and 31.0 (CH3), 31.7 (C(5)), 46.9 and 47.0 
(CH2COCH3), 49.9 (C(6)), 51.9 and 52.0 (CO2CH3), 53.5 and 53.6 (C(8)), 55.0 and 55.1 
(C(12b)), 55.7 and 55.8 (OCH3), 60.6 and 60.7 (OCH3), 80.8 (OC(CH3)3), 86.6 (C(15a)), 101.0 
and 101.1 (C(2)), 102.2 (C(13)), 107.8 (C(16)), 108.8 and 108.9 (C(4)), 110.0 (C(11)), 119.3 
and 119.4 (C(12)), 125.5 (C(8a)), 125.8 (C(12a)), 126.9 (C(15b)), 132.7 (C(4a)), 139.9 (C(9)), 
142.2 (C(16a)), 145.5 (C(3a)), 147.1 (C(10)), 150.2 (NCOO), 150.8 and 152.3 (C(14)), 171.8 
(CCOO), 207.9 (CH2COCH3); IR (nujol): max = 3300, 1716, 1685 cm-1; MS (EI) m/z (%): 621 
(M+) (3), 564 (100), 508 (55), 432 (71); anal. calcd. for C33H39N3O9 (621.6776): C 63.76, H 
6.32, N 6.76; found: C 63.67, H 6.29, N 6.79. 
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Ethyl 15-[(tert-butoxycarbonyl)amino]-9,10-
dimethoxy-14-methyl-5,6,12b,15-tetrahydro-8H-
[1,3]dioxo[4,5-g]pyrrolo[2’,3’:3,4]isoquino[3,2-
a]isoquinoline-13-carboxylate (49e). 
49e was isolated by precipitation in 87% yield. White 
solid; mp: 170172 °C; 1H NMR (400 MHz, DMSOd6, 25 
°C): δ = 1.16 (t, J = 6.8 Hz, 3H, OCH2CH3), 1.20, 1.40 and 1.46 (3s, 9H, OC(CH3)3), 2.14 and 
2.18 (2s, 3H, CH3), 2.252.29 and 2.592.70 (2m, 2H, C(5)H2), 2.352.45 and 2.702.81 (2m, 
2H, C(6)H2), 3.70 (s, 3H, OCH3), 3.76 (s, 3H, OCH3), 3.813.89 and 4.444.48 (2m, 2H, 
C(8)H2), 3.914.04 (m, 2H, OCH2CH3), 4.13 and 4.19 (2s, 1H, C(12b)H), 5.94, 5.97 and 5.99 
(3s, 2H, ,OC(2)H2O), 6.52 and 6.60 (brs and s, 1H, C(16)H), 6.66 and 6.84 (s and brs, 1H, 
C(4)H), 6.786.81 (m, 1H, C(11)H), 7.06 and 7.10 (2d, 1H, J = 8.0 Hz, J = 8.4 Hz, C(12)H), 
7.87, 8.11 and 8.46 (3s, 1H, NH); 13C NMR (100 MHz, DMSOd6, 25 °C): δ = 11.4 and 11.5 
(CH3), 14.1 and 14.2 (OCH2CH3), 27.4 and 27.9 (OC(CH3)3), 28.5 and 28.6 (C(5)), 44.8 and 
45.7 (C(8)), 46.6 and 46.9 (C(6)), 49.0 (C(12b)), 55.4 (OCH3), 58.0 and 58.1 (OCH2CH3), 60.2 
and 60.4 (OCH3), 79.3 (OC(CH3)3), 86.2 (C(15a)), 95.2 and 97.7 (C(13)), 100.8 (C(2)), 105.4 
(C(16)), 107.1 (C(4)), 109.8 and 109.8 (C(11)), 125.4 and 126.0 (C(12)), 127.6 and 127.8 
(C(8a)), 128.4 and 128.4 (C(12a)), 128.8 (C(15b)), 131.8 (C(4a)), 145.0 and 145.2 (C(9)), 
145.4 and 146.2 (C(16a)), 146.5 and 146.7 (C(3a)), 150.0 and 150.1 (C(10)), 155.0 and 155.7 
(NCOO), 159.9 and 160.2 (C(14)), 165.2 and 165.2 (CCOO); IR (nujol): max = 3226, 1713, 
1667 cm-1; MS m/z (ESI): 580.21 (M + H+); anal. calcd. for C31H37N3O8 (579.6409): C 64.23, 
H 6.43, N 7.25; found: C 64.38, H 6.56, N 7.13. 
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Ethyl 15-[(tert-butoxycarbonyl)amino]-9,10-
dimethoxy-14-methyl-8-(2-oxopropyl)-5,6,12b,15-
tetrahydro-8H-[1,3]dioxo[4,5-
g]pyrrolo[2’,3’:3,4]isoquino[3,2-a]isoquinoline-13-
carboxylate (49e’). 
49e’ was isolated by precipitation in 72% yield. White 
solid; mp: 168170 °C; 1H NMR (400 MHz, CDCl3, 25 °C): δ = 1.25 (t, J = 6.4 Hz, 3H, 
OCH2CH3), 1.50 (s, 9H, OC(CH3)3), 1.61 (s, 3H, CH2COCH3), 1.99 and 2.01 (2s, 3H, CH3), 
2.242.25 (m, 1H, CH2COCH3), 2.672.69 (m, 2H, C(5)H2), 3.073.11 (m, 1H, CH2COCH3), 
3.303.40 (m, 2H, C(6)H2), 3.84 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 4.154.20 (m, 2H, 
OCH2CH3), 5.09 (s, 1H, C(12b)H), 5.295.31 (m, H, C(8)H2), 5.95 and 5.96 (2s, 2H, 
,OC(2)H2O), 6.64 (s, 1H, C(16)H), 6.76 (d, 1H, J = 9.2 Hz, C(11)H), 7.03 (s, 1H, C(4)H), 7.19 
(d, 1H, J = 8.8 Hz, C(12)H), 7.40 (s, 1H, NH); 1H NMR (400 MHz, DMSOd6, 25 °C): δ = 1.06 
(t, J = 6.8 Hz, 3H, OCH2CH3), 1.37, 1.41 and 1.43 (3s, 9H, OC(CH3)3), 1.77 and 1.81 (2s, 3H, 
CH2COCH3), 1.99 and 2.07 (2s, 3H, CH3), 2.252.29 (m, 1H, CH2COCH3), 2.542.58 and 
2.672.72 2(m, 2H, C(5)H2), 3.063.11 (m, 1H, CH2COCH3), 3.283.30 (m, 2H, C(6)H2), 3.75 
(s, 3H, OCH3), 3.76 (s, 3H, OCH3), 3.80 CH2CH3), 4.82 (s, 1H, C(12b)H), 
5.105.20 (m, 1H, C(8)H2), 5.936.04 (m, 2H, ,OC(2)H2O), 6.80 (d, 1H, J = 8.8 Hz, C(11)H), 
6.84 (s, 1H, C(16)H), 6.91 (brs, 1H, C(4)H), 7.03 (d, 1H, J = 8.8 Hz, C(12)H), 9.61 (s, 1H, NH); 
13C NMR (100 MHz, CDCl3, 25 °C): δ = 13.9 (OCH2CH3), 14.2 (CH2COCH3), 28.2 
(OC(CH3)3), 30.9 (CH3), 31.6 (C(5)), 47.0 (CH2COCH3), 49.8 (C(6)), 53.4 and 53.5 (C(8)), 
55.1 and 55.2 (C(12b)), 55.7 and 55.8 (OCH3), 60.0 (OCH3), 60.8 (OCH2CH3), 80.8 
(OC(CH3)3), 86.0 (C(15a)), 100.1 (C(2)), 101.1 (C(13)), 107.7 (C(16)), 108.8 and 108.9 (C(4)), 
110.9 (C(11)), 119.7 (C(12)), 125.6 (C(8a)), 125.8 (C(12a)), 126.9 (C(15b)), 132.6 (C(4a)), 
139.7 (C(9)), 142.2 (C(16a)), 145.5 (C(3a)), 147.1 (C(10)), 150.1 (NCOO), 150.8 and 152.5 
(C(14)), 171.2 (CCOO), 207.9 (CH2COCH3); IR (nujol): max = 3312, 1718 cm-1; MS (EI) m/z 
(%): 635 (M+) (4), 578 (100), 522 (62), 432 (75); anal. calcd. for C34H41N3O9 (635.7042): C 
64.24, H 6.50, N 6.61; found: C 64.38, H 6.54, N 6.54. 
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Tert-butyl 15-[(tert-butoxycarbonyl)amino]-9,10-dimethoxy-14-methyl -5,6,12b,15-
tetrahydro-8H-[1,3]dioxo[4,5-
g]pyrrolo[2’,3’:3,4]isoquino[3,2-a]isoquinoline-13-
carboxylate (49f). 
49f was isolated by column chromatography on alumina 
oxide (acetate/cyclohexane 20:80) in 96% yield. White 
solid; mp: 98100 °C; 1H NMR (400 MHz, DMSOd6, 25 
°C): δ = 1.21, 1,35, 1.39, 1.40 and 1,46 (5s, 18H, 2 
OC(CH3)3), 2.09 and 2.11 (2s, 3H, CH3), 2.202.33 and 2.532.60 (2m, 2H, C(5)H2), 2.372.44 
and 2.672.75 (2m, 2H, C(6)H2), 3.70 and 3.70 (2s, 3H, OCH3), 3.75 (s, 3H, OCH3), 3.793.86 
and 4.274.52 (2m, 2H, C(8)H2), 4.07 and 4.14 (2s, 1H, C(12b)H), 5.906.00 (m, 2H, 
,OC(2)H2O), 6.486.76 (m, 2H, C(16)H and C(4)H), 6.797.16 (m, 2H, C(11)H and C(12)H), 
7.87, 8.09 and 8.46 (3s, 1H, NH); 13C NMR (100 MHz, DMSOd6, 25 °C): δ = 11.4 and 11,5 
(CH3), 27.4, 27.7, 28.0 and 28.3 (2 OC(CH3)3), 28.7 (C(5)), 45.0 and 45.9 (C(8)), 46.6 and 47.0 
(C(6)), 49.0 (C(12b)), 55.4 (OCH3), 60.2 and 60.4 (OCH3), 78.1 (OC(CH3)3), 79.3 (OC(CH3)3), 
86.0 (C(15a)), 96.8 and 99.7 (C(13)), 100.9 (C(2)), 105.3 (C(16)), 107.2 (C(4)), 109.6 (C(11)), 
125.4 (C(12)), 126.1 (C(8a)), 127.8 (C(12a)), 128.6 and 128.8 (C(15b)), 132.0 (C(4a)), 145.0 
and 145.4 (C(9)), 146.2 (C(16a)), 146.5 and 146.7 (C(3a)), 150.1 and 150.2 (C(10)), 155.1 and 
155.8 (NCOO), 159.3 and 159.4 (C(14)), 165.0 (CCOO); IR (nujol): max = 3237, 1756, 1679 
cm-1; MS m/z (ESI): 608.24 (M + H+); anal. calcd. for C33H41N3O8 (607.6941): C 65.22, H 6.80, 
N 6.91; found: C 65.04, H 6.76, N 7.03. 
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Dimethyl {15-[(tert-butoxycarbonyl)amino]-9,10-
dimethoxy-14-methyl-5,6,12b,15-tetrahydro-8H-
[1,3]dioxo[4,5-g]pyrrolo[2’,3’:3,4]isoquino[3,2-
a]isoquinolin-13-yl}phosphonate (49g). 
49g was isolated by column chromatography on 
aluminum oxide (acetate/cyclohexane 40:60) in 22% 
yield. White solid; mp: 101104 °C; 1H NMR (400 MHz, DMSOd6, 25 °C): δ = 1.16 (t, J = 6.8 
Hz, 3H, OCH2CH3), 1.20, 1,40 and 1.44 (3s, 9H, OC(CH3)3), 2.06 and 2.08 (s and brs, 3H, 
CH3), 2.132.23 and 2.542.64 (2m, 2H, C(5)H2), 2.312.45 and 2.652.79 (2m, 2H, C(4)H2), 
2.92 and 2.96 (2d, 3H, J = 11.2 Hz, J = 11.6 Hz, POCH3), 3.70, (s, 3H, OCH3), 3.44 and 3.46 
(2d, 3H, J = 11.2 Hz, J = 11.2 Hz, POCH3), 3.68, (s, 3H, OCH3),3.76 (s, 3H, OCH3), 3.783.90 
and 4.414.45 (2m, 2H, C(8)H2), 3.984.07 (m, 1H, C(12b)H), 5.956.02, (m, 2H, 
,OC(2)H2O), 6.48, 6.55, 6.60 and 6.67 (2brs and 2s, 2H, C(16)H and C(4)H), 6.766.88 (m, 
2H, C(11)H and C(12)H), 7.08, 8.41 and 9.54 (brs, s, brs 1H, NH); 13C NMR (100 MHz, 
DMSOd6, 25 °C): δ = 11.9 and 12,1 (CH3), 28.0 and 28.1 (OC(CH3)3), 28.6 and 28.6 (C(5)), 
45.1 and 45.8 (C(8)), 46.7 and 47.2 (C(6)), 50.1 (2JCP = 3.9 Hz (C(12b)), 50.7 (
2JCP = 5.2 Hz 
POCH3), 50.8 (
2JCP = 4.9 Hz POCH3) 55.5 (OCH3), 60.4 and 60.6 (OCH3), 79.3 and 79.3 
(OC(CH3)3), 85.7 (C(15a)), 100.8 (C(13)), 105.6 (C(2)), 107.0 (C(16)), 109.9 (C(4)), 110.1 
(C(11)), 124.8 and 124.9 (C(12)), 127.8 (C(8a)), 128.1 and 128.1 (C(12a)), 129.1 (C(15b)), 
132.2 (C(4a)), 145.3 (C(9)), 145.7 (C(16a)), 146.3 (C(3a)), 146.5 and 146.6 (C(10)), 150.3 and 
150.4 (NCOO) 155.2 and 156.0 (C(14)); IR (nujol): max = 3268, 1751, 1698 cm-1; MS m/z 
(ESI): 616.13 (M + H+); anal. calcd. for C30H38N3O9P (615.6113): C 58.53, H 6.22, N 6.83; 
found: C 58.33, H 6.17, N 6.94. 
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Methyl 15-[(tert-butoxycarbonyl)amino]-9,10-
dimethoxy-14-propyl-5,6,12b,15-tetrahydro-8H-
[1,3]dioxo[4,5-g]pyrrolo[2’,3’:3,4]isoquino[3,2-
a]isoquinoline-13-carboxylate (49h). 
49h was isolated by column chromatography on 
aluminum oxide (acetate/cyclohexane 40:60) in 73% 
yield. White solid; mp: 98100 °C; 1H NMR (400 MHz, DMSOd6, 25 °C): δ = 0.87 (t, J = 7.2 
Hz, 3H, CH2CH2CH3), 1.101.16 (m, 2H, CH2CH2CH3), 1.20, 1.39, 1.40 and 1.47 (4s, 9H, 
OC(CH3)3), 2.082.42 and 2.492.78 (2m, 6H, C(5)H2, C(6)H2 and CH2CH2CH3 ), 3.47 and 
3.52 (2s, 3H, CO2CH3), 3.69 and 3.69 (2s, 3H, OCH3), 3.75 (s, 3H, OCH3), 3.793.94 and 
4.454.49 (2m, 2H, C(8)H2), 4.11 and 4.19 (2s, 1H, C(12b)H), 5.916.00 (m, 2H, OC(2)H2O), 
6.486.68 (m, 2H, C(16)H and C(4)H), 6.777.10 (m, 2H, C(11)H and C(12)H), 7.89, 8.22, 
8.55 and 8.60 (4s, 1H, NH); 13C NMR (100 MHz, DMSOd6, 25 °C): δ = 14.0 (CH2CH2CH3), 
14.1 (CH2CH2CH3), 20.5 (CH2CH2CH3), 27.3 and 28.0 (OC(CH3)3), 28.7 (C(5)), 44.8 (C(8)), 
46.6 (C(6)), 49.1 (C(12b)), 49.6 and 49.7 (CO2CH3), 55.4 (OCH3), 60.3 and 60.5 (OCH3), 79.3 
(OC(CH3)3), 86.4 (C(15a)), 97.5 (C(13)), 100.9 (C(2)), 105.3 (C(16)), 107.1 (C(4)), 109.8 
(C(11)), 125.4 (C(12)), 125.7 (C(8a)), 128.4 (C(12a)), 128.9 (C(15b)), 132.0 (C(4a)), 145.1 
(C(9)), 146.3 (C(16a)), 146.8 (C(3a)), 150.1 (C(10)), 155.7 (NCOO), 164.1 and 160.8 (C(14)), 
165.3 and 165.4 (CCOO); IR (nujol): max = 3271, 1749, 1732 cm-1; MS m/z (ESI): 594.22 (M 
+ H+); anal. calcd. for C32H39N3O8 (593.6675): C 64.74, H 6.62, N 7.08; found: C 64.90, H 
6.67, N 6.96. 
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Ethyl 15-[(ethoxycarbonyl)amino]-9,10-dimethoxy-
14-methyl-5,6,12b,15-tetrahydro-8H-[1,3]dioxo[4,5-
g]pyrrolo[2’,3’:3,4]isoquino[3,2-a]isoquinoline-13-
carboxylate (49i). 
49i was isolated by column chromatography on aluminum 
oxide (acetate/cyclohexane 30:70) in 62% yield. White 
solid; mp: 134136 °C; 1H NMR (400 MHz, DMSOd6, 25 
°C): δ = 1.19 (t, J = 6.8 Hz, 3H, OCH2CH3), 2.13 and 2.16 (2s, 3H, CH3), 2.182.24 and 
2.562.64 (2m, 2H, C(5)H2), 2.332.41 and 2.682.75 (2m, 2H, C(6)H2), 3.61 (s, 3H, 
CO2CH3), 3.69 (s, 3H, OCH3), 3.76 (s, 3H, OCH3), 3.813.88 and 4.414.46 (2m, 2H, C(8)H2), 
3.924.02 (m, 2H, OCH2CH3), 4.13 and 4.17 (2s, 1H, C(12b)H), 5.92, 5.97 and 5.99 (3s, 2H, 
OC(2)H2O), 6.50 and 6.60 (brs and s, 1H, C(16)H), 6.65 and 6.84 (s and brs, 1H, C(4)H), 6.78-
6.80 (m, 1H, C(11)H), 7.05 and 7.12 (2d, 1H, J = 8.4 Hz, J = 8.4 Hz, C(12)H), 8.37, 8.88 and 
9.05 (3s, 1H, NH); 13C NMR (100 MHz, DMSOd6, 25 °C): δ = 11.5 (CH3), 14.3 (OCH2CH3), 
28.5 (C(5)), 45.7 (C(8)), 46.1 (C(6)), 49.0 (C(12b)), 52.1 (CO2CH3), 55.4 (OCH3), 58.2 and 
58.3 (OCH2CH3), 60.3 and 60.5 (OCH3), 86.3 (C(15a)), 97.9 (C(13)), 100.9 (C(2)), 105.3 
(C(16)), 107.1 (C(4)), 109.8 (C(11)), 125.6 and 126.0 (C(12)), 127.7 (C(8a)), 128.2 (C(12a)), 
128.9 (C(15b)), 131.8 (C(4a)), 145.2 and 145.4 (C(9)), 146.3 (C(16a)), 146.5 and 146.8 
(C(3a)), 150.2 (C(10)), 155.2 (NCOO), 160.0 (C(14)), 165.3 (CCOO); IR (nujol): max = 3279, 
1756, 1720, cm-1; MS m/z (ESI): 538.19 (M + H+); anal. calcd. for C28H31N3O8 (537.5612): C 
62.56, H 5.81, N 7.82; found: C 62.80, H 5.87, N 7.67. 
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Methyl 15-[(anilinocarbonyl)amino]-9,10-
dimethoxy-14-methyl-5,6,12b,15-tetrahydro-8H-
[1,3]dioxo[4,5-g]pyrrolo[2’,3’:3,4]isoquino[3,2-
a]isoquinoline-13-carboxylate (49j). 
49j was isolated by column chromatography on 
aluminum oxide (acetate/cyclohexane 50:50) in 61% 
yield. White solid; mp: 130134 °C; 1H NMR (400 MHz, DMSOd6, 25 °C): δ =, 2.20 and 2.24 
(2s, 3H, CH3), 2.322.36 and 2.552.66 (2m, 2H, C(5)H2), 2.442.48 and 2.682.77 (2m, 2H, 
C(6)H2), 3.49 and 3.54 (2s, 3H, CO2CH3), 3.69  and 3. 71 (2s, 3H, OCH3), 3.77 and 3.78 (2s, 
3H, OCH3), 3.813.88 and 4.484.51 (2m, 2H, C(8)H2), 4.15 and 4.26 (2s, 1H, C(12b)H), 5.92, 
6.02,6.04 and 5.42 (4s, 2H, OC(2)H2O), 6.677.40 (C(16)H), C(4)H), C(11)H, C(12)H NHph) 
7.73 (s, 1H, NHph) 8.86 (s, 1H, NH); IR (nujol): max = 3312, 3245, 1746, 1682, cm-1; MS m/z 
(ESI): 585.27 (M + H+); anal. calcd. for C32H32N4O7 (584.62): C, 65.74; H, 5.52; N, 9.58; found: 
C, 65.59; H, 5.56; N, 9.5851.  
 
Menthol 15-[(methoxycarbonyl)amino]-9,10-dimethoxy-
14-methyl-5,6,12b,15-tetrahydro-8H-[1,3]dioxo[4,5-
g]pyrrolo[2’,3’:3,4]isoquino[3,2-a]isoquinoline-13-
carboxylate (49k). 
49k was isolated by column chromatography on aluminum 
oxide (acetate/cyclohexane 70:30) in 55% yield. White solid; 
mp: 112116 °C; 1H NMR (400 MHz, DMSOd6, 25 °C): δ = 
0.511.12(m, 14H, Menthol), 1.581.77(2m, 4H, Menthol), 
2.10, 2.15 and 2.18 (2s, 3H, CH3), 2.272.30 and 2.562.64 (2m, 2H, C(5)H2), 2.352.43 and 
2.662.75 (2m, 2H, C(6)H2), 3.61 (s, 3H, CO2CH3), 3.69 (s, 3H, OCH3), 3.74 (2s, 3H, 
OCH3), 4.13 and 4.17 (2s, 1H, C(12b)H), 4.364.68 (2m, 2H, C(8)H2), 5.91, 5.97 and 5.99 (3s, 
2H, OC(2)H2O), 6.48 (m 4H, C(16)H), C(4)H), C(11)H), C(12)H), 8.38, 8.87, 8.89 and 
9.06 (4s, 1H, NH); IR (nujol): max = 3289, 1732, 1698, cm-1; MS m/z (ESI): 648.39 (M + H+); 
anal. calcd. for C36H45N3O8 (647.76): C, 66.75; H, 7.00; N, 6.49; found: C, 66.89; H, 7.07; N, 
6.43 
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Anilino 15-[(anilinocarbonyl)amino]-9,10-
dimethoxy-14-methyl-5,6,12b,15-tetrahydro-8H-
[1,3]dioxo[4,5-g]pyrrolo[2’,3’:3,4]isoquino[3,2-
a]isoquinoline-13-carboxylate (49l). 
49l was isolated by column chromatography on 
aluminum oxide (acetate/cyclohexane 50:50) in 
61% yield. White solid; mp: 173137 °C; 1H NMR 
(400 MHz, DMSOd6, 25 °C): δ = 2.07 and 2.12 (2s, 
3H, CH3), 2.172.21 and 2.552.61 (2m, 2H, C(5)H2), 2.292.38 and 2.632.69 (2m, 2H, 
C(6)H2), 3.61 (s, 3H, CO2CH3), 3.76 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), 4.024.13 (m, 2H, 
C(8)H2), 4.45 and 4.47 (2s, 1H, C(12b)H), 5.67 and 5.97 (2s, 2H, OC(2)H2O), 6.46 7.60 (s 
and m 16H, C(16)H), C(4)H, C(11)H, C(12)H, 2NHph), 8.57 9.97 (2s, 1H, NH); IR (nujol): 
max = 3313, 3289,3279, 1731, 1719, cm-1; MS m/z (ESI): 646.27 (M + H+); anal. calcd. for 
C37H35N5O6 (645.70): C, 68.82; H, 5.46; N, 10.85; found: C, 68.75; H, 5.42; N, 10.91.  
 
Methyl 15-[(methoxycarbonyl)amino]-9,10-dimethoxy-
14-methyl-5,6,12b,15-tetrahydro-8H-[1,3]dioxo[4,5-
g]pyrrolo[2’,3’:3,4]isoquino[3,2-a]isoquinoline-13-
carboxylate (49m). 
49m was isolated by column chromatography on aluminum 
oxide (acetate/cyclohexane 70:30) in 85% yield. White solid; 
mp: 107111 °C; 1H NMR (400 MHz, DMSOd6, 25 °C):, 2.12 and 2.15 (2s, 3H, CH3), 
2.182.25 and 2.562.63 (2m, 2H, C(5)H2), 2.342.45 and 2.642.76 (2m, 2H, C(6)H2), 3.48 
and 3.53 (2s, 3H, CO2CH3), 3.60 (2s, 3H, CO2CH3), 3.69 (s, 3H, OCH3), 3.76 (s, 3H, OCH3), 
3.823.88 and 4.414.46 (2m, 2H, C(8)H2), 4.12 (brs, 1H, C(12b)H), 5.97 and 6.00 (3s, 2H, 
OC(2)H2O), 6.50 and 6.60 (brs and s, 1H, C(16)H), 6.64 and 6.83 (s and brs, 1H, C(4)H), 6.78-
6.80 (m, 1H, C(11)H), 7.04 and 7.10 (2d, 1H, J = 8.4 Hz, J = 8.4 Hz, C(12)H), 8.89 and 9.07 
(3s, 1H, NH); 13C NMR (100 MHz, DMSOd6, 25 °C): δ = 11.5 (CH3), 28.5 (C(5)), 45.7 (C(8)), 
46.6 (C(6)), 48.9 (C(12b)), 49.8 (CO2CH3), 52.1 (CO2CH3), 55.4 (OCH3), 60.3 (OCH3), 86.3 
(C(15a)), 97.8 (C(13)), 100.9 (C(2)), 105.2 (C(16)), 107.2 (C(4)), 110.0 (C(11)), 125.3 and 
125.6 (C(12)), 127.7 (C(8a)), 128.2 (C(12a)), 128.9 (C(15b)), 131.7 (C(4a)), 145.2 (C(9)), 
146.3 (C(16a)), 146.8 (C(3a)), 150.2 (C(10)), 157.2 (NCOO), 160.0 (C(14)), 165.6 (CCOO); 
IR (nujol): max = 3288, 1750, 1736, cm-1; MS m/z (ESI): 524.11 (M + H+); anal. calcd. for 
C27H29N3O8 (523.53): C, 61.94; H, 5.58; N, 8.03; found: C, 61.78; H, 5.53; N, 8.10  
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N-dimethyl 15-[( tert-butoxycarbonyl)amino]-9,10-
dimethoxy-14-methyl-5,6,12b,15-tetrahydro-8H-
[1,3]dioxo[4,5-g]pyrrolo[2’,3’:3,4]isoquino[3,2-
a]isoquinoline-13-carboxylate (49n). 
49n was isolated by column chromatography on 
aluminum oxide (acetate/cyclohexane 50:50) in 63% 
yield. White solid; mp: 145148 °C; 1H NMR (400 MHz, DMSOd6, 25 °C): δ = 1.21 and 1.23 
(2s, 6H, N(CH3)3), 1.34 and 1.39 (2s, 9H, OC(CH3)3), 2.082.15  (m, 3H, CH3), 2.242.30 and 
2.562.60 (2m, 2H, C(5)H2), 2.332.44 and 2.672.75 (2m, 2H, C(6)H2), 3.69 and 3.70 (2s, 
3H, OCH3), 3.75 and 3.77 (2s, 3H, OCH3), 3.813.87 and 4.484.52 (2m, 2H, C(8)H2), 4.07 
and 4.13 (2s, 1H, C(12b)H), 5.94, 5.97 and 6.00 (3s, 2H, OC(2)H2O), 6.477.16 (m, 4H, C(16)H, 
C(4)H, C(11)H, C(12)H), 7.87, 8.09 and 8.46 (3s, 1H, NH); 13C NMR (100 MHz, DMSOd6, 25 
°C): δ = 11.4 and 11.5 (CH3), 26.3 (OC(CH3)3), 28.0 and 28.3 (C(5)), 45.0 (C(8)), 45.8 (C(6)), 
46.5 (N(CH3)2), 47.0 (N(CH3)2) 49.0 (C(12b)), 55.4 (OCH3), 60.2 and 60.5 (OCH3), 78.1 and 
79.4 (OC(CH3)3), 86.0 (C(15a)), 97.8 (C(13)), 99.7 and 100.8 (C(2)), 105.3 (C(16)), 107.1 
(C(4)), 109.6 (C(11)), 125.3 and 126.0 (C(12)), 127.8 (C(8a)), 128.6 (C(12a)), 128.8 (C(15b)), 
132.0 (C(4a)), 145.0 (C(9)), 146.2 (C(16a)), 146.5 and 146.7 (C(3a)), 150.1 (C(10)), 155.1 and 
155.8 (NCOO), 159.4 (C(14)), 165.0 (CCOO); IR (nujol): max = 3293, 1713, 1689, cm-1; MS 
m/z (ESI): 579.22 (M + H+); anal. calcd. for C31H38N4O7 (578.66): C, 64.34; H, 6.62; N, 9.68; 
found: C, 64.59; H, 6.58; N, 9.61.  
Experimental Section 
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Oxygen Radical Absorbance Capacity (ORAC) assay. The determination of the antioxidant 
activity of the compounds 49a-n was made by the ORAC assay,100 using a Fluostar Optima 
plate reader fluorimeter (BMG Labtech, Offenburgh, Germany) equipped with a temperature-
controlled incubation chamber and automatic injection pump. Incubator temperature was set at 
37 °C. The reaction mixture for the assay was the following: 200 μL of 0.096 μM fluorescein 
sodium salt in 0.075 M sodium-phosphate buffer (pH 7.0), and 20 μL of sample or 6-hydroxy-
2,5,7,8-tetramethyl-2-carboxylic acid (Trolox). The reaction was initiated with 80 μL of 0.33 
M 2,2´-azobis(2-amidinopropane) dihydrochloride (AAPH). A calibration curve was made 
each time with the standard Trolox (500, 300, 100, 50, 25 μM). The blank was 80% acetone 
diluted 1:10 with 0.075 M sodium-phosphate buffer (pH 7.0). Samples were dissolved in 80% 
acetone (1 mg/ml) and diluted 1:10 with 0.075 M sodium-phosphate buffer (pH 7.0) before 
ORAC assay. Fluorescence was read at 485 nm ex. and 520 nm em. until complete extinction. 
ORAC values were expressed as μmol Trolox Equivalents (TE)/mmol. 
Cell culture. Human keratinocytes (NCTC-2544) were grown in RPMI 1640 medium 
supplemented with 10% fetal bovine serum, 2% L-glutamine, and 1% penicillin/streptomycin 
100 U/ml. Cells were maintained in a CO2 incubator at 37°C and 5% CO2. Cell culture 
materials and reagents were from Sigma-Aldrich (Milan, Italy). 
2′,7′-dichlorofluorescin diacetate (DCFH-DA) assay. The antioxidant properties of THB 
derivatives were analyzed in NCTC-2544 cells by DCFH-DA (Sigma-Aldrich, Milan, 
Italy)101,102. DCFH-DA is a cell-permeable non-fluorescent probe which turns to highly 
fluorescent 2′,7′-dichlorofluorescein upon oxidation. Briefly, cells (4000/well) were incubated 
in black 96-well plates with THB derivatives (30 µM) or vehicle (0.1% DMSO). After 1 and 3 
hours of incubation, test compounds were removed and DCFH-DA (5 µM) was added to each 
well for 30 min at 37°C. After excess probe removal, the basal intracellular fluorescence 
emission was recorded. Cells were then treated with hydrogen peroxide (H2O2, 100 µM) and 
fluorescence emission upon probe oxidation was monitored for 30 min. at Ex/Em 485/520 nm 
in the multiwell plate reader FluoStar Optima (BMG Labtech, Germany). Data were expressed 
as relative oxidation versus non-oxidized cells. 
Cell viability assay. The effect of THB derivatives on NCTC-2544 cell viability was analyzed 
by WST-8 reagent [2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-
tetrazolium, monosodium salt] (Sigma-Aldrich, Milan, Italy)]102,103. The assay was based on 
the cleavage of the tetrazolium salt WST-8 by cellular dehydrogenases in viable cells. Briefly, 
cells (1500/well) were incubated in clear 96-well plates with test compounds (30 µM) or vehicle 
(0.1% DMSO, untreated control). After 24, 48, and 72 hours of incubation, WST-8 was added 
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to each well, and cells were further incubated at 37°C up to 4 hours. Color development was 
monitored at 450 nm in a multiwell plate reader (Thermo Fisher Scientific, Milan, Italy).  
Statistical analysis. Antioxidant capacity (ORAC) was established by six independent 
determinations for each sample; each value was the mean ± SD. Statistical significance was 
assessed by one-way ANOVA, using PRISM 5.1 (GraphPad Software, La Jolla, USA). The 
results were considered statistically significant when p < 0.05. Data on DCFH-DA assay and 
cell viability assay were presented as mean ± standard deviation (SD) of at least three 
independent experiments and analyzed by Student’s t-test to compare treated vs. untreated cells. 
Significance level was set at p<0.05 for all analysis. 
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